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Summary 
The dissertation consists of six chapters. Chapter 1 presents 
a brief introduction on immunological markers. Chapter 2 describes 
the discovery of a previously unrecognised marker in hairy-celJ. 
leukaemia (HCL), a receptor for IgM. The rosette method used to 
reveal this receptor, and the conditions affecting rosette formation 
are described. A kinetic study of this receptor is used to provide 
a measure of membrane turnover in HCL. The distribution of the IgM 
receptor among normal and malignant haemic cells is investigated. 
Chapter 3 considers a variety of other immunological markers in HCL. 
Previous controversy in the literature concerning the presence of a 
receptor for complement on hairy cells is resolved and new information 
is provided about the presence of other markers on hairy cells. Chapter 
4 presents experiments designed to investigate conflicting evidence 
regarding the nature of the hairy cell. Monocyt:i.c properties are 
measured and weighed against features of hairy cells which align them 
with the B-lymphocyte series. 'I'he presence of intrinsic surface 
immunoglobulin (Sig) is used as evidence for the B-cell nature of HCL. 
The results obtained showing only IgG on the surface of some cases 
of HCL, and multiple heavy chain isotypes on others, provide a 
solution to the confused literature regarding the presence of Sig on 
hairy cells. Two unusual cases of immunoproliferative diseases are 
extensively investigated in Chapter 5 in order to demonstrate some of 
the problems associated with immunological n:iarker. studies. Chapter 6 
reviews the thesis and draws conclusions about the nosology of HCL. 
A possible position for HCL in schemes of B-cell differentiation is 
given. 
Several papers of unconnected work submitted during the period 
of research for the dissertation are also included for consideration 
by the Examiners. 
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CHAPTER 1 
INTRODUCTION 
Immunological markers and lymphoproliferative disorders 
l 
INTRODUCTION 
Innnunological markers and lymphoproliferative disorders 
Immunological markers have been used in the study of human 
lymphoproliferative diseases (LPD) for less than ten years, but the 
impact of these studies has led to a complete re-appraisal of 
traditional classifications of the LPD. The rapid pace of development 
and the importance of these marker studies is reflected in recent 
monographs and reviews on the subject (Greaves et al, 1974; 
Preud'homme et al, 1975; Dwyer, 1976; Siegal and Good, 1977; Cooper 
and Seligmann, 1977; Whiteside and Rowlands, 1977), and many of the 
simpler techniques are already in routine laboratory use (Rose and 
Friedman, 1976). 
The terms B cells and T cells, originally coined by Roitt et al 
(1969) by extrapolation from animal studies, are now applied, albeit 
loosely, in descriptions of most human lymphoid malignancies, and by 
surface marker studies most LPD can be classified into B-cell 
proliferations or T-cell proliferations. The commoner B-cell 
proliferations such as chronic lymphocytic leukaemia, Waldenstrom's 
macroglobulinaemia and multiple myeloma are often considered as clonal 
expansions of cells blocked at various stages of normal B-cell 
development, and surface marker analysis of the cells from these diseases 
has given rise to schemes outlining possible pathways of B cell 
differentiation (Salmon and Seligmann, 1974; Davis, 1975; Sweet et al, 
1977; Gathings et al, 1977). 
Classification of T-cell disorders such as T-derived chronic 
lymphatic leukaemia and the Sezary syndrome is less sophisticated 
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although marker studies have revealed that some T-cell proliferations 
can be classified into subpopulations of T cells (Moretta et al, 1977a; 
Worman et al, 1978). Further cell surface analysis will probably 
enable more complete classification of T-cell proliferations to be 
made, and the expression and loss of various cell markers will allow 
more precise ontogenic staging of both B- and T-cell disorders. 
The extensive study of a few patients with cells possessing 
unusual surface phenotypes has also revealed possible subsets of cells 
with markers which combine features previously thought to be restricted 
to either B or T cells (Shevach et al, 1974; Sandilands et al, 1974; 
Hsu et al, 1975; Siegal et al, 1976; Burns et al, 1977d; Toben and Smith, 
1977). It is possible, however, that such unusual phenotypes may be 
due to neoplastic changes of the leukaemic cells (Brown et al, 1974; 
Preud'homme et al, 1975) and also that the population of leukaemic 
cells under study may change its phenotype with time (Hsu et al, 1975; 
Burns et al, 1977d). Before studies of this kind are undertaken, it 
is imperative therefore that a panel of markers is used (Brown et al, 
1974; Preud'homme et al, 1975; Burns et al, 1977d); that follow up 
studies are pursued (Hsu et al, 1975; Burns et al, 1977d); and that 
careful consideration is given to various technical problems associated 
with surface marker work (Seligmann et al, 1977). 
The term immunological marker remains to be defined. The 
synonyms - immunological markers, surface markers, membrane markers 
and differentiation markers - have all been used in an approximately 
similar sense, and none is entirely satisfactory. Perhaps the most 
widely used marker in clinical immunology is the receptor for sheep 
erythrocytes found on T lymphocytes, but the title given by Coombs et al, 
(1970) to their original description of the phenomenon clearly excluded 
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involvement of an immunological process. One definition of 
immunological (Herbert and Wilkinson, 1971) is "referring to 
specific immunity ••• or to the study of immunology". This broad 
definition of immunological is preferred here because it incorporates 
all the markers used by immunologists in the study of Band T cells, 
while the terms surface and membrane exclude such useful markers as 
cytochemical stains which differentiate Band T cells (Ranki et al, 
1976; Kulenkampff et al, 1977; Higgy et al, 1977). Also, until much 
more information is gathered about the ontogeny of markers, it cannot 
be claimed that many markers are indicators of differentiation along 
a particular pathway of development. 
The terms marker, receptor, structure, antigen, have all been 
used loosely to describe cell components which help to define the 
immunological status of the cell bearing them. This multiplicity of 
terms reflects the level of knowledge of markers at present, and 
Sela (1975) has stated that "the 'receptor' reflects a range of 
ignorance" rather than a definition. Some markers are well 
characterized: for example, membrane immunoglobulin is a protein which, 
like its serum analogue, has been extensively investigated; the 
receptor for cholera toxin is the ganglioside GMI (Cuatrecasas, 1973); 
many of the oligosaccharides comprising the blood group antigens are 
known; the receptor for sheep erythrocytes present on human T cells 
is probably a glycoprotein (OWen and Fanger, 1974). Other markers 
remain ill-defined and their chemical composition is unknown. Some 
apparent markers may be chance associations caused by the hydrophobic 
nature of a particular arrangement of molecules on the cell membrane 
surface. 
From the above, it is evident that markers can function both as 
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receptors, in the sense that they receive, or bind, otherwise passive 
moieties, and as antigens. The name used depends upon whether 
a specific receptor-ligand interraction was first described and the 
membrane component subsequently isolated, or whether an antiserum was 
first raised to a membrane component later shown to possess some 
receptor function. Also, in cases where the receptor function is well 
defined and an antiserum to the putative antigen blocks receptor-ligand 
binding in an apparently specific manner, the antigen and receptor may 
not be identical membrane components. Recent work has demonstrated 
that several antisera thought to be identifying a specific receptor 
antigen were in fact blocking receptor-ligand binding by steric hindrance 
(Schirrmacher and Halloran, 1975; Woofsy et al, 1977; Galili et al, 1977; 
Gattringer and Wick, 1977). 
Any definition of a marker must also consider the question of 
specificity. When a marker functions as a receptor, for example, is 
it specifically receiving the tool being used to detect it? Since 
the binding of components is the sum of non-covalent physical forces 
dependent upon fit and charge, absolute specificity cannot be claimed 
for any receptor. The situation is analogous to that proposed by 
Burnet (1967) for antibody affinity: 11 ••• no combining site is in 
any evolutionary sense adapted to a particular antigenic determinant. 
The pattern of the combining site is there and if it happens to fit, 
in the sense that the affinity of adsorption to a given antigenic 
determinant is above a certain value, immunologically significant 
reaction will be initiated". In any event, it is difficult to imagine 
that all human T lymphocytes carry a receptor specifically designed 
to receive a determinant on sheep erythrocytes, or that a population 
of human B lymphocytes carries a receptor specific for a mouse 
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erythrocyte antigen. In these two instances the erythrocytes are 
merely the tools used to detect markers of unknown function. 
It has been suggested that recognition is not sufficient for a 
structure to be described as a receptor (Sela, 1975) and that 
recognition must be followed by another event. This may be true for 
many membrane receptors, and Greaves (1976) has provided a model 
whereby the receptor signal may be translated and communicated to the 
cell interior. However, in most cases any event consequent upon 
receptor-ligand binding remains to be elucidated. For example, most 
nucleated animal cells have receptors for plant lectins, but the 
effects of lectin-binding by lymphocytes are unique (Ling and Kay, 1975). 
Furthermore, isolated glycoproteins which specifically bind lectins 
are described as purified receptors. In this work therefore, a 
receptor is defined as a structure on, or from, a cell which binds 
the ligand used to detect it. 
Bearing in mind all the above considerations, an immunological 
marker can be defined as a particular, observable, reaction of a cell 
which is useful in defining the immunological status of that cell; 
this reaction need have no known specific function or be followed by 
another event, but it must be consistent and reproduceable under 
standard conditions. 
Although the use of immunological markers has enabled most LPD 
to be classified into B-cell, or T-cell, proliferations, this 
classification is not entirely true since there are cells from diseases 
such as acute lymphoblastic leukaemia which bear none . of the classical 
B or T markers, and others such as the Reed-Sternberg cells of 
Hodgkin's disease which remain perplexing. Hairy-cell leukaemia (HCL) 
has also proved difficult to classify. The cells from this disease 
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have a unique characteristic appearance as well as features in common 
with both B lymphocytes and monocytes (Catovsky, 1977), and a recent 
report from the World Health Organization and International Union 
of Immunological Societies (Belpomme et al, 1978) described HCL as 
unclassified in type. 
The reasons leading to confusion about the classification of 
HCL will be discussed, in detail, in each of the succeeding chapters. 
In brief, however, there are four main reasons for the continued 
debate about the nature of the hairy cells (HCs) pathognomonic of the 
disease. First, HCs possess markers generally regarded as characteristic 
of B lymphocytes but also certain characteristicsusually associated with 
monocytes (Fu et al, 1974; King et al, 1975; Catovsky, 1977), and this 
has led to HCL being placed in the B lymphocyte or the monocyte-
histiocyte series (reviewed by Catovsky, 1977). The problem here is 
to determine the relative importance of each of the markers used in 
classification, and to decide which, if any, are definitive for either 
series. 
Second, HCs possess several distinctive features which are almost 
unique to HCL (Yam et al, 1971; Katayama and Finkel, 1974; Catovsky, 
1977; Higgy et al, 1978), and this has led to the suggestion that HCL 
is derived from cells unrelated to either B lymphocytes or monocytes 
(Daniel and Flandrin, 1974; Stein and Kaiserling, 1974). The question 
to be answered is whether these distinctive features are absolutely 
restricted to HCs, and whether they are important enough in themselves 
to reclassify HCL as deriving from a distinct and separate lineage. 
The properties of the HC can vary from case to case (Burns et al, 
1973; Burns et al, 1977a), and a third reason for the confused 
literature on the subject has been dogmatic statements based on a 
7 
single case of HCL. Fourth, technical difficulties particularly 
associated with HCs may account for several conflicting reports 
concerning some of the markers present on HCs (Burns et al, 1977c; 
Catovsky, 1977). 
The work described in this dissertation was undertaken in order 
to classify the cells of HCL by means of immunological markers. Their 
position in an immunological scheme of ontogeny will be established, 
and technical problems associated with marker studies will be considered 
in detail. The results of a detailed characterization of HCL are of 
more than academic interest since HCL, although undoubtedly a distinct 
disease (Bouroncle et al, 1958; Catovsky et al, 1974b), presents problems 
of differential diagnosis (LoBuglio, 1976; Catovsky, 1977). Misdiagnosis 
of this chronic indolent form of leukaemia may have disastrous 
consequences, since the vigorous chemotherapy appropriate for certain 
other lymphoproliferative disorders may be lethal for the patient with 
HCL (Katayama and Finkel, 1974). Therefore any laboratory aid to 
the clinician is of value. The clinical criteria used to diagnose the 
patients with HCL studied are beyond the scope of this dissertation, 
but full clinical details of several patients are given in published 
papers containing some of the results of this thesis (Burns et al, 
19,77a; Cawley et al, 1978a) • 
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CHAPTER 2 
A RECEPTOR FOR IgM ON HAIRY CELLS 
Identification and characterization of the receptor 
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A RECEPTOR FOR IgM ON HAIRY CELLS 
I Identification and characterization of the receptor 
1. INTRODUCTION 
In studies designed to investigate the presence of a 
receptor for fixed C3 on the hairy cells (HCs) of hairy-cell 
leukaemia (HCL) by the rosette method of Ross et al, (1973b), it 
was observed that a number of cells formed rosettes with the IgM-
coated ox indicator erythrocytes used as a control. 
This result raised the possibility that some HCs had a receptor 
for IgM. The investigation of this possibility forms the basis of 
this chapter. 
2 . MATERIALS AND METHODS 
A series of 23 patients with HCL was studied • . All the patients 
fulfilled' the normal clinical and morphological criteria for the 
diagnosis of HCL (Bouroncle et al, 1958; Katayama and Finkel, 1974). 
In particular, the diagnosis was confirmed by the demonstration of 
the following: tartrate-resistant acid phosphatase (Li et al, 1970); 
a typical ultrastructure including the ribosome-lamellar complex 
(Katayama et al, 1972a; Daniel and Flandrin, 1974; Catovsky et al, 1974b); 
a high leucocyte alkaline phosphatase score (Katayama and Finkel, 1974; 
Hayhoe et al, 1977); and the characteristic pattern of esterase 
staining (Higgy et al, 1978). 
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Peripheral blood (PB) was obtained, on several occasions, 
from all 23 patients with HCL. In addition, the spleen of 10 patients, 
bone marrow cells from 3 patients and lymph node cells from 1 patient 
were studied. 
Heparinized peripheral blood was obtained either on the same day 
as collection or after one day in the post. After more than one day 
the blood tended to clot and the recovery and viability of leucocytes 
was decreased. 
In the initial experiments, the peripheral blood was allowed 
to settle and the huffy coat collected into Hanks' balanced salt 
solution buffered with 20 mM HEPES (HBSS). The cells were washed 
three times in HBSS and resuspended in EBSS with 0.2% bovine serum 
albumin (HBSSA) to a concentration of 2 x 106 cells/ml before testing. 
Examination of the cells obtained after Ficoll-Isopaque fractionation 
of whole blood, using the mixture made to a density of 1.077 g/ml 
(Boyum, 1968, 1976), demonstrated that HCs remained on the interface 
with virtually no loss of pathological cells. Thereafter, leukaemic 
cells were always isolated over a Ficoll-Isopaque mixture, or 
commercial lymphoprep (Nyegaard and Co., Oslo), before washing and 
resuspending in HBSSA as above. 
Cytocentrifuge preparations made from cells isolated in this 
way demonstrated that, in general, over 95% of the cell preparations 
were mononuclear cells. The proportion of morphological HCs varied 
from case to case, but esterase staining of the preparations confirmed 
the virtual absence of monocytes characteristic of the disease 
(Seshadri et al, 1976; Burns et al, 1976; Higgy et al, 1977). 
Viability of the cell suspensions was assessed by trypan-blue dye 
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exclusion and by the ability of viable cells to convert fluorescein 
diacetate (0.5 µg/ml) to fluorescein (Celeda and Rotman, 1967). In 
all cases viability was greater than 95% unless stated otherwise. 
After initial attempts to obtain viable cells from whole spleens 
processed in the laboratory had failed, the following procedure was 
found to be necessary. Immediately after its removal, the spleen 
was roughly sectioned and small pieces of tissue from different 
areas were forced through a 120 gauge stainless-steel mesh into a beaker 
containing ice-cold HBSS. The cell suspension was transported to the 
laboratory in an ice bucket (1 to 3 hours). The cells were then 
vigorously resuspended in HBSS with a pasteur pipette and washed in 
the same medium before centrifugation over Ficoll-Isopaque. The 
mononuclear cells thus isolated were washed and resuspended in HBSSA 
as for peripheral blood. 
Using the above protocol, although the cell viability was 
generally high, it was found that the numbers of splenic HCs 
expressing the IgM receptor were low. This was later attributed to 
shedding of the receptor (see Section II of this chapter), and the 
final procedure was adapted to prevent this. Foetal-calf serum at 
a final concentration of 10% was added to the transport medium and 
this, to some extent, prevented shedding of the receptor. 
Bone marrow specimens were collected into HBSS cont aining heparin 
(25 IU/ml) and either processed on the same day or after one day in 
the post. As for splenic cells, this transport medium was later 
modified by the addition of 10% foetal-calf serum. In the laboratory 
the bone marrow fragments were broken up with dissecting needles and 
forced through a 120 gauge stainless-steel mesh. Single cell suspensions 
were then processed in the same manner as peripheral blood and spleen cells. 
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2. 3 I ncli..c.a;ton c.ell..6 
Ox erythrocytes coated with IgM antibody (EA) were 
M 
prepared as follows. Primary antisera to ox erythrocytes were raised 
by immunizing rabbits intravenously with 1 ml, 2 ml and 7 ml of 10% 
washed ox erythrocytes in saline on days 1, 2 and 3 respectively 
before bleeding on day 8. Anti-ox erythrocyte IgM was isolated from 
the primary antisera by chromatography on Sephadex G200 in 0.5 M NaCl, 
O.l M Tris (pH 7.25). Fresh ox erythrocytes were washed five times in 
saline and any leucocytes present removed. The erythrocytes were 
suspended to 2% in saline (v/v) and sensitized with IgM by mixing 
with equal volumes of anti-ox erythrocyte IgM antibody and incubating 
at o0 c for 15 min. The resultant EA cells were thoroughly washed M 
and resuspended to 1% in HBSSA before use. Rosette titrations of ox 
erythrocytes sensitized with serial dilutions of IgM antibody indicated 
that a 1/10 dilution was within the plateau region, and this dilution 
was used for most studies. Higher concentrations of sensitizing IgM 
antibody tended to agglutinate the fresh, washed, ox erythrocytes. 
~ Ox erythrocytes coated with rabbit IgG antibody (EAG) were 
prepared in similar fashion. Hyperimmune rabbit antisera to ox 
erythrocytes were obtained by repeating five weeks later the course 
of injections given above for primary antisera. Rabbits were bled 
one week after the last injection and the sera were inactivated at 
0 56 C for 20 min for use as the source of anti-ox erythrocyte IgG 
antibody. EAG indicator cells were prepared from this antiserum by 
the method of Hallberg et al, (1973) by sensitizing ox erythrocytes 
with serial dilutions for 40 min at room temperature. After washing 
three times with phosphate-buffered saline, indicator cells were 
finally resuspended to 1% in HBSSA before use. Titration experiments 
14 
with EAG reagent indicated that a dilution of 1/50 was optimal for 
most sensitizing antisera. Unless otherwise stated, this dilution 
was used to prepare the indicator cells. 
Fluoresceinated (F) indicator erythrocytes for use in mixed 
resetting assays were prepared by the method of Wolf et al (1971). 
Ox erythrocytes were washed in carbonate/bicarbonate-buffered saline, 
(pH 9.3) and directly fluoresceinated by adding 0.6 ml fluorescein 
isothiocyanate (1 mg/ml) to o.2 ml of the packed cell pellet. The 
cells were gently resuspended and incubated at room temperature for 
2 h. After washing, the fluoresceinated red cells were reacted with 
IgM antibody as described above to provide FEA. 
. M 
E Spontaneous sheep erythrocyte (E)-rosette formation was used as 
a marker for T cells (Jondal et al, 1972). The method of Kaplan and 
Clark (1974) using aminoethylisothiouronium bromide (AET)-treated sheep 
erythrocytes was employed. Sheep erythrocytes were washed five times 
in physiological saline and 4 volumes of freshly prepared AET 
(0.143 M, pH 9.0) added to 1 volume of packed erythrocytes. The 
mixture was incubated at 37°c, with regular mixing, for 15 min before 
washing five times with ice-cold phosphate buffered saline (PBS). The 
washed cells were resuspended to 1% in PBS and filtered through a small 
cotton wool plug before use. 
2 • 4 Ro.o e;t;te te.o:t.6 
~ rosettes After preliminary investigations, the following 
standard procedure for EAM-rosette formation was adopted and used for 
all tests unless stated otherwise. Two drops of freshly separated 
6 leucocytes, at 2 x 10 cells/ml, were mixed with two drops of EAM 
indicator erythrocytes (at 1%) in a plastic microtube and incubated 
15 
0 
at 37 C for 10 min. The cells were then remixed by flicking the tube 
and centrifuged at 150 x g for 1 min and the tube containing the pellet 
was placed on ice for an hour or more to stabilize rosettes formed 
0 
at 37 c. In all rosette tests, the pellet was gently resuspended with 
a pasteur pipette and two drops of fluorescein diacetate (diluted lo-4 ) 
added to label live leucocytes (Ramasamy, 1974). Viable fluorescing 
cells were scored under combined phase contrast and incident u.v. 
illumination, and the percentage of rosette-forming cells was 
determined from counts of more than 200 cells. A control tube with 
unsensitized ox erythrocytes was always scored in parallel with each 
test. The morphological nature of EAM rosette-forming cells was 
confirmed by cytocentrifuging the samples and staining with Giemsa. 
~ rosettes Rosette formation with EAG erythrocytes was performed 
in exactly the same way as in the EAM test above, - except that the 
10 min incubation was omitted. 
Mixed rosettes Mixed rosettes were used to detect the presence of 
more than one receptor on the same cell (Wolf et al, 1971). Equal 
volumes of FEAM and either EAM, EAG or E erythrocytes were mixed 
and rosetted with leucocytes as described above. In scoring these 
rosettes as mixed or single in type, fluorescein diacetate was not 
used and examination was carried out under alternate phase contrast 
and u.v. illumination. Cytocentrifuge preparations made from mixed 
rosettes examined under u.v. confirmed the suspension findings. 
E rosettes The method described by Kaplan and Clark (1974) for 
E-rosette formation using AET-treated sheep erythrocytes, was employed. 
Initially, E (at 1%) and leucocytes (at 2 x 106/ml) were incubated 
0 together at 37 C for 15 min before centrifuging and incubating on ice 
as described for EAM rosettes above. The incubation step at 37°c 
l 
! 
J 
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was later found to be unnecessary and was omitted. 
2.5 Fluone-6ee.in-labe11.ed, monomeJu.e human IgM 
IgM was isolated from the serum of a patient with Waldenstrom's 
macroglobulinaemia by five cycles of euglobulin precipitation. No 
IgG was detectable by immunoelectrophoresis. The protein was 
fluoresceinated with fluorescein isothiocyanate (FITC) as follows. 
The FITC was made at a concentration of 2 mg/ml in O.l M sodium 
carbonate/bicarbonate buffer (pH 9.5) and added to the IgM as a single 
addition with stirring (16.8 moles FITC/mole IgM). Stirring was 
0 continued at room temperature for 4 hand then transferred to 4 C 
overnight. After this time the preparation was Swinney-filtered and 
excess FITC removed by chromatography on a G25 Sephadex column. A 
high F/P ratio (8.58) was obtained for maximum sensitivity. This 
preparation of fluoresceinated IgM was then monomerized by reduction 
with 1.4 mM dithiothreitol in 100 mM Tris buffer, pH 8.0 for l hat 
room temperature. The reduced IgM was alkylated with an excess of 6 mM 
iodoacetamide and dialysed overnight against PBS. Final protein 
concentration was 2.57 mg/ml. 
The morphology of freshly isolated hairy cells, and of cells 
forming various types of rosette was examined by electron microscopy. 
Isolated mononuclear cells, or bulk preparations of rosettes formed 
as described above, were fixed in suspension for 24-28 h by adding at 
least 10 ml of 1.5% glutaraldehyde in O.l M cacodylate-HCl buffer 
(pH 7.4) containing 1% sucrose (Cawley and Hayhoe, 1973). The fixed 
cells were then washed in cacodylate-HCl buffer and the final cell 
concentration adjusted to approximately 1.5 x 106 cells/ml. 
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Scanning electron microscopy (SEM) Fixed cells were collected on to 
polylysine-coated coverslips according to the modified method 
(Sanders et al, 1975) of Mazia et al (1974, 1975). This method 
involved placing a 20 µ1 drop of cell suspension on to coverslips 
previously coated with poly-L-lysine hydrobromide (Sigma) and the 
reverse side identified by a locating grid previously attached with 
epoxy resin. 
The samples were then dehydrated in a graded series of ethanol, 
critical point dried using liquid co2 (Distillers water-free; Polaron 
E3000 critical point drier), and then sputter-coated with gold (Polaron 
sputter unit ESOOO). Finally, the coverslips were examined in an 
ISI Super 3A SEM with a 45° tilt and a usual operating voltage of 
20 KV. 
Some of the technical aspects of preparing haemic cells for 
SEM are discussed by Polliack (1977). 
Transmission electron microscopy (TEM) Processing for TEM was 
carried out exactly as described by Cawley and Hayhoe (1973). The 
fixed cells were post-fixed for 1 hat room temperature in 2% osmium 
tetroxide in cacodylate-HCl (pH 7.4). The samples were then rapidly 
dehydrated in 70%, 90% and absolute alcohol and then in two changes 
of propylene oxide before infiltrating with Spurr resin and embedding 
in BEEM capsules in freshly prepared resin. 
Thin sections were cut on an LKB ultratome III with a diamond 
knife, and then mounted on clean uncoated copper 200 mesh grids (LKB). 
Double staining with alcoholic uranyl acetate (15 min) followed by 
Reynolds' lead citrate (30 min) was employed, and the sections were 
examined in an AEI EM6B electron microscope at 80 'fill. 
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A hairy-cell culture was established from the spleen of one 
patient by the method described by Karpas et al (1977). To provide 
a single cell suspension, small pieces of spleen removed aseptically 
in theatre were forced through a sterile stainless-steel gauze into 
RPMI-1640 medium supplemented with 10% foetal-calf serum and 
antibiotics (10 µg/ml streptomycin, 100 iu/ml penicillin, 1 µg/ml 
amphotericin). The cells were grown in stationary cultures in loosened 
screw-topped, 125 ml, Erlenmeyer flasks incubated at 37°c in 5% co2 • The medium was changed every fifth day by aspiration of the upper 
half of the culture fluid from each flask and its replacement with 
an equal volume of fresh medium. The cell cultures were grown for 
about 3 months before they became contaminated and lost for further 
study. The characteristics of cell growth and the full surface-marker 
characteristics of these cells will be described in detail in Chapter 3. 
However, it should be stated here that almost 100% of the cells 
consistently maintained the characteristic hairy-cell morphology and 
continued to display tartrate-resistant acid phosphatase activity. 
Also, after 2 weeks in culture, virtually no T cells were identified 
in the cell population. 
Z.8 Bloek.-lng ne.agen,t,.s 
Various whole sera, heterologous antisera and immunoglobulin 
fractions were used to block BAM-rosette formation in attempts to 
clarify the nature of the receptor. Before testing for blocking 
ability, all sera were heat inactivated at 56°c for 20 min and absorbed 
with washed, packed ox erythrocytes. 
IgM IgM was isolated by repeated cycles of euglobulin precipitation 
from several sera obtained from two patients with Waldenstrom's 
macroglobulinaemia. No IgG was detectable by immunoelectrophoresis. 
Monomerized IgM preparations were prepared by reduction of the IgM 
with 0.7 mM or 1.4 mM dithiothreitol in 100 mM Tris buffer (pH 8.0) 
for 1 hat room temperature. Free -SH groups were alkylated with a 
fourfold excess of iodoacetamide and dialyzed overnight against PBS. 
Aggregated IgM was prepared from the same sera by heat aggregation 
. 0 
at 63 C from 30 min. Fc 5µ and F(ab
1 ) 2µ fragments were prepared from 
the same IgM source by the trypsinization procedure described by 
Shimizu et al (1974). Isolated IgM was made to a concentration of 
10 mg/ml in SM urea, O.lM Tris (pH 8.0) containing 0.15M NaCl, 
O.OlM sodium azide and o.OSM cac12 • To 8 ml of the IgM was added 
1/30 weight of trypsin (2.6 mg) and the reaction was allowed to 
proceed for 2 hat 2s0 c. After this time, ovomucoid trypsin inhibitor 
(Sigma) was added to stop the reaction and the trypsinized IgM was 
dialysed overnight against PBS. The preparation was concentrated by 
negative pressure filtration using the millipore 'immersible molecular 
separator' and fractionated on a column of BioRad Al.SM. Six peaks 
were obtained as described by Shimizu et al (1974), and the peak 
corresponding to a molecular weight of 342,000 was selected as 
containing Fc5µ 
IgG Monomeric IgG was isolated from pooled normal human serum by 
chromatography on QAE-Sephadex (Joustra and Lundgren, 1969). 
Aggregated IgG was obtained from this preparation by heating for 30 min 
0 
at 63 c. Unfractionated human cord serum was also tested for 
blocking. 
Antigen-antibody complex Crude toxoplasma antigen was obtained 
by repeated cycles of freezing and thawing of the whole organism 
followed by centrifugation at 5000 x g for 10 min. The IgM fraction 
from a patient with acute toxoplasmosis was obtained by sucrose 
density gradient ultracentrifugation and titrated against the 
toxoplasma antigen to (visual) equivalence. This concentration of IgM, 
or the antigen-antibody complex diluted 1/2 (IgM-antigen), was used 
as blocking reagents. Dr. Harry Williams of Raigmore Hospital, 
Inverness, kindly supplied the toxoplasma antigen and antiserum. 
Anti-hairy cell serum (AHS) A heteroantiserum to splenic hairy cells 
was prepared in rabbits by a two-pulse method (Levey and Medawar, 
1966). Cells from the spleen of a patient with HCL were isolated 
and the mononuclear cells separated as described previously. As with 
most spleens from HCL patients, the mononuclear cell preparation 
contained over 90% hairy cells. After thorough washing, the cells 
were resuspended in sterile saline to a concentration of 1 x 107 
cells/ml, and 1 ml of the suspension was injected intravenously into 
2 rabbits. At the same time, a proportion of mononuclear cells was 
frozen down and maintained in liquid nitrogen. Two weeks later, the 
0 frozen cells were thawed rapidly at 37 c, washed in HBSS, and tested 
for viability by trypan~blue dye exclusion. The cells were 68% viable, 
therefore dead cells were removed by centrifugation over Ficoll-Isopaque 
(Hannestad et al, 1972) before resuspending in sterile saline at 
1 x 107 cells/ml for injection. The 2 rabbits were then each given 
a 1 ml booster injection of this cell suspension. The rabbits were 
bled after 10 days and 20 days, and finally exsanguinated under 
anaesthetic a week later. The sera obtained from each rabbit were 
complement inactivated by heating at 56°c for 20 min and then rendered 
specific for hairy cells by a series of exhaustive absorptions. After 
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absorptions with red blood cells, normal spleen and tonsil cells, 
T-cell Sezary cells, cells from chronic myeloid leukaemias, acute 
monocytic leukaemias (both Schilling and Naegeli types) and cells 
from a myeloproliferative state with a large number of circulating 
normoblasts, the sera were tested for specificity and staining 
properties by an immunofluorescent technique. Details of the 
properties of these sera in staining reactions will be given in 
Chapter 3. 
Anti-la-like .antigen (anti-p29,34) Monospecific rabbit heteroantiserum 
against purified B-cell associated, la-like, membrane antigen 
(p29,34) was used in blocking studies. This antiserum (Springer et al, 
1976) was the kind gift of Dr. Tim Springer of the Biological 
Laboratories, Harvard University, and its binding properties ip HCL 
will be discussed in Chapter 3. For blocking studies, the serum was 
used at a dilution of 1/50, a concentration demonstrated to stain 
specifically HCL and chronic lymphocytic leukaemia (CLL) cells, but 
not T cells. 
Anti-Ciq serum In order to investigate the possibility of Ciq on 
the hairy-cell surface binding EAM and thus acting as an IgM receptor, 
blocking of rosette formation was attempted with various dilutions 
of an anti-Ciq antiserum. The heterologous rabbit antiserum used was 
a kind gift from Dr. Ian McConnell, M.R.C. Group on Mechanisms in 
Tumour Immunity, The Medical Schooi, Cambridge. 
Chemical agents Various chemical reagents were tested for their 
effect on rosette formation. Rosette formation was carried out in the 
presence of ethylenediamine-tetraacetic acid (EDTA), 10 mM, at pH 7.0; 
puromycin at 2.5 µg/ml; sodium azide at 100 mM; and cytochalasin B. 
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The cytochalasin B was dissolved in dimethyl sulphoxide to a 
concentration of 10 mg/ml and further diluted in HBSSA to 2.5 µg/ml 
before use. The effect of pretreatment of leucocytes with papain 
was also examined. In this test leucocytes were treated with 1% 
papain for 6 min at room temperature and washed 2 times in HBSSA 
before rosette testing. 
2. 9 Bloc./uJ19 :t.eo:t..6 
In all of the blocking studies, one drop of leucocytes at 
4 x 106 cells/ml was mixed with one drop of the reagent under test. 
The mixture was incubated for 15 min at room temperature and then 
rosette tested with 2 drops of indicator cells in the usual way. As 
there is shedding of receptors, even during this short incubation 
period {see Section II, Results), a control was always incubated in 
parallel and the% inhibition calculated by comparison of the 2 
results. 
The effects of various physical treatments such as the 
concentration of indicator erythrocytes and the temperature, time and 
pH conditions used for rosette formation were also considered as 
described in the Results below. 
3. RESULTS 
3 • 1 C eU..6 n otl.mng EA M !Lo -6 et:t.eo 
Peripheral blood Initial studies revealed that a proportion of 
mononuclear cells from the PB of all the HCL cases examined formed 
rosettes with EAM. The percentage of cells forming EAM rosettes 
varied widely from patient to patient and even within any one patient 
when the study was repeated on different occasions. With further 
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understanding of the nature of expression of the receptor for EAM, 
and by carefully controlling the conditions of rosette formation 
accordingly, it was observed that the proportion of cells forming 
EAM rosettes broadly reflected the proportion of HCs in that blood 
sample. Table 2.I presents some selected, but representative, results 
from each of the 23 patients. 
As will be discussed throughout this thesis, peripheral blood 
involvement by HCs in HCL can vary from almost nil to florid 
leukaemia with almost 100% of HCs. However not all the leukaemic 
cells are particularly 'hairy' and in most patients peripheral blood 
involvement is greater than is apparent by examination of Romanowsky-
stained smears. Determination of the leukaemic involvement depends 
on combined immunological, cytochemical and ultrastructural studies 
(see Chapters 3 and 6). In Table 2.I the% HC given is an estimate 
of the true leukaemic involvement based on the above criteria. Two 
points are clear from the Table. When the proportion of non-leukaemic 
T cells is high, the% EAM rosette formation is low. This is 
particularly well illustrated by patients DC and LH whose peripheral 
involvement by HCs fell dramatically after splenectomy, and this was 
accompanied by a fall in the% EAM rosette formation. Second, under 
the conditions employed for rosette formation, at any given tine of 
testing not all hairy cells form EAM rosettes. Patients KD, MB, LS, 
LP and AB, all with very high percentages of circulating HCs, illustrate 
this point. 
Spleens The result obtained when splenic mononuclear cells from 10 
patients were tested for EA rosette formation are shown in Table 2.II. M 
The results from RH, MB and PS serve only to illustrate the 
precautions which must be taken in order to avoid receptor shedding, 
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Table 2.I EA rosette formation by peripheral blood 
leucocytes from HCL patients 
% of mononuclear cells 
Patient Date 
t EA M rosettes T cells 
KD 20. 5.76 36 44 
2. 2. 77 43 10 
18. 1. 78 66 5 
MB 4. 6.76 84 8 
PS 27. 8.76 30 48 
19. 2.77 31 42 
MH 16.10.76 23 47 
HD 29.10.76 10 40 
13. 4.78 33 60 
RH 5.11.76 20 70 
29. 4.77 5 87 
LS 26.11.76 71 10 
DC 13.12.76 64 30 
18. 5.77 24 85 
FB 21. 1. 77 43 50 
17. 6.77 55 50 
AD 25. 1. 77 65 18 
23. 1. 78 27 30 
LP 28. 1. 77 78 11 
LH 26. 2. 77 66 33 
6. 2.78 10 70 
FW 12. 3. 77 52 45 
2. 2.78 13 56 
BN 16. 6.77 37 44 
NW 17. 6.77 12 87 
RR 3. 9. 77 36 60 
HR 11.10. 77 42 19 
Hairy cellsf 
56 
90 
91 
92 
50 
58 
53 
60 
40 
30 
13 
90 
70 
15 
50 
50 
78 
40 
83 
77 
30 t 
55 
37 
56 
13 
40 
71 
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Table 2.I (continued) 
% of mononuclear cells Patient Date 
t 
cells+ EAM rosettes T cells Hairy 
AB 22.11.77 42 32 68 
23 .11. 77 56 0 98 
GH 19.12.77 30 43 47 
TN 15. 1. 78 18 30 70 
LK 18. l. 78 49 20 78 
DA 2. 3.78 38 26 70 
6. 4.78 22 51 48 
* JC 27. 4.78 15 9 90 
9. 5.78 74 <l 99 
t The percentage of T cells in the mononuclear preparation was usually the% cells forming E rosettes (Chapter 3). In some cases this was 
confirmed by the% cells staining with an anti~T cell serum, or giving the T-cell esterase pattern (Chapter 3) and in patient LH this last 
marker was used as the only measure of T cells, since this patient's hairy cells also formed E rosettes (Chapter 5). 
t The percentage of hairy cells given is that established by immunological techniques described in Chapter 4. 
* This sample of peripheral blood was obtained, through the post, as 
a leucophoresis pack. 
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and this feature of EAM rosette formation is considered in detail in 
Section II of the present chapter. The results from the other patients 
show that hairy cells can form EAM rosettes and, as will be shown in 
Section II of this chapter, this lack of receptor expression by 
splenic HCs is probably not due to technical artifact. 
Since HCs are probably produced in the bone marrow and accumulate 
in the spleen following sequestration from the PB, the possibility 
exists that HCs begin to lose their receptor for EA with ageing. A M 
more detailed study of EAM receptor expression by PB HCs following 
splenectomy would seem to substantiate this theory. Figure 2.1 illustrates 
that, following splenectomy, there is a sharp rise in the absolute 
numbers of HCs in the PB and that the absolute HC count quickly falls 
to pre-splenectomy levels. Examination of PB taken immediately before 
and after splenectomy demonstrated that this brief increase in cell 
numbers was not directly due to release of splenic cells during 
surgery, but took some hours to appear. It therefore seems that the 
sharp rise in HC numbers in the PB is caused by the appearance of HCs 
from some other extravascular site. During the time of study the 
proportion of HCs in the PB did not greatly alter, and consistently 
some 70-80% of PB mononuclear cells were HCs. The sharp fall in EAM 
receptor expression corresponding to the supposed release of 
extravascular HCs (Figure 2.1), followed by receptor reexpression a 
week later when the absolute HC count had returned to normal, suggests 
therefore that these released HCs lack the EAM receptor. Disappointingly, 
the single lymph node from one patient, and the bone marrow aspirates 
from 3 patients did not yield further information on this point, and 
further samples of biopsy material will be required. The results 
obtained from the lymph node and bone marrow specimens examined are 
Patient Date 
RH 12. 5.76 
MH 4. 6.76 
PS 19.10.76 
NW 19.12.76 
LH 12. 1. 77 
19. 1. 77 
DC 14. 1. 77 
LP 3. 2.77 
AD 2. 3.77 
HR 10.10. 77 
AB 22.11.77 
Table 2.II EA rosette_formation by splenic leucocytes from HCL patients 
% of mononuclear cells 
EAM rosettes T cells Hairy cells 
8 22 80 
0 3 97 
5 13 86 
37 16 82 
0 5 >90 
77 >90 
58 22 80 
55 18 80 
47 9 90 
35 6 91 
46 10 90 
Comments 
Poor cell viability obtained. This patient's spleen 
was transferred to the laboratory as a whole spleen 
before processing (see Methods). However, subsequent 
~B samples from this patient revealed that he may in 
fact fortuitously, have HCs of poor viability 
Processed before appreciation of receptor shedding 
(Section II) • 
Processed before appreciation of receptor shedding 
(Section II) • 
Difficult operation requiring several hours. Also, 
splenic cell suspension transported to laboratory for 
3 h in HBSSA without foetal calf serum (FCS) (See 
Methods). 
Result following 1 week of culture in RPM! 1640 + l0%FCS 
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Figure 2.1 Absolute hairy cell numbers and EA receptor expression by 
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given in Table 2.III and demonstrate only that HCs expressing the EA M 
receptor are present. 
cultured hairy cells The characteristics of the established hairy-cell 
culture will be considered in detail in Chapter 3. However, during the 
period of study (3 months) the cultured cells maintained a definite HC 
morphology and consistently displayed the cytochemical and immunological 
features of hairy cells. The cultured cells were examined for EA M 
rosette formation after 18, 29, 46 and 66 days of culture, when 92, 95, 
93 and 86% of cells respectively formed rosettes. 
Morphological identification Cells forming EAM rosettes were identified 
by morphology and cytochemistry of cytocentrifuge preparations, and by 
electron microscopy of bulk preparations. Figures 2.2 to 2.6 are 
typical of cells forming EAM rosettes, and clearly demonstrate that 
hairy cells form EAM rosettes. 
Very few cells other than hairy cells were seen to form EAM 
rosettes. The few monocytes and polyroorphonuclear leucocytes present 
in rosetted mononuclear cell preparations were invariably negative. 
Occasional platelets were, however, seen to form EAM rosettes. 
Mixed rosettes By the use of mixtures of fluorescein-labelled EAM(FEAM) 
and unlabelled EAG and sheep erythrocyte (E) indicator cells, it was 
found that the cells forming rosettes with FEAM also invariably formed 
rosettes with EAG. Control mixtures of FEAM and unlabelled EAM showed 
that the fluorescein labelling of the indicator erythrocytes did not 
affect the ability of the indicator erythrocytes to form rosettes. In 
the mixed tests with FEAM and EAG, adherent indicator erythrocytes on 
individual rosette-forming cells were scored as being all non-fluorescent 
(EAG only), all fluorescent (FEAM only), or mixed fluorescent and non-
fluorescent (FEA and EA). M G In these tests the proportions o
f EAG only 
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given in Table 2.III and demonstrate only that HCs expressing the EA M 
receptor are present. 
Cultured hairy cells The characteristics of the established hairy-cell 
culture will be considered in detail in Chapter 3. However, during the 
period of study (3 months) the cultured cells maintained a definite HC 
morphology and consistently displayed the cytochemical and immunological 
features of hairy cells. The cultured cells were examined for EA M 
rosette formation after 18, 29, 46 and 66 days of culture, when 92, 95, 
93 and 86% of cells respectively formed rosettes. 
Morphological identification Cells forming EAM rosettes were identified 
by morphology and cytochemistry of cytocentrifuge preparations, and by 
electron microscopy of bulk preparations. Figures 2.2 to 2.6 are 
typical of cells forming EAM rosettes, and clearly demonstrate that 
hairy cells form EAM rosettes. 
Very few cells other than hairy cells were seen to form EAM 
rosettes. The few monocytes and polymorphonuclear leucocytes present 
in rosetted mononuclear cell preparations were invariably negative. 
Occasional platelets were, however, seen to form EAM rosettes. 
Mixed rosettes By the use of mixtures of fluorescein-labelled EAM(FEAM) 
and unlabelled EAG and sheep erythrocyte {E) indicator cells, it was 
found that the cells forming rosettes with FEAM also invariably formed 
rosettes with EAG. Control mixtures of FEAM and unlabelled EAM showed 
that the fluorescein labelling of the indicator erythrocytes did not 
affect the ability of the indicator erythrocytes to form rosettes. In 
the mixed tests with FEAM and EAG, adherent indicator erythrocytes on 
individual rosette-forming cells were scored as being all non-fluorescent 
(EA only), all fluorescent (FEA only), or mixed fluorescent and non-G M 
fluorescent (FEAM and EAG). In these tests the proportions of EAG only 
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Table 2.III EA rosette formation by bone marrow and 
l ymph node leucocytes from HCL patients 
% of mononuclear cells 
Patient 
HR 
AB 
LH 
Date 
26.10.77 
22.11.77 
22.11. 77 
3.12.77 
Material 
bone marrow 
bone marrow 
lymph node 
bone marrow 
EAM rosettes 
37 
37 
25 
25 
T cells 
13 
38 
31 
23 
Hairy cells 
66 
50 
70 
40 
30 
Figure 2.2 
' 
Figure 2.3 
Figure 2.4 
I 
! 
:i 
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Figure 2.5 
Figure 2.6 
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Figure 2.2 Cytocentrifuge preparation of an EA rosette-forming cell 
from the peripheral blood of a patient (LS) wit~ HCL. The characteristic 
hairy-cell morphology of the rosetting cell is clearly illustrated. 
Stained with Giemsa. 
Figure 2.3 Cytocentrifuge preparation of an EAM rosette-forming cell from 
the peripheral blood of a patient (LK) with HCL. Stained with Giemsa. 
Figure 2.4 Cytocentrifuge preparation of an EA rosette-forming cell 
stained for non-specific esterase by the methodMof Higgy et al,(1978). 
The rosetted hairy cell from the peripheral blood of patient LH shows 
the granular composition of the crescent of esterase positivity typical 
of hairy cells. 
Figure 2.5 Transmission electron micrograph of a hairy cell from the 
peripheral blood of patient (Lp) forming an EA rosette. The indicator 
erythrocytes make contact with the morphologic~lly typical hairy cell 
mainly at the ends of the fine surface projections (x 7500). 
Figure 2.6 . Scanning electron micrograph (SEM) of a hairy cell from the 
peripheral blood of patient (PS) forming an EA rosette. The central 
cell demonstrates the typical hairy-cell morph~logy of both ridges or 
ruffles and microvilli seen under SEM (x 7000). 
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and mixed FEA and EA varied from case to case, but examples of FEA M G M 
only were never seen. Mixtures of indicator cells in the proportions 
1 FEAM: 1 EAG and 2 FEAM: 1 EAG were used and the 2 : 1 ratio was 
found optional for mixed rosette formation. Many individual rosettes 
from several patients were carefully examined for mixed and non-mixed 
rosettes. But because of the nature of examination percentage scores 
of mixed to non-mixed were not made. 
When FEAM and E indicator erythrocytes were mixed and read for 
mixed rosette formation as above, no mixed rosettes were observed 
although in all the HCL cases examined both fluorescent and non-
fluorescent rosettes were present. 
Since hairy cells have an avid receptor for the Fe of IgG as 
detected by EAG rosette formation (above and Chapter 3), the possibility 
was considered that trace amounts of IgG in the IgM anti-ox erythrocyte 
antibody were causing apparent EAM rosette formation. No IgG was 
detectable by gel diffusion of the IgM fraction of the primary bleed used 
to sensitize indicator erythrocytes. Also, the IgG fraction obtained by 
Sephadex G200 chromatography of this same primary bleed did not 
agglutinate ox erythrocytes, nor did it lyse ox erythrocytes in the 
presence of fresh complement. Neither normal monocytes, nor monocytes 
from 6 cases of myelomonocytic leukaemia, formed rosettes with EAM 
indicator cells (Section III), but both normal and leukaemic monocytes 
had receptors for the Fe of IgG (yFcR) as demonstrated by their strong 
rosette formation with EAG. The pathological T cells of Sezary's syndrome, 
on the other hand, did form rosettes with EAM following culture (Section 
III), but did not form rosettes with EAG. 
EAG rosette titration experiment If apparent EAM rosette formation by 
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HCs was caused by trace aIDounts of IgG in the sensitizing IgM 
preparation, it would require that the yFcR on HCs be extra-sensitive. 
A titration experiment was set up to investigate this possibility. Ox 
erythrocytes were coated with serial dilutions of anti-ox-erythrocyte 
IgG antibody to form EAG of progressively lower sensitivity. These 
cells were tested for rosette formation with the mononuclear cells 
from the peripheral blood of 5 cases of HCL and of 12 normal individuals. 
The results are illustrated in Figure 2.7. Since no attempt was made 
to remove monocytes from the normal leucocyte preparations, the normal 
titration reflects EAG rosette formation by both monocytes and B 
lymphocytes. From the graph, it can be seen that the end point of the 
titration is similar for both HCs and normal leucocytes, indicating that 
HCs do not possess extra--·avid yFc receptors. Also, since there is no 
tail of HCs forming rosettes at very high antibody dilutions, there is 
probably no subpopulation of HCs with extrasensitive receptors. 
Morphology of EA and EAG rosettes Further evidence for the specificity M . 
of EAM rosette formation was obtained by the examination of EAM and EAG 
rosettes by electron microscopy. Figure 2.8 displays the morphology of 
typical EAM and EAG rosettes formed by HCs as viewed by transmission (TEM) 
and scanning (SEM) electron microscopy. It is clear from the figure 
that the two types of rosette are morphologically different. While 
receptor density cannot be excluded as the sole cause of this difference, 
the distortion of the EAG indicator erythrocytes shown in Figure 2.8 
is particularly characteristic of EAG rosette formation by HCs. 
Heterophil antibody The possibility that the IgM preparation used to 
make EAM was detecting a heterophil antigen shared by HCs and ox 
erythrocytes was also excluded in the following way. Hairy cells from 
the peripheral blood of one patient (MB) were incubated with the IgM 
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Figure 2.7 EAG rosette titration. Percentage rosette formation with 
ox erythrocytes treated with serial dilutions of IgG antibody 
mononuclear cells from 5 individual HCL patients;•, mean of peripheral 
blood mononuclear cells from 12 normal individuals, error bars 
indicating± 1 SD. 
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Figure 2.8 
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Figure 2.8 EAM and EAG rosette formation by HCs (a) TEM of EAM rosette 
(x 7500), (b) TEM of EAG rosette (x 6500) (c) SEM of EA rosette (x 7000) 
(d) SEM of EAG rosette (x 7500). In the EA rosettes (~ and c), indicator 
erythrocytes made contact with the HC mainl~ at the ends of the fine 
surface projections. Furthermore, relatively fewer indicator cells were 
involved in most rosettes and the erythrocytes usually preserved their 
regular biconcave shape. In contrast, in the EA (band d), the indicator 
erythrocytes made contact with extensive areas o~ the HC surface including 
areas of well-developed ruffles. In addition, many erythrocytes seemed to 
be distorted by the rosetting process since control EA indicator cells 
had a regular biconcave shape. G 
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preparation at the dilution used to make EAM. After 10 min incubation 
the cells were washed and rosette tested with unsensitized ox 
erythrocytes and with EAM indicator cells. The treated HCs did not 
form rosettes with unsensitized ox erythrocytes. The percentage of 
cells forming EAM rosettes, compared with a control treated in the 
same way with normal rabbit serum, was not reduced by the above 
treatment. 
Complement components In order to investigate whether complement 
components, in particular Ciq, could be causing apparent EAM rosette 
formation by HCs, 2 experiments were conducted. In the first, the IgM 
0 used to prepare EAM indicator cells was heat treated at 56 C for 20 min 
before reacting with ox erythrocytes. In addition, IgM was reacted 
with ox erythrocytes in HBSS containing 10 mM EDTA. The EAM indicator 
erythrocytes thus prepared were thoroughly washed in HBSS before being 
used in the rosette test. In the second experiment, isolated mononuclear 
cells from a patient with HCL were reacted with serial dilutions of an 
anti-Ciq serum for 10 min at room temperature. The leucocytes were 
then washed and rosette tested with EAM in the usual way. The results 
of these experiments, which are given in Table 2.IV, clearly exclude 
the possibility of Ciq binding causing EAM rosette formation. 
Blocking experiments In order to confirm that the rosettes formed 
between EAM indicator cells and hairy cells were the result of antibody 
binding by a receptor for IgM (µFcR) on the HCs, attempts were made to 
block rosette formation by the addition of whole antibody or antibody 
fragments. The results of these experiments are shown in Table 2.V and 
Figure 2.9. The data confirms that the EAM reagent was detecting a 
receptor for IgM and that IgG was not involved in EAM rosette formation. 
It is also clear that IgM in its monomerized form blocked much more 
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Table 2.IV Experiments to exclude Clg as a 
cause of EA rosette formation 
Treatment of indicator 
erythrocytes 
nil 
heat-treated IgM 
EAM formed in lOmM EDTA 
nil 
Treatment of leucocytes 
Patient LS 
nil 
nil 
nil 
Patient MB 
no serum 
normal rabbit serum 
anti-Clq serum 1io 
anti-Ciq serum l~o 
anti-Ciq 1 serum io 
anti-Clq serum l~o 
\o 
EAM rosette 
formation (%) 
55 
56 
59 
73 
82 
86 
74 
62 
74 
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efficiently than in the pentameric form; some preparations of pentameric 
IgM blocked quite efficiently while others completely failed to block 
rosette formation even at 1 mg/ml. IgM complexed to its antigen was 
a more effective blocking reagent than unbound IgM, and the Fe piece 
rather than the Fab region is probably involved in µFcR binding. 
Various physical factors were found to effect EAM rosette 
formation by hairy cells, and these were taken into account before 
adopting the routine procedure described above in Methods. 
Indicator erythrocyte concentration The maximum number of EAM rosettes 
were formed when an equal volume of leucocytes at 2 x 106/ml were mixed 
with EAM indicator cells at a concentration of 1% (v/v). When the 
concentration of indicator erythrocytes was lowered to 0.5%, the% 
rosette formation fell by about 50%. At a concentration of 2% EAM, no 
increase in rosette formation by HCs was observed but the preparations 
were more difficult to score because of the relative paucity of 
leucocytes. 
Time and temperature The effects of time and temperature on EAM rosette 
formation are considered in some detail in Section II of this chapter. 
In brief, however, it was observed in most cases studied that rosette 
formation was possible at o0 c, room temperature, and 37°c. However, the 
0 percentage of cells forming rosettes at O C was always much lower than 
at the higher temperatures. In general, but by no means always, rosette 
formation was higher at 37°c than at room temperature. At both 
temperatures the percentage of cells forming rosettes reached a maximum 
after a short period of incubation (generally about 15 min) and then 
fell rapidly. With some patients, on some occasions, this time was 
slightly shorter and an incubation time of 10 min was adopted as standard. 
41 
Table 2.V The blocking effect of different 
immunoglobulins and immunoglobulin fragments on EA rosette M 
formation by hairy cells 
% inhibition of rosette formationt 
Inhibitor Concentration 
mean range 
Human cord serum 0 
Monomeric IgG 10 mg/ml 0 
Aggregated IgG 10 mg/ml 0 
Pentameric IgM 1 mg/ml 20 0-81 
Aggregated IgM 1 mg/ml 0 
Fc5µ 0.5 mg/ml 72 65-79 
F (ab') 2µ 0.5 mg/ml 0 
Toxoplasma antigen 6 
Anti-toxoplasma IgM 17 
IgM-antigen complex 80 
t The result given is the mean and range of 2 or more experiments 
on freshly isolated PB or splenic HCs and on cells from the HC culture. 
The% inhibition is calculated in terms of a control incubated for the 
same time to allow for receptor shedding (Section II). 
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Table 2.VI records selected, but representative, results obtained 
from the peripheral blood mononuclear cells of 20 HCL patients tested 
for EAM rosette formation for 10 min at the two temperatures. Table 
2.VII records the results obtained from the 5 spleens tested at both 
temperatures, and it can be seen that a higher percentage of splenic 
cells form rosettes at 37°c. 
£!!. When cells were being tested for the effect of EDTA on EA rosette 
M 
formation, it was thought possible that the drop in% rosette formation 
observed might be due to the acid conditions of the EDTA solution. Cells 
from the peripheral blood of a patient with HCL were therefore tested 
at the routine pH of 7.0 - 7.2, and the% EAM rosette formation 
compared with that obtained at pH 5.6. At the acid pH there was a 65% 
reduction in rosette formation, and all subsequent EAM rosette tests 
(including blocking with EDTA) were carried out at neutral pH. 
Stabilization on ice If EAM rosettes were allowed to form, centrifuged, 
and read immediately, the score obtained did not differ from 
preparations kept on ice for a period before reading. However, 
cytocentrifuge preparations from the samples which had not been stabilized 
on ice were poor. Furthermore, if the preparation was kept at room 
temperature after rosette formation and centrifugation, but before 
scoring, the percentage of rosettes obtained was much lower than 
preparations scored immediately. This last result can be attributed 
to continued shedding of µFcR by hairy cells (Section II of this 
chapter). Therefore when more than one test was being carried out it 
was found convenient to place the tube containing formed rosettes in 
ice until all tests were ready to be read. In cytocentrifuge preparations, 
the morphology of rosettes was much better preserved when the samples 
had been on ice for an hour or more before centrifugation. The results 
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Table 2.VI The effect of temperature on EA rosette 
- M 
Patient 
KD 
MB 
PS 
HD 
LS 
DC 
FB 
AD 
LP 
LH 
FW 
BN 
NW 
RR 
MR 
AB 
GH 
TN 
LK 
JC 
t formation by PB hairy cells 
% rosette formation 
37°c 24°c* 
62 66 
84 70 
28 30 
20 2 
15 31 
16 1 
55 71 
59 64 
24 12 
37 28 
48 55 
65 42 
78 66 
66 51 
41 52 
45 34 
15 37 
18 18 
12 1 
36 55 
42 54 
32 18 
59 35 
39 56 
26 15 
50 50 
18 12 
49 26 
38 74 
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Table 2.VII The effect of temperature on EAM 
rosette formation by splenic hairy cellst 
% rosette formation at: 
Patient 
24°c* 37°c 
NW 37 5 
LP 55 49 
AD 47 37 
HR 35 3 
AB 46 18 
Splenic mononuclear cells were incubated with EA indicator 
erythrocytes for 10 min at the temperature indicate~. The mixtures 
were then centrifuged and placed on ice before reading as described 
in Methods. 
* Approximate room temperature. 
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suggest that a period on ice after rosette formation stabilizes 
formed rosettes. Consequently, a routine stabilization period of 
1 h on ice was adopted for all test. 
3. 4 Ve.n.6U!f oo the. 1te.c.e.pto1t 001t IgM on ha.J.Ay c.e.11..6 
Various experiments were carried out to examine the density of 
the receptor for IgM (µFcR) on hairy cells. 
~ rosette titration Figure 2.10 shows the dose response curves 
obtained when EA prepared from progressive dilutions of sensitizing 
M 
IgM antibody were rosette tested with HCs. After a plateau phase, 
weaker sensitization is accompanied by progressively lower percentages 
of EAM rosette formation. The quantity of sensitizing IgM required 
for detection of µFcR appears to parallel that required for complement 
fixation; for if the same progressive dilutions of EAM reacted with a 
fixed dilution (1/10) of AKR mouse complement, and then titrated with 
normal mononuclear PB cells for EAC rosette formation, the dilution 
of IgM marking the end of the plateau phase of rosette formation is 
similar in both tests. 
Sensitization with human IgM Sera from 2 cases of infectious 
mononucleosis were employed to sensitize ox erythrocytes, and the 
sensitized EA thus obtained were used in rosette tests with PB hairy 
M 
cells from 2 cases of HCL. The results obtained are presented in 
Table 2.VIII; the given dilutions of antibody had to be used to avoid 
agglutination of sensitized ox erythrocytes. The% rosette formation 
obtained with these human EAM is very low. Previous blocking 
experiments (Table 2,V) demonstrated that the µFcR on hairy cells 
recognised human IgM. 
Binding of fluorescein-labelled, monomerized, human IgM Attempts were 
made to detect the µFcR on PB hairy cells employing the fluoresceinated, 
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Figure 2.10 EA rosette titration. Percentage rosette formation by 
hairy cells frofil the peripheral blood of 7 individuals with HCL when 
rosetted with ox erythrocytes treated with serial dilutions of IgM 
antibody. Upper figure is the mean ± ISD of mononuclear cel·ls from 
the PB of 3 normal persons rosetted with the same EA indicator cells 
reacted with a fixed concentration of AKR mouse comp~ement. 
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Table 2.VIII Rosette formation with ox erythrocytes sensitized 
with Paul-Bunnell-positive sera 
Patient 
MB 
RH 
EA hu(l)t 
M 
4 
3 
% cells rosetting with: 
EAM hu(2)f 
0 
0 
52 
17 
t EAM hu(l). Ox erythrocytes sensitized with serum from a patient 
with infectious mononucleosis. Dilution 1/40. 
+ EA hu(2). Ox ery,hrocytes sensitized with serum from a second 
patieMt with infectious mononucleosis. Dilution 1/80. 
* EAM rabbit. Standard EAM reagent (Methods) Dilution 1/10. 
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monomerized human IgM preparation in a manner analogous to the 
detection of yFcR on B cells with aggregated IgG (Dickler and 
Kunkel, 1972; Dickler, 1976a). The labelled IgM was employed at about 
3 mg/ml at room temperature, as recommended for aggregated IgG 
binding (Dickler, 1976a). 
The experiment was attempted on the freshly isolated mononuclear 
cells from 6 patients with HCL, all tested at a time when the% of rosette 
formation with EAM was high. Cells from 3 patients (RH, LS, MB) 
completely failed to stain. The HCs from patients HD and FW showed 
faint, but definite, cap fluorescence; and, at a different time of 
testing, the HCs from PS stained with a very faint diffuse fluorescence. 
The results of specific blocking experiments with immunoglobulin 
fragments have already been given in 3.2 of this section. Here, the 
effect of various chemicals and heteroantisera on EAM rosette 
formation are considered. 
Chemical inhibitors Table 2.IX illustrates that rosette formation 
. . f ++ d/ ++ h 'h. requires the divalent cations o Ca an or Mg toget er wit active 
metabolic activity by the hairy cell involved. Possible involvement 
of microfilaments is suggested by the results obtained using 
cytochalasin B, but as will be shown in the next section (Section II), 
the presence of either cytochalasin B or puromycin prevents re-expression 
of the µFcR after it has been shed. The result obtained with papain 
possibly shows that there is only partial proteolysis of the µFcR 
by this enzyme. 
Heteroantisera EAM rosette formation by HCs was found to be 
exquisitely sensitive to blocking by the anti-hairy cell serum (AHS). 
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Table 2.IX The effect of various inhibitory r
eagents on EA 
-----
-----
-----
-----
-----
-~----
------l'M 
rosette formation by hairy cells 
% inhibition of rosette formation 
Inhibitor Concentration Mean Range 
EDTA, pH 7.0 10 mM 
85 75-100 
sodium azide 100 mM 
90 80-100 
cytochalasin B 20 µg/ml 
34 26-34 
puromycin 2.5 µg/ml 
6 0-12 
papain 1% 
34 
* The result given is the mean of two or more e
xperiments and t he % 
inhibition is calculated in terms of a contro
l incubated for the same 
time to allow for shedding. 
* 
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The PB mononuclear cells from 7 cases, and splenic cells from 3 cases, 
of HCL were treated with dilutions of AHS from 1/20 to 1/400 and 
tested for EAM rosette formation. In very case 100% inhibition of 
rosette formation was obtained. At dilutions of AHS greater than 
1/400, inhibition of rosette formation started to fall off as is shown 
for 2 cases (LH and DC) in Figure 2.11. This blocking of the HC µFcR 
by AHS at very high dilutions was peculiar to this particular receptor. 
Thus, as will be discussed in succeeding chapters, rosettes formed 
between HCs and EAG, mouse erythrocytes, anti-irrnnunoglobulin-coated 
erythrocytes, or sheep erythrocytes (1 case, Chapter 4), were either 
unaltered by treatment with AHS or blocked only by high concentrations 
of the serum. Similarly, the µFcR possessed by the B cells of chronic 
lymphocytic leukaemia (Section III) was only partially blocked by the 
AHS at a dilution of 1/20, and the µFcR expressed by T cellsfollowing 
culture (Section III) was not at all blocked by AHS when tested at a 
dilution of 1/100. 
Cells from the HC culture, 95% of which formed EAM rosettes, 
were incubated with serum against the p29,34 la-like antigen, at a 
dilution of 1/50. The cells were then tested for EAM rosette formation 
and compared with a control incubated with normal rabbit serum for 
the same time. The anti-p29,34 serum completely abolished rosette 
formation. At this dilution of anti-p29,34 serum, EAG rosette 
formation was reduced by only 4%. 
4. DISCUSSION 
In this section, the hairy cells from PB, spleen, bone marrow 
and lymph node of patients with HCL are shown to possess a receptor 
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Figure 2.11 Blocking of EA rosette formation by AHS. The isolated 
mononuclear cells from the ~eripheral blood of 2 patients with HCL 
were treated with various dilutions of AHS for 10 min at room 
temperature before testing for EA rosette formation. The percentage 
rosette formation obtained was cofilpared with that of a control incubated 
with normal rabbit serum at the same time, and the percentage inhibition 
thus obtained is plotted against the dilution of AHS serum employed 
for blocking. 
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for homologous and heterologous IgM. The EAM rosette method used 
to detect the receptor, and the conditions required for rosette 
formation, are described. Morphological evidence clearly demonstrates 
that it is the pathological hairy cells which form EAM rosettes, and 
this is confirmed by receptor expression by the cells from a cultured 
hairy-cell line. The receptor is expressed without culture in 
serum-enriched medium, and cells bearing µFcR simultaneously express 
yFcR. This original observation of µFcR on HCs has subsequently been 
confirmed by 2 other groups (Habeshaw, Dewar and Ramsy, personal 
communication; Ferrarini et al, 1977). 
The simultaneous presence of yFcR on the cells forming EAM 
rosettes makes the purity of the indicator system crucial. The 
possibility of Ciq acting as a cementing substance for both IgM and IgG 
(Gmelig-Meyling et al, 1976) was excluded. No IgG was detectable in 
the IgM preparation used to prepare EAM when tested by immunoprecipitation, 
and the IgG fraction from this same early bleed appeared to have no 
anti-ox erythrocyte activity. Further, neither normal nor pathological 
monocytes, both of which have strong receptors for the Fe of IgG 
(Koziner et al, 1977), formed rosettes with the EAM reagent. Thus HCs 
would have to possess an extra-avid yFcR to detect trace amounts of 
The IgG in the EAM reagent, and this was shown not to be the case. 
possibility was also excluded of EAM rosette formation being a mixed 
agglutination reaction between antigens shared by HCs and ox 
erythrocytes. 
The characteristically different morphology bf EAM and EAG rosettes 
when seen by EM is further evidence that the EA rosettes are not the M 
result of trace IgG contamination. It is possible that the point 
attachments seen in EAM rosettes are the result of low receptor density 
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on the HC surface, and that, conversely, the extensive areas of 
contact and erythrocyte deformation seen in EAG rosettes reflect a 
high receptor density. However, other evidence suggests that the 
different morphology of the two types of rosette is the result of a 
different kind of ligand binding. The SEM pictures of HCs in this 
section confirm previous studies showing both microvilli and broad-
based ruffled membranes or ridge-like structures on the cell surface 
(Golomb et al, 1975; Deegan et al, 1976; Matre et al, 1977). This 
characteristic surface topography is one of the hybrid features of 
HCs. Ridges and ruffles are features associated with normal and 
leukaemic monocytes,(Polliack et al, 1974; Golomb et al, 1975), while 
the villous surface is a feature of normal and leukaemic lymphocytes 
(Lin et al, 1973; Polliack et al, 1973). The EAM rosettes are mostly 
formed by the microvilli of the HC, and this may be a B-lymphocyte 
feature of HCs (Section III). Figure 2.8 illustrates that EAG rosettes, 
on the other hand, are formed by attachment of the indicator erythrocytes 
over much broader areas of the HC surface, including the broad-based 
ruffles. This type of rosette formation is typical of the rosettes 
formed by monocytes (LoBuglio et al, 1967; Parker and Stuart, 1978), 
and the deformation of the attached erythrocytes is also a feature of 
monocyte rosettes (LoBuglio et al, 1967; Parker and Stuart, 1978). 
Other evidence pointing towards the monocytic nature of the yFcR of 
HCs will be given in Chapters 3 and 4. 
Blocking of EA rosette formation by IgM, but not by IgG, further M 
confirmed the specificity of the EAM reagent. Whole pentameric IgM, 
however, did not always block rosette formation; some preparations 
blocked efficiently, while others failed to block. When monomerized 
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IgM was used, blocking of a dose-dependent type was obtained. These 
results were attributed to the exposure of a binding site on the 
IgM molecule either by monomerization of the pentamer, or by the 
'stapling' rearrangement undergone by IgM when it binds to antigen 
(Feinstein, 1976). This interpretation was confirmed by using an 
antigen-antibody system employing the large toxoplasma antigen: in 
this system, the complexed IgM-antigen blocked much more efficiently 
than free IgM alone. Similar results have recently been obtained 
by Pichler and Knapp (1978), who used ovalbumin-IgM anti-ovalbumin 
complexes in their investigation of the µFcR on normal human B 
lymphocytes. This requirement for IgM monomerization, or 'stapling', 
may account for the rather inefficient blocking obtained by Ferrarini 
et al, (1977) when they attempted to block the µFcR on normal human B 
cells with whole IgM, since this receptor may be similar to the µFcR 
on both HCs and the cells of chronic lymphocytic leukaemia (Section III). 
The blocking of EA by whole IgM obtained by these authors may have 
M 
been the result of IgM monomers in their reagent. For blocking, they 
used IgM isolated from the serum of a patient with Waldenstrom's 
macroglobulinaemia, and such sera often have a high proportion of 
monomeric IgM (Stobo and Tomasi, 1967; Damacco et al, 1970). 
Aggregated IgM did not block EAM rosette formation. In this 
regard the µFcR on HCs differs from the yFcR on both lymphocytes and 
macrophages. Whereas normal lymphocytes and macrophages can bind 
monomeric IgG (Phillips-Quagliata et al, 1971; Ramasamy et al, 1976), 
efficient binding requires the IgG to be complexed to its antigen, or 
heat aggregated (Phillips-Quagliata et al, 1971; Basten et al, 1972; 
Dickler and Kunkel, 1972; Shevach et al, 1974; Ramasamy et al, 1976). 
It has been suggested that the enhanced binding of complexed or 
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aggregated IgG is due to increased energy of binding resulting from 
summation of individual binding sites, rather than to the occurrence 
of allosteric change (Phillips-Quagliata et al, 1971; Ramasamy et al, 
1976). However, a recent report of separate yFcR on murine leukaemia 
cells (Cooper et al, 1977), one for native IgG and one for IgG 
complexed to antigen, suggests that the situation might be more complex. 
The Fe region of the antibody was required for IgM receptor 
binding, and this requirement is similar to that for IgG binding by 
B cells (Paraskevas et al, 1972; Dickler, 1974). Confirmation that 
the Fe region of IgM is involved in binding was obtained by the ability 
of Fc5µ fragments to block EAM rosette formation, and 
by the failure 
of F(ab) 2µ fragments to do so; normal human T cells (Gmelig-Meyling 
et al, 1976; Conradie and Bubb, 1977) and B cells (Ferrarini et al, 
1977) also bind IgM through the Fe region. 
The density of µFcR on HCs appears to be low. For example, the 
EAM rosette titration experiment demonstrated that the indicator 
erythrocytes had to be coated with quite a high density of IgM for 
EAM rosette formation to take place. Coating of ox erythrocytes with 
natural, rather than hyperimmune, antibody to form EAM resulted in 
the virtual failure of HCs to form rosettes. The analogous situation 
of using natural anti-erythrocyte antibodies (such as anti-Rhesus or 
anti-Forssman) to identify yFcR detects only lymphocytes with a high 
density of receptor (Shevach et al, 1973; Natvig and Fr~land, 1976). 
Attempts to detect fluorescein-labelled, monomerized, IgM bound by 
HCs were only of limited success, and this might be attributed to a 
low receptor density making the labelled cells difficult to visualize. 
It is probable, however, that labelled IgM-antigen complex would provide 
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a better experimental system. Nevertheless, when hyperimmune 
heteroantisera are used in the rosette method, a higher number of 
yFcR-bearing normal lymphocytes are identified than when FITC-
labelled immune complexes are used (Winchester et al, 1976), and 
the former method is probably slightly more sensitive. Kinetic 
experiments following shedding of µFcR by HCs (Burns et al, 1977b) 
provided further evidence for the rather low density of µFcR. Shedding 
and re-expression of the µFcR was monitored by rosette formation with 
the standard EA indicator erythrocyte but in order to detect a similar 
M 
shedding yFcR by HCs, the indicator EAG erythrocytes had to be coated 
with very small amounts of IgG {Burns et al, 1978a). 
The ability of the AHS to block EAM rosette formation by HCs, 
even at very high dilutions, might suggest that the µFcR is 
particularly immunogenic and that much of the AHS antibody is directed 
against this receptor. However, previous studies of blocking of 
rosette formation by antisera require a more cautious interpretation. 
Anti-macrophage serum blocks yFcR binding of EAG by mouse macrophages 
(Holland et al, 1972), but in this system the Fe as well as the 
F(ab 1 ) 2 region of the antiserum is involved in blocking and the 
authors conclude that the antibody is not directed toward the yFcR 
pe!L ~e but to an adjacent antigen. Similarly, steric hindrance has 
been suggested as a reason for the blocking of E-rosette formation 
following anti-human T-cell serum treatment of human T cells (Galili 
et al, 1977; Gattringer and Wick, 1977). It may be that the µFcR on 
HCs is closely adjacent to an antigen detected by the AHS, or even 
that IgM binding by this receptor is weak and therefore particularly 
susceptible to steric hindrance. Blocking of EAM rosette formation 
by serum to the p29,34, anti-Ia-like antigen might be interpreted in 
I 
II 
I' 
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the same way. EAM rosette formation by the cultured HCs was completely 
blocked by this antiserum whereas EAG rosette formation was almost 
unaffected, This result differs from that of Ferrarini et al, (1977) 
who reported no blocking of EAM rosette formation by pretreatment of 
normal B cells with anti-Ia-like antiserum. It is possible that these 
conflicting results are due to differences between normal B cells and 
hairy cells, since Ferrarini et al did not attempt prestaining of HCL 
cells. However, similar conflicting results have been obtained 
concerning the specific blocking of the yFcR by anti-Ia serum both in 
mouse and man (Dickler and Sachs, 1974; Schirrmacher and Halloran, 1975; 
Solheim et al, 1976), and such blocking has been attributed to either 
steric hindrance by the antiserum (Schirrmacher and Halloran, 1975) or 
to ligand binding of the Ia antigen altering the cell membrane and 
affecting the function of the yFcR (Dickler et al, 1977). Others have 
failed to demonstrate any relationship between the two membrane 
components in either mouse or man (Woofsy et al, 1977; Chess et al, 1976). 
Such conflicting results could be attributed to steric hindrance which 
might vary in different studies. Three factors could cause variations 
in the sensitivity of the test and thus the ease of blocking by steric 
hindrance: (a) Both receptors for Fe on B cells, µFe and yFc, are 
cyclically shed and re-expressed (Section II; Burns et al, 1977a; 
Sarmay et al, 1978). Thus, although there is probably always some 
receptor present on the membrane, its density of expression fluctuates. 
(b) The methods used for receptor detection vary as described above, 
and these different methods have varying degrees of sensitivity. 
(c) The amount of anti-Ia antibody required to sterically hinder 
Fe-ligand binding is possibly not present in all the antisera used. 
The antibody concentration is rarely cited, but in any case the antibody 
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is not affinity purified since it takes 100 kg of cells to prepare 
a few micrograms of pure antigen (Schlossman, 1976). When blocking 
of the yFcR by anti-la antibody was quantified (Dickler et al, 1975), 
a higher concentration of F(ab) 2 fragments, compared with whole 
antibody, was required. The failure to block EAG rosette formation 
by HCs with anti-p29,34 serum reported here may be due to the same 
factors, particularly since yFcR expression by HCs is high. However, 
it has been reported that anti-la serum has no effect on the binding 
of complexed IgG by the yFcR of macrophages, (Dickler, 1976b), and the 
yFcR of HCs bears many resemblances to the yFcR of macrophages 
(Chapter 3). It may be that this yFcR is a different structure from 
that of B cells. 
I 
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II Kinetic studies on the turnover of the receptor for I gM 
1. INTRODUCTION 
Shedding is a term employed to describe the release by the cell of 
plasma membrane antigens (Loor, 1977). In studies of the µFcR on HCs it 
was observed that the percentage of HCs forming EA rosettes fell rapidly 
. 
M 
after the final wash. Evidence is presented here that the cells were 
shedding the µFcR. 
By following the rate of shedding and subsequent re-expression of 
receptors, an estimate of the membrane turnover time of the receptor-
bearing cells can be obtained. Previous estimates of membrane turnover 
in haemic cells have employed a variety of methods: these have included 
measurements of the incorporation into the plasma membrane of 
radiolabelled aminoacids and the subsequent disappearance of label after 
the removal and chase of the radioactive precursor (Nachman et al, 1971); 
of the release of surface immunoglobulin (Sig) labelled either externally 
by lactoperoxidase-catalysed radio-iodination or following the biosynthetic 
incorporation of radiolabelled amino acid (Melchers et al, 1975); of the 
release of radiolabelled antibodies against surface HLA antigens (Menne 
and Fladd, 1973; Lewis et al, 1976); and of the half-life of Sig in 
terms of both its release and re-expression after proteolysis (Ferrarini 
et al, 1976a) or antibody stripping (Loar et al, 1972; Wilson et al, 1972). 
Measurements of membrane turnover made by most of the above techniques 
involve antigenic modulation (Bretscher and Raff, 1975) - the artificial 
removal of membrane protein - and must be treated with caution since 
such methods may alter the rate of replacement of the protein (Loor, 1977). 
Membrane kinetic studies of the chronic leukaemias have been confined to 
61 
lymphocytic leukaemia (CLL) (Menne and Fladd, 1973; Lewis et al, 1976; 
Lewis and Pegrum, 1977) in which the cells have been shown to have a 
markedly reduced turnover rate. It has been suggested both that this 
is a manifestation of the leukaemic state and that this change in membrane 
function may account for the reduced immunological responsiveness of the 
cells of CLL (Lewis et al, 1976). 
In this section, the kinetics of spontaneous µFcR shedding and 
resynthesis are used to provide a measure of membrane turnover in HCL. In 
addition, since CLL cells also bear a µFcR (Section III), the same method 
is used to study the membrane kinetics of CLL cells. The data presented 
provide new information concerning the relationship between HCs and CLL 
cells and also demonstrate that reduced membrane turnover rates are 
not a necessary feature of chronic leukaemia. 
2. MATERIALS AND METHODS 
2 • 1 Pa.tien:U 
The peripheral blood from seven patients with HCL and four patients 
with typical CLL (with a high peripheral leucocyte count) was examined. 
In one of the cases of HCL splenic HCs were also studied. All the HCL 
cases belong to the series studied in Section I. 
2. 2 Mononuc..lea.Jt c.ell ptLepaJta.tion 
Leukaemic cells from PB and spleen were isolated over Ficoll-Isopaque, 
washed and resuspended in HBSSA as described in Section I. Cells 
isolated from the HCL spleen comprised >90% HCs, and those from all 7 
cases of HCL >50% HCs. All four cases of CLL studied had PB leucocyte 
3 
counts of >100,00/mm, and the isolated mononuclear cells were >90% 
leukaemic B lymphocytes both morphologically and by light chain restriction 
1, 
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of Sig. 
2 • 3 I n.dic..a.to.tr.. c..e.U.6 
Ox erythrocytes coated with rabbit IgM antibody were prepared as 
described in the previous section. 
2 • 4 KlYLe,tlC,6 0 0 fr..O .6 e;t;t.e, 0 O.tr..mati..O YL 
6 Leucocytes at 2 x 10 cells/ml were mixed with an equal volume of 
EA (1%) in HBSSA. The mixture was incubated at 37°c in a water bath M 
and samples were removed for reading at times O, 10 min, 30 min, 1 h, 
and at hourly intervals thereafter until the end of each experiment. 
Mixing was only carried out as each sample was removed. In some 
experiments incubation was at room temperature as stated in Results. Also, 
in some tests, leucocytes were incubated for the various time periods 
in the absence of EAM, indicator cells only being added at the time of 
removal of samples. 
At the times of sampling, 3 drops were removed from the mixture 
with a pasteur pipette and the sample was immediately centrifuged at 
150 x g for 1 min. The pellet was placed on ice for an hour or more to 
stabilise formed rosettes before gently resuspending. The percentage 
of resetting cells was assessed by using a fluorescein diacetate method 
(Ramasamy, 1974) in which only viable fluorescing cells were scored 
under combined U.V. and phase contrast illumination; no loss of viability 
was noted during the period of each experiment. The morphological nature 
of the resetting cells was confirmed by cytocentrifuging the samples and 
subsequently staining with Giemsa. 
2.5 Conc..e.ntl1.a.ted µFc..R ma.te./1.,[al 
The supernatants from PB HCs, cultured for 3 h in HBSSA (but in the 
absence of indicator erythrocytes), was concentrated (x 10) by positive 
pressure filtration. The resulting concentrate was used as a blocking 
i', II 
i 1· 
,I ,, 
•'1' 
I
i' Ii 
!1 
63 
reagent in tests designed to demonstrate shedding of µFcR material. 
3. RESULTS 
3.1 Shedd,[ng 06 the µFeR 
Reduction in EA rosette formation It was observed that the percentage 
of HCL cells or CLL cells forming EAM rosettes fell rapidly after the 
0 final wash, whether maintained at room temperature or at 37 c. Thus, for 
example, cells from the HC culture formed 92% EAM rosettes when tested 
immediately after washing in HBSSA. After 30 min on the bench, the same 
washed cell preparation formed only 48% EAM rosettes. If, however, 
cultured cells which had remained on the bench in culture medium 
(RPMI-1640 medium+ 10% foetal calf serum (FCS)) were washed in HBSSA 
and rosette-tested immediately, 92% of cells formed EAM rosettes. No 
cells were ever seen to form rosettes with the unsensitized ox erythrocyte 
control. 
Freshly isolated, and washed, HCs also rapidly lost the ability to 
form EAM rosettes, whether maintained at 37°c or at room temperature. This 
is illustrated in Figure 2.12 where the freshly isolated cells were 
incubated in HBSS in the absence of EAM indicator particles: the subsequent 
re-expression of the µFcR will be considered below. 
The rate of fall in EAM rosette formation with time was very similar 
whether EAM indicator cells were present or not during incubation of the 
HCs. This is shown in Figure 2.13 where it is also shown that when the 
cells were incubated in HBSS containing 10% FCS there is no loss of µFcR 
material as measured by EA rosette-forming ability. Thus it would appear 
M 
that the µFcR on HCs is shed spontaneously, rather than as the result of 
antigenic modulation, or stripping, by the EAM indicator cells. Also, 
I 
I 
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since there was no loss of viability in the absence of FCS and only 
viable cells were counted, the presence of serum in the incubation medium 
probably stabilises this loosely bound receptor. 
Capping The manner in which µFcR was shed in the absence of EA cells 
M 
is not clear. Under phase contrast there appeared to be particles of 
plasma membrane which may have been released with the receptor. In the 
presence of EAM indicator particles, cells were seen to be capping and 
occasional clusters of indicator erythrocytes without a central leucocyte 
(as identified by fluorescent positivity) co11;,;i_d be seen. Capping of 
EAM is illustrated in Figure 2.14. 
Supernatant blocking Cells from the HC culture were EA rosette tested 
M 
in the presence of concentrated supernatant from cultured PB HCs. In two 
experiments, 66% and 90% inhibition was obtained. This result demonstrates 
that the µFcR is actually shed from the cell membrane and not simply 
obscured or reprocessed by the cell. 
3. 2 Rec.eptoJc. -6 yn:thu.l6 and twrnove.Jr. by HC-6 
µFcR regeneration Freshly isolated, and washed, PB HCs from one patient 
were mixed with EAM and incubated at 37°c. Aliquots from the mixture 
were tested for rosette formation after various time intervals, and 
shedding of receptor as described above was seen to have occurred. Thus 
at time o, EAM rosette formation was 65% falling to 10% after 1 h, and 
to 4% after 2 h. After 3 hand 4 h the% rosette formation was 5 and 14 
respectively. The mixture of leucocytes and indicator cells was now 
divided and incubated overnight at both 4°c and at 37°c. After this 
time, the two samples were tested for rosette formation. The sample 
maintained at 4°c did not form any EAM rosettes whereas the sample 
0 
incubated at 37 C yielded 35% EAM rosettes. 
Figures 2.12 and 2.13 both show that receptor regeneration by HCs 
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Figure 2.12 Mononuclear cells from three different cases of HCL 
incubated at 37°c ( O ,.,) and at room temperature (x) without added EA • 
At the time intervals indicated, cells were removed and the% EA ros~ttes 
obtained are graphed. The rate of fall in the absence of EA isM 
comparable to that observed in the presence of EA indicatorMcells 
(Figure 2.13), and the secondary rise in receptorMpositivity is also seen 
to occur. The vertical bars represent 1 SEM. 
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Figure 2.13 Receptor shedding and re-expression by the mononuclear 
cells from a case of HCL. Cells were cultured in either HBSSA (O,X) 
or HBSS + 10% FCS ( e ) in the presence ( o; •> or absence (x) of EA 
indicator cells. Aliquots were removed for rosette testing at theMtimes 
indicated and more than 200 cells were counted in each determination. 
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also took place in the absence of EA indicator cells, and that the 
M 
shedding and regeneration of receptor is a cyclical process. 
Membrane turnover The percentage EAM rosette formation obtained after 
incubating HCs for various periods of incubation at 37°c was monitored 
in a further 6 patients with HCL, and the results are shown in Figure 2.15. 
The cyclical pattern observed whereby rosettes are formed, shed and 
reformed is clearly illustrated. In general, few weak rosettes were 
seen; cells either formed strong rosettes with more than 10 adherent 
erythrocytes or were completely negative. The rate of fall, both initially 
and after each regeneration peak, was rapid in all cases, and the 
percentage EAM rosette formation by HCs in the re-expression peaks was 
always lower than the peak intially present. 
Four, and possibly five; of the HCL patients illustrated in Figure 
2.15, and the case in Figure 2.13, had a peak-to-peak time of around 6 h. 
One patient's cells (KD; Figure 2.15) had a peak-to-peak expression time 
of 8 h, and it is of interest to note that HCs from this case appeared 
morphologically more mature in possessing more heavily condensed 
peripheral nuclear chromatin than most typical HCs (Figure 2.16). 
Since the surface of splenic HCs has been reported to differ from 
that of PB HCs in the same case (Catovsky, 1977), it was of interest 
to examine the relative rates of re-expression of µFcR in splenic 
compared with PB HCs. Figure 2.17, which compares the rate of turnover 
of splenic HCs and PB cells from the same patient taken at the time 
of splenectomy, shows that cells from the two sites have a comparable 
rate of re-expression of the receptor. 
In the presence of 10% FCS, the percentage of cells forming EAM 
rosettes continued to increase to 77% after 10 h of culture (Figure 2.13). 
The receptor profile of this patient's cells (Sig (IgDA) 67%; E 34%;EAG 74%) 
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Figure 2.14 Phase contrast micrographs of EA rosette-formation by 
HCs. A, The morula-like pattern of rosetting ~ndicator cells is shown. 
B, The indicator cells are clearly beginning to cap. C, After a further 
period of incubation at 37°c the indicator cells are completely capped 
at one pole of the hairy cell. 
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suggested that only approximately 67% of the cells belonged to the 
monoclonal HC proliferation, while the remaining 34 % of cells were T 
cells. Thus, after some 5 h culture in 10% FCS (a time corresponding 
to the first re-expression peak of HC µFcR), a percentage of the EA 
M 
rosette-forming cells were probably µFcR-bearing T cells. Also, since 
+ + the sum of percent E and EAG cells exceeded 100%, and since there is 
a virtual absence of both normal monocytes and normal B lymphocytes in 
HCL (Chapter 3), the overlap probably represents a small population of 
yFcR-bearing T cells. This is a general feature of HCL, where the 
proportion of yFcR-bearing T cells is often high. A consideration of 
the T-cell populations in HCL will be given in Chapter 3. 
Requirement for Frotein s ynthesis It has been stated above that HCs which 
were maintained at 4°c overnight after shedding their µFcR did not 
regenerate receptors. This suggested that receptor re-expression was an 
energy-dependent process. In two experiments, the kinetic test in the 
presence of indicator cells was carried out with and without added 
puromycin (final concentration 2.5 µg/ml) as an inhibitor of protein 
synthesis. As is illustrated in Figure 2.18, the puromycin had no effect 
on the initial rosette formation, but rapidly inhibited re-expression of 
the receptor even when added shortly before the re-expression peak. 
These experiments show that re-expression of the µFcR requires continuous 
protein synthesis and does not simply represent passive uptake of 
previously shed receptor. 
Cytochalasin B, which only partially inhibits EAM rosette 
formation at a concentration of 20 µg/ml (Section I), prevented receptor 
re-expression, almost completely, at a concentration of 10 µg/ml. Hence 
intact microfilament function is probably also required for µFcR 
regeneration. 
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Figure 2.15 Kinetics of EA rosette formation by HCs. The percentage 
..... - M 
of total mononuclear cells forming EAM rosettes obtained from counts of 
>200 cells after different periods of continuous incubation at 37°c, in 
the presence of EAM, is shown. Cytological examination of cytocentrifuge 
preparations at each time of sampling showed that only HCs were forming 
rosettes. The symbols represent the data obtained on a single occasion 
from each of the 6 patients with HCl tested, mean± SEM. The experiment 
was repeated on 4 patients with exactly comparable results for each 
individual. (A, patient KD). 
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Figure 2.16 Cells from patient KD. Cytocentrifuge preparation stained 
with Giemsa, and EM (x 10,000) of EA rosette formation. The nucleus is 
more central and spherical than in m~st HCs from typical cases, and 
the rather heavy peripheral chromatin condensation is well illustrated. 
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Figure 2.17 Comparison of the kinetics of EAM rosette formation by 
HCs from the spleen ( O ) and PB ( @ ) from the same case of HCL 
taken at the time of splenectomy. HCs from both sources show similar 
rates of shedding and re-expression. Vertical bars represent 1 SEM. 
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Figure 2.18 Kinetics of EA rosette formation in the presence (e;&) 
and absence (O;D) of purom~cin (2.5 µg/ml). The failure of HCs to 
re-express µFcR in the presence of puromycin is clearly shown. In one 
experiment (0;9) puromycin was added at time zero, and in the other 
experiment (O; 8) puromycin was added at the time illustrated. Error 
bars= 1 SEM. 
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Figure 2.19 Kinetics of EA rosette formation by CLL lymphocytes. 
Vertical bars represent 1 sMM. 
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3.3 Membnane tU/1..noven in CLL 
The same kinetic experiment carried out on four cases of CLL is 
illustrated in Figure 2.19. In these cases the re-expression times 
were 12, 12, >12, and >13 h. 
4. DISCUSSION 
In this section the shedding and the kinetics of re-expression of 
the receptor for IgM on the HCs of HCL and the lymphocytes of CLL are 
described. 
Receptor shedding and re-expression is not a feature peculiar either 
to the µFcR or to pathological cells. Very recently Sarmay et al, (1978) 
described a similar process for the yFcR, complement receptors, and 
sheep erythrocyte receptors in both normal human and CLL cells. Early 
experiments failed to demonstrate yFcR shedding by HCs (Burns et al, 1977b), 
but by reducing to very lo~ levels the amount of sensitising rabbit IgG 
used to form EAG it was possible to do so (Chapter 3). Sarmay et al used 
anti-Rhesus antibody on human erythrocytes as their indicator system for 
yFcR, and this relatively insensitive system probably requires high 
receptor density for rosette formation to occur. When any of these 
receptors are shed, some receptor probably remains on the membrane; however, 
the density of residual receptor is much reduced and requires more 
sensitive techniques for its detection. Indirect evidence of yFcR 
shedding has also come from the isolation of yFcR material from cell 
culture supernatants (Molenaar et al, 1977), and these authors were 
probably also detecting shed µFcR material since their isolated receptor 
bound IgM and since it has recently been demonstrated that human 
lymphoblastoid cell lines possess µFcR (Pichler et al, 1978). 
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The nature of shedding remains uncertain (reviewed by Loor, 1977). 
It is generally stated that shedding depends on capping, and, like the 
µFcR shedding described in this section, shedding of the complement 
receptor on lymphocytes is accompanied by capping (Gormus and Shands, 
1975). Cap formation is an energy-requiring process (Taylor et al,1971; 
Loor et al, 1972), whereas the process of shedding is not inhibited by 
either azide (Sarmay et al, 1978) or by puromycin (Figure 2.18). 
Recently, Yefenof et al, (1978) have presented evidence that there is 
no direct quantitative relationship between capping and shedding. In 
this study, it was also observed that in the EAM rosette preparation 
immediately preceeding the µFcR regeneration peak, many of the cells had 
attached clusters of indicator erythrocytes at one, or sometimes two, 
poles. Further, in this same preparation, many of the indicator EA M 
cells appeared to be 'sticky' since frequent pairs or even triplets of 
erythrocytes were seen. Thus it would appear that µFcR regeneration 
begins at one pole and the receptors then spread over the surface of the 
cell. This is similar to Sig re-expression where re-expression also 
starts at one pole (Loor et al, 1972). The indicator cell 'stickiness' 
observed can possibly be attributed to secretion of receptor material 
during the re-expression process: but there is no clear operational 
difference between shedding and secretion (Loor, 1977), hence the 
observed phenomena are probably a continuum of shedding, secretion, and 
integration of new receptor material into the cell membrane. 
The kinetics of EA rosette formation and re-expression by HCs M 
follow a cyclical pattern with a modal peak-to-peak re-expression time 
of 6 h. The turnover of the receptor was followed through three cycles 
and it is of interest to note that each re-expression peak was lower than 
I l 
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that preceeding. It is difficult to offer any definitive explanation 
for this observation, but it may reflect a consumption of available 
mRNA, since continued protein synthesis was shown to be required for 
re-expression of the receptor. However, since the HCs and indicator 
EAM cells were incubated together as a mixture in most tests, it is 
also possible that the indicator cells became progressively less 
sensitive due to binding free µFcR released by the HCs. Some support 
is lent to this interpretation by the higher re-expression peaks observed 
when the HCs were incubated without indicator erythrocytes and then 
rosette tested at the various time intervals. 
The requirement for protein synthesis together with the other 
general features of the receptor such as its inhibition by azide, its 
temperature dependence, and its inhibition by cytochalasin B make it 
likely that the receptor is an integral membrane component. Therefore 
the receptor kinetics probably reflect plasma membrane turnover. Another 
possibility is that this expression of membrane receptor is dependent on 
the cell cycle. However, this proposition is less attractive since no 
mitotic figures were seen through three cycles of re-expression, and 
cell cycle synchrony of the major population of cells throughout this 
time seems unlikely. 
It is of interest that in six of the seven HCL patients the 
peak-to-peak re-expression time was 5-8 h, a time directly comparable 
with the replacement of other membrane components in normal human 
(Ferrarini et al, 1976a; Lewis and Pegrum, 1977) and mouse (Wilson et al, 
1972; Vitetta and Uhr, 1972; Loor et al, 1972) B lymphocytes reported 
by others. This turnover time is considerably shorter than that 
reported for membrane protein turnover in rabbit alveolar macrophages 
I , 
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(Nachman et al, 1971), and it is tempting to speculate that this 
substantiates other recent immunological evidence favouring a B lymphocyte, 
rather than monocyte, lineage for the HCs of HCL (Catovsky, 1977). 
However, it is possible that the difference in membrane turnover times 
is attributable to. a species effect rather than to a true difference 
between lymphocytes and monocytes, or indeed to the population of 
lymphocytes under study since Melchers et al, (1975) have shown that 
memory B cells have a slow membrane turnover time. 
Since the cells of some cases of CLL also have a receptor for bound 
IgM it was possible to study the re-expression of this receptor using 
the same method. Whilst confirming previous reports of a reduced rate 
of membrane turnover in CLL cells (Minty and Sachs, 1975; Lewis et al, 
1977), this was also quantitated to around 12 h in four cases. One case 
of HCL with a membrane turnover time of 8 h appeared cytologically 
more mature than the 6 h cases and the range of turnover times reported 
here therefore strengthens suggestions that HCL encompasses a range of 
clinical and cytological features (Burns et al, 1973; Burns et al, 1977a) 
and suggests that cells from the more mature end of the spectrum closely 
resemble CLL cells. On the other hand, the pattern of turnover seen in 
the majority of cases of HCL indicates a clear difference between HCL 
and CLL and also shows that substantially reduced rates of membrane turnover 
are not an essential feature of chronic leukaemias. 
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III Distribution of the µFcR on haemic cells and the 
relationship of the µFcR on HCs to that on other cell types 
1. INTRODUCTION 
Receptors for IgM have been described on rabbit and guinea-pig 
macrophages and neutrophils (Henson, 1969), mouse peritoneal macrophages 
(Lay and Nussenzweig, 1969) and guinea-pig splenic macrophages (Rhodes, 
1973) • 
It is only recently that µFcR have been described on human haemic 
cells, and such receptors on human lymphocytes are currently the subject 
of considerable interest. A receptor for IgM was first described on 
normal peripheral T cells after a period of in v,lt/io incubation in 
IgM-free medium containing FCS (Moretta et al, 1975; McConnell and Hurd, 
1976). Later, an IgM receptor which did not require a period of 
preincubation for its detection was described in some patients with 
Hodgkin's disease (Habeshaw et al, 1976), on a small but uncharacterized 
population of normal lymphocytes (Barker et al, 1976), and on the 
pathological cells of both HCL (Burns et al, 1977a) and CLL (Pichler 
and Knapp, 1977; Cawley and Burns, 1977; Burns et al, 1977b). Recently, 
the presence of a µFcR on the cells of HCL and CLL has been confirmed 
(Ferrarini et al, 1977), and the same study has revealed that the 
receptor is also present on a population of normal human B lymphocytes. 
Very recently, independent confirmation of a receptor for IgM on human 
B cells has come from two other groups (Pichler and Knapp, 1978; 
Romagnani et al, 1978). 
The recognition of a µFcR on some T cells, and the subdivision of 
normal T cells into TM and TG populations, depending on whether they have 
I ' 
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a receptor for IgM or igG (Moretta et al, 1976), has found application 
in the study of lymphoproliferative disorders. Thus some cases of T-cell 
acute lymphoblastic leukaemia have been shown to be derived from the 
TM population (Moretta et al, 1977a), as have two cases of Sezary's 
syndrome (Worman et al, 1978). It has been shown that normal TM cells 
possess a helper function, while the mutually exclusive population of 
TG cells fulfills a suppressor function in the immune response (Moretta 
et al, 1977b), and since cells from the Sezary syndrome can also act as 
helper T cells (Broder et al, 1976) this function of TM cells probably 
remains true for pathological T-cell proliferations. 
The µFcR on B cells may also prove to have nosological and functional 
significance, and it is therefore of importance to establish the 
distribution of this receptor in populations of human haemic cells. The 
present section investigates a wide variety of lymphoproliferative 
disorders for the presence of IgM receptors and also considers differences 
in receptor expression between T cells and B cells. 
2. MATERIALS AND METHODS 
Clinical material from patients with a wide variety of haematological 
diseases was obtained, and details of the tissues studied are presented 
in the Results. The patients were diagnosed on clinical and haematological 
criteria, but where immunological marker studies assisted in the diagnosis 
these data are included in the relevant tables. In addition, PB samples 
obtained from 18 normal volunteers and 2 'normal' spleens were studied. 
The spleens, collected immediately after surgical removal, were from (a) 
a patient with hereditary spherocytosis and (b) a patient undergoing 
I : 
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radical surgery for stomach cancer. 
Z. Z Cul.:twte.d hae1t1ic. c.el.lo 
Cells were obtained from established cell lines as a kind gift 
from Dr. A. Karpas, Department of Haematological Medicine, University 
of Cambridge. Two of the lines studied were EBNA-positive B-cell lines 
(Lines 117 and 284) and details of these cells have been given by 
Karpas et al, (1977). The ENBA-positive B-cell line, Raji, was obtained 
as a kind gift from Dr. I. McConnell, MRC Group on Mechanisms in Tumour 
Immunity, Cambridge. Cells from a monoblastoid-cell line (230) (Karpas 
et al, 1978a), and cells from a cell line established from a patient 
with myelomonocytic leukaemia which had possessed T-cell features (241) 
(Karpas et al, 1978b) but which was now either transforming to, or 
being replaced by, cells with B-cell characteristics were also studied. 
Z.3 Ve;te.c,t.l,on oo the. µFc.R 
The indicator cells and the methods used for detection of the µFcR 
was exactly as described in Section I of this chapter. It should be 
emphasized that, unless otherwise stated, the receptor was detected on 
cells washed and resuspended in HBSSA without serum and that, apart 
from the routine 10 min incubation, no period of culture was involved. 
3. RESULTS 
3. 1 Notunal ma no Vlllc.le.M c.el.lo 
Peripheral blood At different times, the PB from 18 normal individuals 
was collected and the mononuclear cells isolated over Ficoll-Isopaque 
were rapidly tested for EAM rosette formation. At a time when the 
unsensitized ox erythrocyte control was negative, either 0% (4), 1% (3), 
2% (4), 3% (1), 5% (4) or 6% (1) formed EAM rosettes. 
: 11 
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Spleen The results obtained from 2 'normal' spleens are shown in 
Table 2.X. 
Nature of the cell forming EA rosettes Stained cytocentrifuge preparations 
revealed that the cells from normal PB which formed EAM rosettes were 
nearly all large esterase-negative lymphocytes. 
The very small percentages of cells forming rosettes in normal 
PB made further characterization difficult, however preliminary 
experiments were carried out in attempts to identify further these cells. 
PB mononuclear cells were allowed to adhere to a glass petri dish 
in the presence of 10% serum. After incubation for 15 min at 37°c, 
the dish was inverted and non-adherent cells collected. Weakly adherent 
cells were then washed from the dish with phosphate-buffered saline 
and glass-adherent cells were removed by treating them with 10 mM EDTA. 
The cells from each group were then washed and tested for EAM rosette 
formation. No rosettes were observed in the glass-adherent group, 1% 
was seen in the weakly adherent group, and 2% in the non-adherent cell 
group. 
In another experiment, T cells were removed from the PB mononuclear 
cells of 2 volunteers by E resetting the cells and centrifuging the 
rosetted population through a Ficoll-Isopaque mixture. Non-T cells 
were collected from the interface and tested for EAM rosette formation. 
In one sample 6% of cells formed rosettes, but in the other no rosette-
forming cells were seen. 
The surface marker characteristics of PB mononuclear cells from 
5 cases of ALL are given in Table 2.XI. It is clear that very few, if 
any, ALL cells form EAM rosettes. 
In one case (patient 5), mononuclear cells were incubated at 37°c 
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Table 2.X Immunological marker studies on the 
mononuclear cells from two 'normal' spleens 
Spleen 
a) hereditary spherocytosis 
b) stomach cancer 
yFc % 
35 
34 
µFe% 
4 
5 
E % 
45 
51 
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overnight in culture medium (RPMI) containing 10% FCS. After this 
time, 3% of cells formed EAM rosettes. 
3.3 B-Qe,lt lymphoma..6 and leukaemia..6 
Non-Hodgkin's lymphoma The mononuclear cells from the PB of 4 patients 
and from lymph nodes of 2 different patients with non-Hodgkin's lymphoma 
were examined for EA rosette formation. No patient had >3% rosette M 
formation by either PB or node mononuclear cells. 
Hodgkin's disease (HD) Mononuclear cells from the PB of 3 patients with 
HD were examined. One of the patients was in the terminal stage IV phase 
of the disease, and another had the rare leukaemic form of HD with 
some 39% of the pathognomonic Reed-Sternberg cells in the PB. In none 
of these patients were any EAM rosette-forming cells seen. 
The spleen of another patient with HD was also obtained for study; 
only 4% of splenic mononuclear cells formed EAM rosettes. 
In one case of HD, the PB mononuclear cells were cultured overnight 
in medium (TC 199) containing 10% FCS. After this time, the cells were 
washed and marker studies were repeated. The results are shown in 
Table 2.XII. It can be seen that the T cells in this case of HD 
required culture before forming E rosettes and that most T cells belong 
to the TG population with only some 20% cells forming EAM rosettes after 
culture (TM cells). 
Prolymphocytic leukaemia (PL) The PB from one patient with PL was 
obtained for study. The marker profile of mononuclear cells from this 
patient is given in Table 2.XIII. It can be seen that very few, if 
any, PL cells possess the µFcR. 
Chronic lymphocytic leukaemia (CLL) Mononuclear cells were obtained 
from the PB of 45 patients with CLL and tested for EAM rosette formation. 
In 15 cases, repeat blood samples were obtained on one or more occasions. 
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Table 2.XI Immunological markers in 5 cases of ALL 
Patient 
1 
2 
3 
4 
5 
% rosette formation 
yFc 
31 
5 
21 
5 
7 
µFe 
7 
0 
1 
0 
0 
E 
7 
9 
9 
2 
0 
' 
'' 
1.+·· r,I., 
. ' 
'· :, i}) 
':i ', 
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Table 2.XII Immunological markers in a case of HD 
* 
Material 
Freshly isolated 
mononuclear cells 
* Cultured cells 
% rosette formation 
yFc ]JFc E 
76 0 36 
63 20 66 
Cultured overnight in TC 199 + 10% FCS 
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Table 2.XIII Immunological markers of mononuclear cells 
from the PB of prolymphocytic leukaemia 
+ 
++ 
yFc 
58 
% rosette formation 
µFe 
4 
+ EAC 
15 
++ Mo 
1 
E 
1 
Receptor for fixed C3 (see Chapter 3) 
Receptor for mouse erythrocytes (see Chapter 3) 
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The results obtained for EA rosette formation in the 45 patients are M 
presented in Table 2.XIV. From the table, it is clear that the majority 
of cases of CLL possess the µFcR. Also, with some exceptions, the 
receptor is consistently expressed on about the same proportion of cells 
when repeat testing is carried out on a single case. 
Full surface marker phenotyping was carried out on 25 of the cases 
of CLL. Comparison of the surface receptors with µFcR expression in 
these cases did not reveal any definite pattern. However, of the 25 
cases only 5 failed to express Sig (Chapter 4), and 4 of these cases 
also had very low µFcR expression (Table 2.XIV). On the other hand, 
the fifth Sig-negative case had a high percentage of cells expressing 
the µFcR, and at least 2 cases with low µFcR expression had a high 
percentage of Sig positive cells {Table 2.XIV). None of the 5 Sig 
negative cases had >5% T cells as assessed by E-rosette formation, and 
indeed none of the 45 cases of CLL were of the T-cell type by this 
criterion. All of the CLL cases tested invariably possessed a high 
percentage of cells which also bore a receptor for the Fe of IgG. 
It was observed that the percentage EAM rosette formation obtained 
in some cases of CLL was much higher under standard conditions (37°c, 
10 min) than when the test was performed at room temperature. This 
was confirmed in all but 4 of 21 cases of CLL tested, and the results 
shown in Table 2.XV illustrate that the difference in percentage rosette 
formation at the two temperatures, is much more pronounced than that 
in PB HCs (Table 2.VI, Section I) and is similar to that in splenic HCs 
(Table 2.VII, Section I). Incubation at 37°c for longer than 10-15 min 
caused CLL lymphocytes, like HCs, to shed the µFcR (Figure 2.19, 
Section II) • 
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Table 2.XIV EA rosette formation in CLL 
; \ i Patient % EAM rosettes 
1 61, 59, 62, 48 
2 51, 77 
3 55 
4 16, 33, 3, 34, 14 
5 40, 45, 27 
6 11 
7 43, 51 
8 36 
9 24 
10 30, 31 
11 10 
12 79 
* 13 <1, 5, 3 
* 14 5, 2, <l 
15 36 
16 14 
17 38, 74 
18 45, 80, 26 
19 3 
20 72 
21 26, 16 
22 25 
23 48 
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Table 2.XIV continued 
I, 
Patient % EA 
M rosettes 
24 53 
25 20 
26v 89, 78 
27 79 
28 54, 17 
29+ 11 
* 30 8 
31+ 0 
32 25 
33 53 I 17 
* 34 8 
35 54 
36 20 
37 o, 65 
38 31 
39 49 
40 87 
41 97 
42 72 
43 95 
44 50 
45 15 
* Negative for surface immunoglobulin (Sig) 
V 
Negative for Sig 
+ 
The majority of cells possess monoclonal Sig 
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The pathological plasma cells from a total of 25 patients with a 
variety of immunoproliferative diseases was studied. These patients 
included: 8 with IgG myeloma (2 with plasma cell leukaemia); 6 with 
IgA myeloma; 1 with Bence-Jones myeloma and one with primary amyloidosis; 
2 with IgD myeloma; 2 with IgM myeloma; and one with IgE myeloma. In 
addition, 4 patients with mixed lymphoid/plasmacytoid proliferations 
were studied: one of these presented the typical clinical and 
pathological features of Waldenstrom's macroglobulinaemia, while 2 
others presented a similar picture, but with IgA paraproteinaemia; the 
final patient presented with substantial hepatosplenomegaly and 
widespread lymphadenopathy, and a marrow infiltration with 15% and 6% 
of lymphoid and plasmacytoid cells respectively (lymphoma with IgM 
paraproteinaemia). 
PB and bone marrow was examined in all the cases, and in none did 
EAM rosette formation exceed 6%. No plasma cells were ever seen to 
form EAM rosettes. 
3.5 Monoey~e..o and hlo:tloey~e..o 
Acute monocytic leukaemia (AMoL) The results obtained in 6 cases of 
AMoL are presented in Table 2.XVI. These results clearly show that 
the majority of leukaemic monocytes do not form EAM rosettes and the 
high percentage of cells with (strong) yFcR incidentally confirms the 
purity of the EAM reagent. 
Chronic myelomonocytic leukaemia The PB from 3 patients, and a lymph 
node and bone marrow aspirate from one of these patients was examined 
for cells forming EA rosettes. In only one patient were the PB cells 
M 
found to form any rosettes (6%), and these cells had a lymphoid 
morphology. 
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Table 2.XV The effect of temperature on EA rosette formation 
by CLL lymphocytes from PB 
% rosette formation at: 
Patient 
24°c* 37°c 
59 45 
1 48 5 
61 39 
2 51 40 
3 51 55 
4 33 8 16 1 
5 40 34 
6 11 3 
7 52 26 
8 36 20 
9 24 21 
10 30 18 
11 10 21 
12 79 22 
13 5 0 
14 5 2 
15 36 12 
16 14 20 
17 38 27 
18 45 19 
19 3 0 
20 72 15 
21 26 32 
* 
approximate room temperature 
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Table 2.XVI Immunological marker data on isolated 
mononuclear cells from the PB of 6 cases of AMoL 
% monocytoid 
% cells resetting Patient cells in cytocentrifuge 
preparations yFc µFe E 
1 96 99 0 4 
2 70 33 0 t 
3 90 85 11 3 
4 40 36 0 2 
5 70 66 0 <l 
6 so 87 0 14 
t 
not done 
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Histiocytic diseases Mature histiocytes; from the spleen of a case 
of Gaucher's disease, from the bone marrow of a case of sea-blue 
histiocytosis, and from the PB of a case of sinus histiocytosis were 
examined for EA rosette formation. The results given in Table 2.XVII M 
show that histiocytes do not possess µFcR. 
Acute promyelocytic leukaemia (APL) Peripheral blood cells from one 
case of APL and bone marrow cells from another case were examined for 
EAM rosette formation. The immunological markers obtained in these 2 
cases of APL are given in Table 2.XVIII, and it is clear that the 
promyelocytes, or hypergranular myeloblasts, of this disease do not 
form EAM rosettes. 
Chronic granulocytic leukaemia (CGL) The PB cells from 4 cases of CGL, 
and BM cells from 2 of these cases, were examined for EAM rosette 
formation. In no case was more than 1% of rosette-forming cells seen. 
3.7 Pa.-thologieal T ee.£.l6 
Two patients with Sezary's syndrome were examined. Mononuclear 
cell preparations from the PB of both patients contained over 90% of 
the typical pathological T cells. By the standard EAM technique, freshly 
isolated mononuclear cells from the 2 patients formed 4% and 9% EAM 
rosettes respectively. 
Surface marker studies of cells from these 2 patients showed that 
whereas over 90% of cells formed E rosettes, cells from both patients 
lacked receptors for yFc and fixed C3 (Table 2.XIX). The patients' 
cells were then cultured overnight in either RPMI medium alone, or 
the same medium supplemented with 10% FCS or 10% autologous serum. 
After this time, the marker studies were repeated; these results are 
given in Table 2.XIX. Throughout the period of culture the cells retained 
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Table 2.XVII Immunological markers in histiocytic diseases 
% rosette formation 
Disease tissue yFc µFe + EAC E 
Gaucher's spleen 71 0 68 5 
Sea-blue histiocytosis bone marrow 80 0 50 24 
Sinus histiocytosis PB 84 0 4 0 
+ Receptor for fixed C3 (Chapter 3) 
I 
,I 
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Table 2.XVIII Immunological surface markers in APL 
% rosette formation 
Case tissue 
yFc µFe EAC+ E 
1 PB 70 0 2 25 
2 BM 17 0 0 28 
+ Receptor for fixed C3 (Chapter 3) 
100 
100% viability, as assessed by trypan blue dye exclusion. The 
percentage of cells forming E rosettes was consistently high and did 
not fall with culture in the one patient tested. Following culture 
in medium containing 10% serum, but not in medium alone, a large 
proportion of the Sezary cells in both cases were seen to form EA 
M 
rosettes, but not EAG rosettes. This observation of µFcR without 
yFcR incidentally confirms that contaminating IgG in the EAM reagent 
is not the cause of EAM rosette formation. 
The time course of µFcR expression by Sezary cells was followed 
by removing aliquots from the cultured cells at various time intervals 
and testing for E and EA rosette formation. As is shown in Figure M 
2.20, there was a progressive rise in the percentage cells forming EAM 
rosettes until about 6 h when a plateau was reached. At no time 
did more than 10% cells form EAM rosettes i.n the absence of serum, and 
autologous serum was as effective as FCS in enhancing rosette formation. 
Cytocentrifuge preparations from the rosette populations confirmed that 
it was the pathological Sezary cells which were forming rosettes 
(Figure 2. 21) • 
The effect of temperature on µFcR expression by Sezary cells was 
tested by maintaining leucocytes on ice in parallel with the time-course 
experiment described above. In no instance was more than 11% cells 
observed to form EAM rosettes when removed from the ice and mixed with 
indicator erythrocytes for 10 min prior to scoring. 
3.8 Cul:t.u!ted Qe£.l6 
The three B-cell lines examined for µFcR (Raji, Line 117 . and Line 
284) were all weakly positive. The percentage EAM rosette formation 
was: Raji, 4%; 117, 6%; 284, 3%. The EBNA-negative monoblastoid-cell 
line was completely negative for EAM and for all other surface markers 
1 
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Table 2.XIX Surface marker profile of the m~nonuclear cells from two patients 
with Sezary 's syndrome on initial isolation and following culture 
% rosette formation 
Patient E yFc µFe 
* Cultured Cultured Cultured Fresh Fresh Fresh 
1 2 3 1 2 3 1 2 3 
l+ 96 nt§ 96 nt 2 2 2 2 4 9 66 66 
2++ 93 nt 3 nt 9 6 43 nt 
* 
EAC 
Fresh 
I-' 
0 
I-' 
<l 
3 
Culture in 1. RPMI alone 2. RPMI + 10% FCS 3. RPMI + 10% autologous serum 
+ Culture for 12 h: mean of 2 occasions studied. 
++ Culture for 9 hat 37°c. 
§ Not tested 
. .~ . . ·-· - .,. -· -' - - -
~; ~~"~-:i:~-~~~:-~:-~:?;.~ =; -_~-;;-~q-- ~ ----
.-~ -",._.:,__. 
-
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ct 
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Figure 2.20 The effect of time and serum on the percentage EA 
rosette formation by Sezary cells from patient 1 cultured at 3,0 c : 
RPMI alone {O); RPMI supplemented with 10% FCS (~); RPMI supplemented 
with 10% autologous serum (O). 
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examined. 
Cells from line 241 did not form EAM rosettes on the first 
occasion of study (Table 2.XX). At this time, the majority of the 
cells formed E rosettes and were possibly T cells although there was 
a population of cells, possibly B cells, which formed spontaneous 
rosettes with mouse erythrocytes. A repeat marker study after a 
further 3 mo in culture (Table 2.XX) revealed the emergence of a 
B-cell clone which was Sig positive and E rosette negative. At this 
time, 20% of the cells formed EAM rosettes. 
4. DISCUSSION 
This study has shown that the µFcR which is present on HCs is 
absent from the cells of a wide variety of human leukaemias, lymphomas 
and allied disorders when the same methods of detection are used. Of 
the diseases studied, only CLL had a significant proportion of cells 
which express this receptor. 
Thus the lymphoblasts of non-TALL, the prolymphocytes of PL 
(Galton et al, 1974), and the mature B cells from several patients with 
lymphoma, all lacked the µFcR. 
Although the exact nature of the Hodgkin's infiltrate is unknown, 
it is assumed that the large Reed-Sternberg cell is involved in the 
neoplastic process (Siegal and Good, 1977). This cell may be of 
B-cell (Hayhoe et al, 1978) or of histiocytic lineage (Siegal and Good, 
1977). Material from a case of Reed-Sternberg cell leukaemia (Hayhoe 
et al, 1978) afforded an opportunity to study the immunological markers 
present on such cells. Cells from this case, and morphologically normal 
cells from the PB and spleen of other cases of HD uniformly lacked 
:, jL 
:1 
,: 
' 
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Table 2.XX Surface marker profile of cell line 241 
on two occasions of study 
% rosette formation 
Date of study 
yFc µFe EAC 
16.3.77 0 0 0 
27.6.77 13 20 23 
+ Receptor for mouse erythrocytes 
++ Surface immunoglobulin (Chapter 
+ Mo 
15 
0 
(Chapter 
4) 
E 
90 
0 
3) 
++ Sig 
0 
D19, 
Ml5, 
K9 
I I 
105 
Figure 2.21 Cytocentrifuge preparation of a Sezary cell forming an 
EA rosette after 6 h in culture. The convoluted nucleus of this 
ty~ical Sezary cell is well illustrated. 
. j 
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receptors for IgM. This result is at variance with a single report 
from Habeshaw et al, (1976) who obtained EAM rosette formation in the 
morphologically normal PB of 5 of 32 patients with HD studied. Habeshaw 
et al, did not preincubate their cells but used the same procedure as 
is described in this chapter. It may be that the limited studies 
reported here have merely failed to encounter a case of µFcR-positive 
HD. However, Habeshaw et al, comment that they were perhaps detecting 
immature T cells, and their PB findings of only 34% T cells in the single 
case in which data are presented, together with only 29% EAM rosette 
formation in the same case, suggests that this might be the case. A 
serum factor in the PB of HD patients often prevents a large proportion 
of T cells from forming E rosettes (Siegal, 1976), and these cells can 
be made to reattain normal rosette-forming ability by culturing overnight 
in medium containing FCS. Since these are the same requirements as for 
EAM rosette formation by T cells (see below), it was of interest to 
examine PB cells from patients with HD for the proportions of TM and 
TG cells (Moretta et al, 1977b). This was done in a single case. Culture 
of the lymphocytes from HD patients restored the E-rosette forming-ability 
of T cells but also revealed a gross distortion in the proportions of 
TM to TG in this disease; TM cells were markedly depressed and TG cells 
correspondingly increased. This result may be of some interest since 
the T cells in HD respond poorly to PHA and since the PB of patients with 
HD has increased suppressor lymphocyte activity (Siegal, 1976): both of 
these features characterize the functional capacities of TG cells 
(Moretta et al, 1977). 
Terminal B cells, as seen in a variety of inyelomas, universally 
lacked the µFcR. Human leukaemic monocytes, histiocytes and granulocytic 
cells also lacked the receptor and may thus differ from animal cells of 
11 1 
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these types (Henson, 1969; Lay and Nussenzweig, 1969; Rhodes, 1973). 
Incidentally the results from two cases of APL recorded here, whilst 
showing the absence of the µFcR, substantiate studies of murine 
neutrophil maturation which show that the yFc receptors appear at an 
early phase of neutrophil differentiation that precedes the appearance 
of complement receptors (Rabellino et al, 1978). 
The B lymphocytes of CLL and the T lymphocytes from two cases of 
the Sezary syndrome both expressed a receptor for IgM; and the µFcR was 
also present on a small population of normal PB and spleen cells. The 
different conditions required to demonstrate IgM receptor expression by 
B cells and T cells are well illustrated by the pathological cells from 
these two conditions. 
Thus the B cells of CLL express the receptor without culture in 
medium containing serum, and cells bearing the µFcR simultaneously bear 
yFcR. This result agrees with the findings of Pichler and Knapp (1977), 
and Romagnani et al (1978) for CLL cells. The failure of Ferrarini et al, 
(1977) to detect µFcR on some of their cases of CLL without preincubation 
can almost certainly be attributed to receptor shedding during the cell 
isolation procedure. Whether these conditions are also true for normal 
B cells is difficult to determine. The results in this section suggest 
that the few normal PB cells which express µFcR without culture may be B 
lymphocytes. However, normal PB contains very few IgM receptor-bearing 
B cells (B cells), most B cells being found in the tonsil (Pichler and M M 
Knapp, 1978; Ferrarini et al, 1977). Also, the techniques required for 
BM cell detection are prolonged (T cell depletion) and probably enable 
µFcR shedding to take place. 
The expression of µFcR without incubation appears to be a feature 
of BM cells as opposed to TM cells. There have been reports of receptor 
I I 
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expression by TM cells immediately after isolation (Gmelig-Meyling 
et al, 1976; Bolhuis and Nooyen, 1977), but this has not been the 
experi.ence of most authors either for normal TM cells (Moretta et al, 
1975; McConnell and Hurd, 1976; Ferrarini et al, 1977; Conradie and 
Bubb, 1977; Preud'homme et al, 1977b; Romagnani et al, 1978), or for 
the pathological TM cells of the Sezary syndrome recorded here. It is 
difficult to account for the findings of Gmelig-Meyling et al, and 
Bolhuis and Nooyen, but the latter workers do manipulate their cells in 
PCS-containing medium and, particularly in their mixed rosette tests, 
their washing and incubation steps can take as long as 40 min: the 
data presented in this section shows that this time is probably long 
enough for µFcR expression by some TM cells. The observation that 
autologous serum was as effective as FCS in the culture medium 
contradicts the findings of Moretta et al (1975}. This. is not due to 
a peculiarity of Sezary cells since Romagnani et al (1978) have recently 
recorded the same findings for normal human T cells. It is possible 
that there is a serum factor present in only some sera, analogous to 
the blocking factor for E rosette formation present in some HD sera but 
not others (Siegal, 1976). 
Receptors for IgM and IgG on both pathological and normal human T 
cells appear to be mutually exclusive (McConnell and Hurd, 1976; Moretta 
et al, 1976, 1977b), and this therefore is another major difference 
between TM cells and (pathological) BM cells. 
Recent reports have agreed in showing that detection of the µFcR 
on BM cells requires the EAM indicator cells to be coated with a higher 
concentration of IgM than is required for TM receptor detection 
(Ferrarini et al, 1977; Pichler and Knapp, 1978; Romagnani et al, 1978). 
These same reports also emphasise the difficulty encountered in blocking 
"I. J 
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EA rosette formation by B cells when using whole IgM. Pichler and 
M 
Knapp (1978) have demonstrated that the µFcR of CLL cells is much more 
effectively blocked when IgM is complexed to its antigen, and this is 
also true for HCL cells (Section I). These findings may reflect a 
difference between the receptors on T and B cells since the T M M M 
receptor is very efficiently blocked by native IgM (Moretta et al, 1975; 
McConnell and Hurd, 1976; Ferrarini et al, 1977; Romagneni et al, 1978). 
Since the IgG receptors for native and complexed IgG on murine leukaemia 
cells may be separate (Cooper et al, 1977), the difference in TM and 
BM µFcR binding may have a molecular basis, although there is one 
report of more efficient monomeric IgM binding by T cells (Preud'homme 
et al, 1977b). 
The finding of the µFcR on a small number of cultured human B-cell 
lines agrees with the recent findings of Pichler et al (1978). Pichler 
et al, established that the EAM indicator cells had to be coated with a 
high density of IgM, that all of the 4 B-cell lines tested, but not 
the MOLT 4 T-cell line, expressed µFcR and that receptor expression did 
not necessarily indicate a particular class of Sig expression or secretion. 
In this section it is shown that B-cell lines, but not cultured 
monoblastoid cells or T cells, express the receptor. However, it is 
also shown that receptor expression is not dependent on either EB virus 
infection or on any Sig expression since the HC line (Section I) was 
EBNA negative and line 117 is Sig negative (Karpas et al, 1977). 
Finally, mention should be made of the possible significance of 
the B cell µFcR both in T-B cell co-operation and in B-cell ontogeny. 
The important functional differences between TM and TG cells are 
established (Moretta et al, 1977), and there is mounting evidence that 
under some conditions yFc can activate both human (Moller, 1969; Cooper i, .j l' 11) 
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Seligmann, 1977) and mouse (Berman and Weigle, 1977) lymphocytes. 
The role of the BM cell awaits further study, but it is shown here 
that of a wide variety of B-cell disorders, the µFcR is restricted 
to the cells of HCL and CLL. Several pieces of evidence, including a 
slow Slg replacement time and the presence of SigG in many cases 
(Chapter 4) make it possibl e that both HCL and CLL represent clonal 
expansions of memory B cells. The intriguing possibility exists that 
binding of IgM-antigen complexes to memory B cells is one of the signals 
inducing them to secrete IgG. 
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CHAPTER 3 
OTHER IMMUNOLOGICAL MARKERS IN HAIRY-CELL LEUKAEMIA 
I The y Fc receptor and the la-like antigen 
1. INTRODUCTION 
2. MATERIALS AND METHODS 
2. 7 Pa;Ue.nu, .tl6-6u.v.i and c.eil. p11-e.pcvz.a;Uo n 
2.2 lncltc.ax.on c.eil.-6 and EAG no-6e;t;te. 6onma;Uon 
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OTHER IMMUNOLOGICAL MARKERS IN HAIRY-CELL LEUKAEMIA 
I The yFc receptor and the Ia-like antigen 
1. INTRODUCTION 
Most of the major studies of HCL have agreed that HCs have 
receptors for the Fe of IgG (yFcR) (Fu et al, 1974; Haegert et al, 1974; 
Jaffe et al, 1974; Utsinger et al, 1977; Catovsky, 1977; Cawley et al, 1978, 
1978a; Jansen et al, 1978). However, the methods used to detect the 
receptor have varied, and some workers have concluded that the nature 
of the yFcR on HCs is evidence for these cells belonging to the 
monocyte-histiocyte series (Jaffe et al, 1974; King et al, 1975). 
Various human haemic cells can be shown to possess yFcR and 
subpopulations of most cell types probably express the receptor at some 
stage of development, thus: T cells (Ferrarini et al, 1975); B cells 
(Dichler and Kunkel, 1972); monocytes (Huber et al, 1968); and neutrophils 
(Messner and Jelinek, 1970) have all been demonstrated to possess surface 
receptors for IgG. Unclassified cells variously described as third 
population cells (Fr~land and Natvig, 1973), null cells (Chess et al, 1975), 
K cells (Perlmann et al, 1976) and L cells (Horwitz and Lobo, 1975) also 
carry yFcR. Although these unclassified cells are probably heterogeneous 
in terms of both their surface marker phenotypes and their potential 
function (Horwitz and Garrett, 1977; Schlossman and Chess, 1976), a 
characteristic finding among studies of the various cell types within this 
group is the possession of a strong receptor for IgG. The yFcR on this 
uncJassified cell group (UCG) bears many similarities to the yFcR on 
monocytes and macrophages, and differs in many respects from the yFcR 
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present on Sig-positive B lymphocytes; these differences are set out 
and compared with the yFcR on HCs in Table 3.I. 
A differentiation antigen has been identified in man by absorbing 
alloantigens of the HLA-A, HLA-B and HLA-C groups from pregnancy sera 
with platelets and studying the properties of the residual serum 
(Winchester et al, 1975). At the same time, a heteroantiserum raised to 
purified glycoprotein from the HLA-D linked B-cell antigen complex 
(p 29,34) (Humphreys et al, 1976; Springer et al, 1976, 1977), has been 
tested and found to be identifying the same antigen as the allosera. The 
alloantigens thus identified have been provisionally designated HLA-DR 
(.for D-related) (WHO Report, 1977), although the name of, Ia-like antigen, 
is in general use because of its relationship to the Ia antigen of the 
murine H-2 system. 
The Ia-like antigen is present on normal and leukaemic human B 
cells (Arbeit et al, 1975; Schlossman et al, 1976; Billing et al, 1976), 
on subsets of the UCG and monocytes (Schlossman et al, 1976; Chess and 
Schlossman, 1977) and on the cells from non-T acute lymphoblastic leukaemia 
(Schlossman et al, 1976). Human T cells bearing a receptor for the Fe 
of IgG (.TG cells) probably also possess the Ia antigen but at low density 
(.Samarut et al, 1977), and the antigen is also to be found on human 
myeloid stem cells (Cline and Billing, 1977), and on the neoplastic cells 
of both acute myeloid (Schlossman et al, 1976) and some cases of chronic 
myeloid (Janossy et al, 1977; Barnard et al, 1978) leukaemias. However, 
since the Ia-like antigen is not found on mature granulocytes or on the 
plasma cells of multiple myeloma of any class (Schlossman et al, 1976; 
Kadin and Billing, 1978; Halper et al, 1978; Burns et al, 1978d), the 
Ia-like antigen is probably an early differentiation antigen which is 
lost in the final maturation steps of B cells and myeloid cells (Burns et al, 
I, j 
a, 
Table 3.I Comparison of the yFcR on monoQytes and UCG+ , on B l ymphocytes, and on HCs 
Test 
EA rosette formation with erythrocytes 
co~ted with <5,000 IgG molecules (e.g. with 
anti-Rh or anti-Forssman antibodies) 
Deformation of sensitized erythrocytes 
forming rosettes 
Binding of EAG by frozen sections of 
tissue 
Receptor sensitive to protease 
Receptor blocked by anti-Ia-like antigen++ 
Monocytes and UCG B lymphocytes 
+ 
+ 
+ 
+ 
+ 
HCs 
+ 
+ 
+ 
Reference 
Shevach et al, 1973 
Jaffe et al, 1974 
King et al, 1975 
Natvig and Froland, 1976 
Lobo and Horwitz, 1976 
Lo Buglio et al, 1967 
Parker and Stuart, 1978 
Burns et al, 1978a 
Shevach et al, 1973 
King et al, 1975 
Deegan et al, 1976 
Matre et al, 1977 
Dickler, 1974, 1977a 
Matre et al, 1977 
Dickler, 1976a, 1976b 
Schlossman and Chess, 1976 
Solheim et al, 1976 
Burns et al, 1978a 
+ 
++ Unclassified cell group includes null cells, K cells, third population cells and L cells (see text1. Blocking of EAG rosette formation, but not antibody-mediated cell cytotoxicity. 
I-' 
I-' 
O'I 
L.l'B" . ...... _-...c.._. ·=-- ~~~~f~ ~~~~~-:-·~;=~~~·'.~~ - - ·-;?:2,~-=~:-~~,-~~~ L ~:~~- ~~ 
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1978d; Ross et al, 1978). 
The !a-like antigen is probably interrelated with but not identical 
to, the yFcR (Solheim et al, 1976; Chess et al, 1976; Dickler et al, 
1977; Woofsy et al, 1977). The nature of this relationship, whilst 
not fully understood, appears to be different with different cell 
types. Thus, anti-la-like serum blocks IgG binding by B cells 
(Dickler 1976a, 1976b; Solheim et al, 1976; Dickler et al, 1977) and 
TG cells (Samarat et al, 1977), but not binding by the UCG or 
monocytes (Chess et al, 1976; Dickler, 1976b). 
This section sets out to determine the nature of the yFcR on 
HCs, and while confirming previous reports that HCs possess the !a-like 
antigen (Naeim et al, 1977; Burns et al, 1977d) establishes that IgG 
binding by HCs is not blocked by anti-la-like serum. 
2. MATERIALS AND METHODS 
The details of all the patients with HCL studied, and details 
of the tissues and mononuclear cell isolation have been given in 
Chapter 2. On every occasion that cells from a case of HCl were 
obtained, the cells were tested for the presence of the yFcR. 
The preparation of EAG indicator cells was exactly as described in 
Chapter 2. On occasions when indicator erythrocytes coated with a low 
density of IgG were required, this was done by sensitizing the ox 
erythrocytes with serial dilutions of IgG antiserum as described 
previously (Chapter 2.I). 
,J 
H 
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Rosette formation with EAG was performed in 3 ways: 
a) The formation and scoring of EAG rosettes has been 
described in Chapter 2. After the suspension scores had been read 
Suspension 
the morphology of rosette-forming cells was checked by staining 
cytocentrifuge preparations with Giemsa. 
b) Monolayers The ability of HCs to adhere to glass (Rieber et al, 
1977) was utilised. Lab-Tek (Miles Laboratories Inc., Illinois) 
tissue culture slides were employed as suitable chambers to hold 1 ml 
washed mononuclear cell preparations at 1 x 106/ml in 20% homologous 
serum over the clean glass slides. The cultures were incubated at 37°c 
for 80 min before thoroughly washing in HBSSA to remove non-adherent 
cells. As a control both for glass adherence and for EAG rosette 
formation, monolayers of monocytes from normal PB were prepared and 
tested in the same way. 
The chambers holding the monolayers were then flooded with 1 ml 
EAG at 1% in HBSS, and indicator cells of different degress of 
sensitization were tested for EA rosette formation. After 30 min at 
. G 
room temperature, the chambers were inverted and gently rinsed with 
HBSSA before reading for rosette formation by the monolayer of cells. 
These monolayers were occasionally stained with Giemsa, although red 
cell attachment could be seen without staining. 
c) Frozen sections Cryostat sections were cut from pieces of 
spleen from one patient (HR) with HCL. The sections were cut immediately 
after the spleen was removed, and allowed to attach to glass slides. 
Cytological and cytochemical staining of the sections demonstrated that 
most of the cells were HCs. The glass slides with the sections 
attached were transported to the laboratory in containers filled with 
HBSSA. The slides were then placed in petri dishes and flooded with 
i I 
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indicator cells at 1% (EAG, EAM, EAC, E) for 30 min at room 
temperature, or 15 min at 37°c followed by 1 hat 4°c (for EA and E). 
M 
After this time the sections were washed gently with HBSSA, then 
stained with Giemsa and read for erythrocyte attachment. 
2.3 Immun.ot5luo1tuc.e.n.t 1.,.ta.inin.9 wdh a.n:U-Ia.-Uk.e. f.>e.Jtum 
The rabbit antiserum raised against purified p29,34 Ia-like 
antigen (Springer et al, 1976) has been described in Chapter 2. Very 
little of the antiserum was available and therefore F(ab) 2 fractions 
were not prepared. Because of this, staining was usually carried out 
on cytocentrifuge preparations of cells which had been acetone fixed 
at -20°c overnight in order to prevent Fe binding of the antisera. 
An indirect staining technique was employed; the cells were first 
stained with the anti-Ia-like serum at a dilution of 1/50, washed 
with HBSS, and then stained with a goat anti-rabbit serum at 
appropriate dilution. 
Under these conditions, control preparations of freshly-isolated 
CLL cells, and cells from several B-cell lines, showed strong membrane 
fluorescence, whereas freshly isolated cells from a case of T-cell 
Sezary Syndrome and cells from an established T-cell line (Line 45) 
(Karpas et al, 1977) did not stain at all. Preparations examined with 
this serum were particularly clean, and it is interesting to note 
that the bone marrow cells from several cases of myeloma were also 
negative (Burns et al, 1978d) thus confirming the results of others 
for plasma cells (Kadin and Billing, 1978; Halper et al, 1978). 
2 • 4 Blo c.k.in.g by a.n;U- Ia.-Uk.e. f.> e.Jtum 
The procedure used for blocking by antisera has been described 
in Chapter 2. For blocking, the anti-Ia-like serum was diluted to 
1/50 in HBSS, and a normal rabbit serum at the same dilution was employed 
as a control. 
I 
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3. RESULTS 
It was shown in Chapter 2 that HCs formed rosettes with the EAG 
reagent. The standard EA reagent is very sensitive and in all 
G 
the cases of HCL studied, most, or all, HCs formed rosettes. 
Percentage EAG rosette scores obtained from the PB of HCL cases 
reflect mostly the varying HC involvement. The spleens obtained from 
HCL patients, however, comprise of >80% HCs, and the point of yFcR 
expression by HCs is better made by examination of splenic EAG scores. 
The results of EAG rosette formation by the splenic mononuclear cells 
from 11 patients with HCL are given in Table 3.II. Cultured HCs continue 
to express the yFcR; after 18 days in culture 99% of cells formed EAG 
rosettes and after 66 days 93% continued to do so. 
HCs which had adhered to glass as a monolayer, and HCs in ~.lt.u 
in frozen sections of spleen, bound EAG. Monolayers of HCs bound ox 
erythrocytes coated with dilutions of IgG at 1/50, 1/100, 1/200 and 
l/300 just as effectively as the monolayers of normal human monocytes 
used as a control. In neither the monolayer preparations, nor the 
sections of spleen, were any HCs observed to bind unsensitized ox 
erythrocytes, erythrocytes sensitized with IgM, or with IgM + mouse 
complement (EAC). 
3.2 yFeR den.6,i.;ty, ~hedd,i,ng and mo~phology 
Percentage rosette titrations were carried out with EAG indicator 
cells coated with serial dilutions of IgG. The results of these 
experiments were given in Chapter 2 (Figure 2.7), and it was shown 
that rosette formation between PB HCs and normal PB monocytes started 
to fall off at around the same dilution of sensitizing IgG antibody. 
i, ... :! i:11:,•i 
! 
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Table 3.II EAG rosette formation b y the mononuclear cells 
obtained from the spleens of 11 patients with HCL 
Patient % EAG rosette formation 
RH 80 
MB 78 
PS 91 
NW 82 
LH 96 
DC 90 
LP 94 
AD 93 
HR 91 
AB 91 
AF 95 
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In order to determine whether the yFcR, like the µFcR, is 
shed and regenerated, it was necessary to reduce the sensitivity of 
the indicator EAG cells to a minimum. A repeat EAG rosette titration 
was carried out with the PB HCs from 1 patient (HR). The highest 
plateau dilution of coating IgG was found to be 1/600. Figure 3.1, 
which plots the% rosette formation with time by PB HCs when held as a 
mixture with 1/600 EAG at 37°c in the presence and absence of puromycin, 
demonstrates that the receptor for IgG is shed and that the regeneration 
process requires protein synthesis. 
Electron microscopy revealed that the EAG indicator cells were 
deformed by rosette formation with HCs. This has previously been 
illustrated in Chapter 2 (Figure 2.8), and a further example is shown 
in Figure 3.2 Such deformation of the indicator erythrocytes was a 
general feature of EAG rosette formation but was not seen with EAM 
rosettes. 
Staining for the Ia-like antigen was performed on splenic HCs 
from 2 patients (LP and LH) and the PB mononuclear cells from 3 patients. 
The results are given in Table 3.III, and it is clear that when allowance 
is made for T cells (which are negative by this method of identification) 
almost all HCs are positive for the la-like antigen. Over 90% of 
cultured HCs also stained with this anti-p29,34 antiserum. 
Blocking of EAG rosette formation in the presence of anti-la-like 
serum was attempted, on two occasions, with cultured HCs. On one 
occasion 3%, and on the other 4%, blocking was obtained from an initial 
EAG rosette formation of 93%. This concentration of serum both stained 
the HCs and totally blocked EAM rosette formation by them. 
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Figure 3.1 Kinetics of EA rosette formation by HCs. Mononuclear 
cells were incubated with Ei~G at 37°c in the presence ( O) and 
absence (O) of puromycin (2.5 µg/ml). Aliquots were removed for 
rosette testing at the times indicated and more than 200 cells were 
counted in each determination. 
'i 
Figure 3.2 EAG rosette formation by HCs. 
, I 
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Table 3.III Anti Ia-like, p29,34 antigen staining b y HCs 
Patient 
LH 
LP 
LH 
LH 
DC 
BN 
Material 
spleen 
spleen 
PB 
PB 
PB 
PB 
T cells (%) 
5 
18 
50 
23 
86 
44 
% cells staining 
Ia antigen 
90 
75 
50 
79 
16 
50 
I 
''I i' 
i 
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4. DISCUSSION 
In this section the presence of a receptor for IgG on HCs is 
confirmed, and it is shown that the heteroantiserum-erythrocyte complex 
used for detection identifies almost all HCs as yFcR positive. 
Various features suggest that the yFcR on HCs is different from 
the yFcR present on a population of human B lymphocytes and that it 
bears resemblances to the µFcR on monocytes and the UCG (Table 3.I). 
Thus, in agreement with others (Jaffe et al, 1974; King et al, 1975), 
it is demonstrated here that HCs form rosettes with indicator erythrocytes 
coated with low levels of IgG. It is of interest that EAG made with 
such low levels of sensitizing IgG were required to show that the yFcR on 
HCs is shed, thus confirming the observation of Sarmay et al, (1978) for 
normal and CLL cells. The time taken for shedding and re-expression of 
the yFcR by HCs is also seen to resemble the time for µFcR re-expression 
(Chapter 2; Burns et al, 1977b) by HCs. 
HCs, like monocytes, adhere strongly to glass in the presence of 
high levels of serum (Rieber et al, 1977), and in this section it is 
shown that they will bind EAG when tested in such monolayers. Similarly, 
macrophages in frozen sections of tissue bind EAG but lymphocytes do 
not (Shevach et al, 1973). The observation that HCs in frozen sections 
also bind EAG (Jaffe et al, 1974; King et al, 1975; Deegan et al, 1976; 
Matre et al, 1977) is confirmed here. The deformation of erythrocytes 
caused by HCs binding to EAG has been commented upon in Chapter 2, and 
this feature is also comnon to monocyte, but not lymphocyte, EAG rosette 
formation (Lo Buglio et al, 1967; Parker and Stuart, 1978). 
The finding of the Ia-like antigen on HCs (Naeim et al, 1977; Burns 
et al, 1977d), confirmed here, is not a specific feature of either 
(: 
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lymphocytes or monocytes. Nor is this an unexpected finding since it 
has been reported that HCs have the capacity to stimulate in allogeneic 
mixed lymphocyte cultures (MLC) (Kitani, 1976; Boldt et al, 1977) - a 
feature coded for by the HLA-D region of the HLA chromosomal complex. It 
has been suggested that in man, as for some Ia antigens in the mouse, 
the Ia-like antigens may be the major MLC-activating determinants (Arbeit 
et al, 1975; Zeijlemaker et al, 1976; Solheim et al, 1976). In this 
regard, it is of interest that only some 20% of the UCG are positive for 
the Ia-like antigen (Schlossman and Chess, 1976), and that antibody to 
this antigen, as with HCs reported here, does not block EAG binding by 
the yFcR of these cells whereas the yFcR of B cells is blocked by anti-Ia-
like serum (Arbeit et al, 1975; Solheim et al, 1976; Dickler et al, 1977). 
Within the UCG, an la-negative population (the L cells of Lobo 
and Horwitz (1976)) is very poor at stimulating in MLC (Horwitz and 
Garrett, 1977) as are human monocytes (Zeijlemaker et al, 1976). If, 
therefore, HCs are related to the UCG by virtue of the nature of the yFcR, 
it would most likely be to the la-positive subpopulation. This 
subpopulation has the capacity to secrete imrnunoglobulin and probably 
has low density Sig on the cell membrane (see Chapter 6). 
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II Receptors for fixed C3 and the Epstein-Barr virus 
1. INTRODUCTION 
There have been conflicting reports concerning the presence of a 
receptor for C3 on HCs, and this controversy is, as yet, unresolved 
(Catovsky, 1977). Some authors have reported the presence of a 
receptor for C3 on HCs when employing a resetting system using ox 
cells coated with IgM and complement (Haegert et al, 1974; Catovsky 
et al, 1974a, 1975). Others (Shevach et al, 1973; Jaffe et al, 1974; 
King et al, 1975; Jansen et al, 1978) have failed to find a receptor 
for C3 on HCs. 
The present section reports observations relating to this controversy 
and suggests that technical difficulties may account for previous 
reports showing the presence of a C3 receptor on HCs. Also, since there 
is a close relationship between C3 receptors on human B cells and 
receptors for the Epstein-Barr virus (EBV) (Jondal et al, 1976; 
Yefenof and Klein, 1977), a limited study was undertaken to investigate 
the presence, or absence, of receptors for EBV on HCs. 
2. MATERIALS AND METHODS 
2. 1 Pa.,tle.n;u and monon.u.cle.aJz. c.eU ,loola.,tlon 
Mononuclear cells were obtained from patients with HCL, CLL and 
normal individuals. The criteria for diagnosing the patients have been 
described in previous chapters, as have the cell isolation techniques. 
Briefly, a Ficoll-Isopaque mixture was employed and no particular 
precaution was taken to avoid monocyte contamination since monocytes 
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are virtually absent in HCL (Seshadri et al, 1976; Higgy et al, 1978; 
Burns et al, 1978b). 
2.2 CU-ltu.Jr.ed QeLf'...o 
Cultured hairy cells The establishment of the HC culture has been 
described in Chapter 2. After several weeks in culture the cells 
continued to display the typical morphological appearance of HCs and 
contained the isoenzyme 5 (tartrate resistant) of acid phosphatase 
characteristic of HCs (Yam et al, 1971) (Figure 3.3). 
The cells of this culture did not form the large clusters typically 
seen with lymphoblastoid cell lines, but grew very slowly as small 
clusters of a few cells over a monolayer of cells (possibly fibroblasts) 
from the original splenic material. Throughout the period of culture, 
the great majority of cells resembled HCs morphologically although, 
after 60 days, increasing numbers of larger cells (up to 10%) with a 
transformed appearance began to appear. Virtually all the leucocytes, 
including the larger cells, were positive for tartrate-resistant acid 
phosphatase. 
After 2 weeks of culture, attempts were made to infect the HCs 
with Epstein-Barr virus (the EBV was obtained from a producer lymphoblastoid 
cell line and was a gift from Professor Epstein, Department of Pathology, 
University of Bristol). The cell line resulting from EBV infection in 
no way resembled HCs morphologically or immunologically. More than 
2 weeks elapsed before cluster formation was observed and then the EBV 
infected cells grew rapidly in very large clusters typical of cultured 
lymphoblastoid cell lines. 
Raji cell line This line is an EBV-carrying non-producer cell line 
derived from a patient with African Burkitt Lymphoma (Epstein et al, 1966). 
This established lymphoblastoid cell line will form strong EAC3d rosettes 
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Figure 3.3 Hairy cells after 6 weeks in culture. The kidney shaped 
nucleus with nucleolus and the cytoplasmic 'hairs' with vacuolation are 
all typical features of HCs. In addition, this preparation demonstrates 
the tartrate-resistant acid phosphatase isoenzyme. Acid phosphatase 
staining was performed by the method of Goldberg and Barka (1962) in 
the presence of L(+) tartaric acid at a concentration of O.OSM (Li et al, 
1970). 
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but few cells, if any, form EAC4 rosettes (Bokisch and Sobel, 1974). 
However, although Raji cells do not possess immune adherance receptors 
(C4, C3b), they will form rosettes with EAC3b due to the strong C3d 
receptors binding the C3d of the EAC3b reagent (Ross and Polley, 1976). 
cells were a kind gift from Dr. I. McConnell. 
2.3 Comp.le.me.n,t -6 e.noilize.d Jie.d c.e.U-6 (EAC J 
Routine EAC EAM prepared with ox erythrocytes and rabbit IgM were 
prepared as described in Chapter 2. Complement sensitized red cells 
(EAC) were prepared from the EAM cells by the method of Ross et al, (1973b). 
In this method the EAM cells are incubated at 37°c for 15 min with AKR 
(CS-deficient) mouse serum (diluted 1/10 in CFT buffer) as a source of 
complement. The resultant EAC were washed and suspended to 1% in HBSSA. 
EAC indicator cells prepared in this way from whole mouse serum are 
probably coated with some C3b but mostly with the C3d fragment that remains 
after cleavage by the C4b-C3b inactivator (KAF) 
Rabellino and Metcalf, 1975). 
(Ross et al, 1973a; 
EAC3b and EAC3d Indicator cells coated with a preponderance of C3b 
were prepared with the use of suramin (Antrypol R ) which inhibits the 
serum of C4b-C3b inactivator, probably by binding to C3b, so that most 
of the fixed C3 remains in the C3b form (Tamura and Nelson, 1967; 
Lachman et al, 1973). The EAC3b indicator cells were prepared from 
EAM by incubation with zymosan-absorbed human serum (R3 reagent) which 
contains little CS and C6 and is non lytic for EAM (Lachmann et al, 1973). 
The R3 serum was diluted 1/10 in CFT buffer and mixed with an equal 
volume of EA (.at 2% in CFT buffer) prewarmed to 37°c. The complement M 
0 activation was allowed to proceed for 70 sec at 37 C before adding 5 µl 
of Antrypol (50 µg/ml) to the reaction mixture and thoroughly mixing 
for 2 min. EAC3d cells were prepared in a similar manner, but incubation 
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was for 30 min at 37°c without added Antrypol to enable KAF to 
inactivate the fixed C3b. The indicator cells thus prepared were 
thoroughly washed and resuspended to 1% in HBSSA. 
2 • 4 Ca mple.me.n..t 1.:, e.n.6iliz e.d y e.M.t c.. e,U,,6 (Y e.M .t C 3 b ) 
Yeast cell walls spontaneously trigger the alternative pathway of 
complement activation and as a result become coated with C3b. This 
alternative pathway-derived C3b is bound to the yeast cell wall in such 
a way that it is relatively resistant to cleavage by KAF (Fearon and 
Austen, 1977) • 
For the preparation of Yeast C3b particles the method of Mendes et al, 
(1974), as modified by Nash (1976) was initially employed. Briefly, yeast 
cells were fixed with glutaraldehyde and sonicated to remove clumps. 
8 These were then washed in CFT buffer and adjusted to 2 x 10 cells/ml. 
Fresh human serum, diluted 1/5 in CFT buffer, was mixed with an equal 
0 
volume of the yeast suspension and incubated for 30 min at 37 c. The 
complement-coated yeast cells were then washed four times with cold CFT 
buffer and adjusted to a concentration of 108 cells/ml. As control cells, 
yeast particles were incubated with heat-inactivated serum. 
In later tests, the modification described by McConnell and Hurd 
(1976) was used in order to reduce non-specific protein adherence. In 
these tests washed, glutaraldehyde-fixed, and sonicated yeast cells 
0 
were incubated in fresh human serum (0.5 ml undiluted) for 5 min at 37 c. 
The particles were then washed six times in 2M NaCl, filtered through a 
cotton-wool plug and resuspended to 1% in HBSSA. Control particles were 
obtained by incubating yeast cells in serum containing 10 mM EDTA which 
prevents complement activation. 
2. 5 Ro1.:, e..t.te. .te.1.:,u 
Rosette tests with the EAC reagent were performed as previously 
!', 
J: 
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described for EA in Section I. Briefly, two drops of indicator cells 
G 
6 
were mixed with two drops of leucocytes (2 x 10 /ml) and centrifuged 
at 150 g for 1 min. The pellets were kept on ice before scoring by 
the method of Ramasamy (1974). Control indicator cells coated with IgM 
alone (EAM) were included with every test. 
The yeast C3b test was performed in exactly the same way with the 
Yeast C3b cell suspension (and appropriate control) replacing EAC. Some 
difficulty was encountered in scoring because of the autofluorescence of 
the glutaraldehyde-fixed yeast cells, and the unavoidable presence of 
small aggregations of these cells which·appear as brightly fluorescing 
rosettes. This was overcome by omitting the white light and changing 
the u.v. filter to the Zeiss UGl exciter, whereby the yeast cells fluoresced 
a blue-green and the leucocytes a brighter apple-green. In this way 
pseudo-rosettes were readily distinguished from true rosettes in which 
the central cells could be clearly seen. 
2.6 Bioelu.ng w-lth monomeJu.zed 1gM 
HCs were incubated for 10 min at room temperature with different 
concentrations of IgM obtained from a case of Waldenstrom's macroglobulinaemia I( 
and monomerized by dithiothreitol reduction and iodoacetamide reduction 
(Rhodes, 1973) as described in Chapter 2. These cells were then tested 
for EAC rosette formation. As a control, the test was performed using 
lymphocytes from four normal volunteers. 
The EBNA antigen was sought using the indirect fluorescent method 
of Reedman and Klein (1973) on acetone-fixed leucocytes. Cells to be 
tested were cytocentrifuged and fixed, in acetone, at -20°c overnight. 
Fresh serum from a Paul-Bunnell-positive donor was diluted 1/10 in HBSS 
and incubated over the fixed cells for 30 min at 37°c. The slides were 
thoroughly washed and then stained with 
an FITC-coupled rabbit anti-
human C3 serum (kindly supplied by Dr. A. Karpas) 
at room temperature, 
and rewashed. Positive controls were se
veral established B-cell lines 
and a negative control was an establishe
d T-cell line (Karpas et al, 
1977). Positive cells were identified by the cha
racteristic strong 
nuclear staining and almost completely u
nstained cytoplasm; cells 
displaying spotty cytoplasmic staining w
ere scored as negative. 
3. RESULTS 
All of the EAC indicator cells formed 10
0% rosettes with the Raji 
cell line. In addition, the Yeast C3b 
particles formed >SO% rosettes 
with the monocytes from a case of acute
 monocytic leukaemia. Results of 
rosette formation with normal PB leucoc
ytes are given in the relevant 
tables. 
The results of the various rosette test
s with PB HCs are given in 
Tables 3.IV and 3.v. 
As is shown in Table 3.IV, the percentag
e of HCs forming EAC rosettes 
was consistently lower than the percenta
ge forming EAM rosettes (at the 
same temperature). In addition, it should be not
ed that, in general, 
when EAM rosette formation was low EAC r
osette formation was very low or 
absent; this was particularly noticeable
 with splenic HCs which generally 
showed <5% EAC rosette formation and low 
EAM at room temperature. 
3.2 EAC3b and EAC3d ~o~e;ttel.) 
As is seen from Table 3.V, a similar per
centage of mononuclear cells 
from all 6 cases of HCL tested formed EA
C rosettes whether the indicator 
erythrocytes were coated with C3b or C3d
. In all cases this percentage 
I . 
135 
Table 3.IV Percentage of PB mononuclear cells 
from HCL rosetting with different indicator particles 
Indicator particle 
Patient 
+ C3b EA EAC Yeast Yeast control M 
KD 42 31 0 0 
MB so 32 0 0 
* MH 23 0 
HD 33 10 3 2 
LS 55 28 3 0 
DC 49 41++ 
FB 55 33 
AD 47 26 
. LP 66 0 0 
LH 21 13 
BN 37 13 
RR 55 29 
HR 54 19 
AB 24 4 
GH 50 19 
TN 12 4 
LK 11 0 0 
26 22 
Normal 6. 3±1 21.5±2 20±3 4±2 
+ 
carried out at room temperature as control for EAC EAM 
* Not done 
++ Blocking with monomeric IgM carried out on this occasion 
(Figure 3.4) 
6. 
results from 4 volunteers (±1 SD) Average 
1:36 
Table 3.V Percentage of rosettes formed with different 
C3 reagents by PB mononuclear cells from HCL patients 
Indicator particle 
Patient 
EAM+ EAC3b EAC3d Yeast C3b 
MB 33 10 18 4 
RH 20 9 11 
++ 
LS 71 34 22 3 
DC 44 20 16 <l 
LH 20 16 12 0 
NW 37 3 2 
Normal b. 3±1 33±3 26±2 18±2 
+ EAM at room temperature as EAC control 
++ 
Not done 
Mean ±SD of 3 normal individuals 
'1· I:.) 
I 
40 
35 
15 
10 
5 
0 r 
0 
I I 
20 20 100 500 
Concentration of monomeric /gM ( pg/ml ) 
Figure 3.4 Inhibition by monomeric IgM of apparent EAC rosette 
formation by HCs ( A) and a normal lymphocyte control ( O ) • 
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Table 3.VI Complement receptors on CLL cells 
.j,· 
J:. 
j:1: 
% rosette formation If t;.!j 
Patient 11;,1· 
C3b EAC3b EAC3d tir Yeast 
~· :, . 
1 24 7 39 ~:r 
2 8 6 21 
3 17 19 73 
4 5 1 22 
5 + 15 37 
6 4 22 
+ Not done 
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was lower than that obtained with EAM. 
These results are in contrast to EAC rosette formation by normal 
PB mononuclear cells (Table 3.V) where EAC3b rosette formation was higher 
than EAC3d rosette formation. In CLL, on the other hand, rosette 
formation with EAC3d was higher than that with EAC3b and the results for 
6 cases of CLL are given in Table 3.VI. 
3.3 BloQ/u.ng w,L;th monome/L,[Q IgM 
As is shown in Figure 3.4, monomeric IgM caused substantial inhibition 
of apparent EAC rosette formation by the HCs of patient DC, chosen because 
of the high percentage of EAC rosettes observed (Table 3.IV). It has 
been previously shown that EAM rosette formation by HCs is specifically 
inhibited to a similar degree by monomeric IgM (Chapter 2). 
EAC rosette formation by lymphocytes from normal PB was not reduced 
by this treatment even at an IgM concentration of 500 µ1/ml. 
3.4 Yea.6t C3b no~ette t~t 
All the HCL patients tested with the Yeast C3b reagent showed a very 
low percentage of rosette formation (Tables 3.IV and 3.V), while in 
normal individuals a similar percentage of lymphocytes formed EAC and 
Yeast C3b rosettes. 
3.5 EBNA and Qul;tu,Jted celi.-6 
Cells from the spleen of 2 patients (LH and LP) and from the PB 
of 1 patient (DC) with HCL were tested for EBNA at the same time as 
positive controls from established B-cell lines. The cells from all 
of the HCL patients were EBNA negative. 
Cells from the cultured HCs were tested for EBNA after 18 days 
and after 66 days of culture. These cells were completely negative. 
After 18 days a portion of this HC culture was 'infected' with EBV 
and an aliquot tested for EBNA the next day. These cells were also EBNA 
! t, 
I ! 
Time in 
culture (days) 
18 
29 
46 
Table 3.VII Marker data of culture established from splenic HCs 
and on transformed cells following EBV 'infection' 
Untreated cell line (% rosettes) EBV 'infected' cell line 
E yFc ]JFc Slg E yFc EAC 
(% rosettes) 
Slg 
4 99 92 36 EBV added at this time 
+ 95 75 20 2 
0 92 93 82 0 0 85 0 
+ Not done 
-;-· - ... --- ~ ...... :---~'.;i·-:::~ = 
I-' 
w 
~ 
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negative at this time. Unfortunately the 'infected' line became 
contaminated and lost for study before the EBNA test was repeated, 
although the transformed, blastic, appearance of these cells some 
4 weeks after infection suggested that they would have been positive. 
The rather incomplete marker studies carried out on the HC culture and 
the transformed line are given in Table 3.VII, and it can be seen that 
cells from these 2 cultures bear no apparent relation to one another. 
Also, although cells from the non-infected HC culture were not tested 
for EAC because of the high percentage of cells bearing the µFe receptor, 
it should be noted that a high proportion of the 'infected' cells bore 
an EAC receptor. 
4. DISCUSSION 
The results presented in this section suggest that EAC rosettes 
formed by HCs are the result of binding of IgM used to form the EAC 
indicator cells by the µFcR of HCs. 
By the use of yeast cells coated with C3b activated by the alternative 
pathway it is shown here that HCs do not have a receptor for complement. 
The fact that the percentage of EAC rosettes was consistently lower than 
that of EAM rosettes supports the contention of IgM binding, and this was 
confirmed by the blocking data in which EAC rosette formation was blocked 
by monomeric IgM in a manner analogous to µFcR blocking (Chapter 2). 
It is also of interest that the apparent EAC receptor was, like the 
µFcR, exquisitely sensitive to blocking by high dilutions of the anti-
hairy cell serum. The variable difference between the percentage of EAM 
and EAC rosette formation is probably, at least in part, attributable 
to varying degress of steric hindrance of the bound IgM by the complement, 
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but may also be the result of imperfect mixing when complement is 
bound to the EAM. It is interesting to note that by reducing the 
dilution of complement (serum) used to sensitize the EA from 1/10 to M 
1/5, EAC rosette formation in one case of HCL fell by over 30%. It 
is known that EAC made from IgG and complement will bind to monocytes 
via the yFcR (Shevach et al, 1973), and that a proportion of cultured 
T cells can bind IgM which has been bound with complement (McConnell 
and Hurd, 1976), therefore probably the complement coat does not 
totally obscure the Fe piece of bound Ig. In this regard, it is of 
interest that the figure given by Catovsky (1977) illustrating a 'hairy 
cell forming a rosette with ox cells coated with IgM and CJ (EAC rosette) 
electronmicrograph' is identical to the TEM pictures of EAM rosette 
formation shown in Chapter 2, and this is in contrast to the broad areas 
of contact described and illustrated for typical B cell EAC rosette 
formation (Bentwich et al, 1973). 
The failure of some workers (Shevach et al, 1973; Jaffe et al, 1974; 
King et al, 1975; Deegan et al, 1976; Matre et al, 1977; Jansen et al, 1978) 
to detect an apparent C3 receptor with a rosette test involving IgM is 
probably attributable to their use of sheep, rather than ox, indicator 
erythrocytes. Ox erythrocytes are able to absorb much higher levels 
of IgM before agglutinating than are sheep erythrocytes (Uhlenbruck 
et al, 1967) and it was previously shown that high concentrations of 
sensitizing IgM are necessary for EAM rosette formation (Chapter 2). 
When ox erythrocytes coated with IgM and complement have been employed 
in a resetting system, some authors have concluded that HCs do have a 
receptor for EAC (Haegert et al, 1974; Catovsky et al, 1975; Catovsky, 
1977). 
The simple tests used in this report to distinguish between EAC3b 
• 
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and EAC3d rosettes were performed because HCL has been regarded as 
a variant of CLL, and because CLL cells have been reported to possess 
a receptor for C3d, but not C3b (Ross et al, 1973a). On the other 
had, the EAC3b reagent detects a higher percentage of complement 
receptors than the EAC3d reagent in both normal lymphocytes (Ross and 
Polley, 1976) and in blood from patients with Waldenstrom's 
macroglobulinaemia (Ross and Polley, 1975). Therefore the test 
described was performed on HCs in order to discount the possibility 
that EAC rosette results were spuriously low, not because of incomplete 
hindrance of EAM, but because of a lack of either C3b or C3d. In fact, 
while previous results for CLL and normal lymphocytes were confirmed with 
these reagents, there was no difference in percentage rosette formation 
by HCs using either indicator particle. Also, whether EAC3b or EAC3d 
indicator cells were used the percentage rosette formation was 
consistently lower than in the EAM test. 
The conclusion of a lack of receptors for fixed C3 is supported by 
other information. Thus, monolayers of glass-adherent HCs do not bind 
EAC under conditions permitting monocytes to do so (Zidar et al, 1977), 
and cryostat sections of HC spleens fail to bind EAC whereas the B-
lymphocyte areas of spleens from patients with nodular lymphomas firmly 
bind this reagent (Shevach et al, 1973; Jaffe et al, 1974; Matre et al, 1977): 
both of these findings showing the failure of HCs to bind EAC were 
confirmed in the previous section. Recently, Catovsky (1977) has utilised 
human erythrocytes coated with C3b prepared in serum in a low ionic 
strength solution (thus avoiding the presence of IgM) to show that 
nine cases of HCL lacked a receptor for C3b. 
Further, indirect, evidence for the lack of C3 receptors on HCs comes 
from cultural studies. Despite numerous attempts, HC lines have proved 
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and EAC3d rosettes were performed because HCL has been regarded as 
a variant of CLL, and because CLL cells have been reported to possess 
a receptor for C3d, but not C3b (Ross et al, 1973a). On the other 
had, the EAC3b reagent detects a higher percentage of complement 
receptors than the EAC3d reagent in both normal lymphocytes (Ross and 
Polley, 1976) and in blood from patients with Waldenstrom's 
macroglobulinaemia (Ross and Polley, 1975). Therefore the test 
described was performed on HCs in order to discount the possibility 
that EAC rosette results were spuriously low, not because of incomplete 
hindrance of EAM, but because of a lack of either C3b or C3d. In fact, 
while previous results for CLL and normal lymphocytes were confirmed with 
these reagents, there was no difference in percentage rosette formation 
by HCs using either indicator particle. Also, whether EAC3b or EAC3d 
indicator cells were used the percentage rosette formation was 
consistently lower than in the EAM test. 
The conclusion of a lack of receptors for fixed C3 is supported by 
other information. Thus, monolayers of glass-adherent HCs do not bind 
EAC under conditions permitting monocytes to do so (Zidar et al, 1977), 
and cryostat sections of HC spleens fail to bind EAC whereas the B-
lymphocyte areas of spleens from patients with nodular lymphomas firmly 
bind this reagent (Shevach et al, 1973; Jaffe et al, 1974; Matre et al, 1977): 
both of these findings showing the failure of HCs to bind EAC were 
confirmed in the previous section. Recently, Catovsky (1977) has utilised 
human erythrocytes coated with C3b prepared in serum in a low ionic 
strength solution (thus avoiding the presence of IgM) to show that 
nine cases of HCL lacked a receptor for C3b. 
Further, indirect, evidence for the lack of C3 receptors on HCs comes 
from cultural studies. Despite numerous attempts, HC lines have proved 
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exceedingly difficult to establish. Reports of established HC lines 
are few (Sinkovics et al, 1976; Golde et al, 1977b; Saxon et al, 1978b), 
and one of these lines (Golde et al, 1977b; Saxon et al, 1978b) was 
established from a very unusual case of HCL, the diagnosis of which 
has been questioned (Katayama, 1976; Banerjee et al, 1978). Moreover, 
cells from this line were EAC positive (by the Yeast C3b method). Of 
the other two lines established in culture from HCL patients by Golde 
and colleagues, one has changed the isotype of immunoglobulin being 
secreted during the period of culture and the other is a T-cell line. 
The two lines established by Sinkovics et al (1976) were reported to have 
intranuclear Herpes-type virus particles in most of the cells, and 
the authors suggested that these viral particles may be related to EBV. 
However, serological tests for EBV infection were not performed and 
there has been no subsequent paper following this brief report. There 
has also been a recent report demonstrating replication -of type 1 Herpes 
simplex virus replication in freshly isolated and infected HCs, including 
the demonstration of intranuclear virus particles (Pozner et al, 1978), 
and it is possible therefore that Sinkovics et al were observing Herpes 
simplex particles. It is of passing interest that the ability to 
support herpesvirus replication was observed in cells from all four cases 
of HCL tested, but not in cells from any of nine cases of CLL tested 
(Pozner et al, 1978). Receptors for EBV in man are the exclusive 
property of B lymphocytes (Jondal and Klein, 1973; Greaves et al, 1975), 
and most established cell lines are both B lymphoblasts (Gordon et al, 1977; 
Karpas et al, 1977) and EBNA positive (Reedman and Klein, 1973). Generally 
the ability to 'immortalise' cells in a feature of EBV infection, and 
non-B, EBNA negative, cell lines are both rare and difficult to establish 
(Kaplan et al, 1974; Karpas et al, 1978a). The cultured HCs described 
-
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in this section were EBNA negative even after 66 days of culture when 
a typical B-cell line would be EBNA positive. Also, the time taken 
for the EBV 'infected' line to grow out and the major morphological 
and marker differences from HCs, suggested that this line was an 
outgrowth of a minor subpopulation of EBV-permissive B cells rather 
than an EBV infection of HCs; most cell lines are of this type no matter 
what the initial disorder or the original majority population of cells 
being cultured (Gordon et al, 1977; Karpas et al, 1977). These results 
might suggest a monocytic origin for the HC since cultured monoblast cell 
lines are EBNA negative (Karpas et al, 1978a), however it cannot be 
excluded that the HCs were infected by EBV and totally transformed. In 
addition, if the absence of a receptor for EBV on HCs is correct, this 
provides strong evidence for the lack of a C3 receptor on these cells 
since there is a strong association between these two receptors (Jondal 
et al, 1976; Yefenof and Klein, 1977). More work investigating the 
presence or absence of a receptor for EBV on HCs is clearly required. 
Finally, two suggestions have been made to account for the absence 
of C3 receptors on HCs. Shevach and colleagues (Shevach et al, 1973; 
Jaffe et al, 1974) have shown that splenic macrophages, in contrast to 
macrophages from other sites, do not express receptors for C3, and 
they suggest that HCs derive from the same cell type as splenic 
macrophages. Some support is perhaps given to this theory by Ross et al 
(1978) who propose that during neutrophil maturation not all neutrophils 
pass through a complement receptor-positive stage. Jansen et al (1978) 
draw attention to murine studies indicating that the environment of the 
spleen is required for B cells to acquire the C3 receptor (Ryser and 
Vassalli, 1974) and suggest that HCs are not properly handled by the 
grossly deranged spleen of HCL and therefore do not acquire C3 receptors. 
ilii 
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' J 
145 
A third suggestion is possible. Some animal and human lymphoid cells 
can activate complement by the alternative pathway in both autologous 
and heterologous sera (reviewed by McConnell and Lachmann, 1976). It 
is possible that HCs activate the alternative pathway in vlvo and thus 
block their own C3 receptors. Alternatively, activation of complement 
may be mediated by low affinity antibodies directed against the 
neoplastic HCs; specific autoantibody activity has been described in both 
CLL and chronic myeloid leukaemia (Metzgar et al, 1975) and has possibly 
been demonstrated in a case of HCL (Banerjee et al, 1978). Some evidence 
possibly supporting this hypothesis accounting for the lack of receptors 
for fixed C3 on HCs will be given in the next section. 
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III Receptors for mouse erythrocytes and for 
monkey erythrocytes 
1. INTRODUCTION 
Spontaneous rosette formation between human lymphocytes and 
sheep erythrocytes (Bach et al, 1969; Brain et al, 1970; Coombs et al, 
1970) was established as a feature of T cells very shortly after the 
first descriptions of this phenomenon (Fr~land, 1972; Jondal et al, 1972). 
This discovery has been vigorously pursued in many laboratories and 
spontaneous rosette formation is now a major tool for the classification 
and fractionation of human T lymphocytes. At the same time, many 
investigators looked for spontaneous rosette formation between human 
lymphocytes and erythrocytes of many other animal species, from the 
rhinoceros to the warthog (Bach, 1973). Only two such reactions have 
proved of much value in clinical research. 
Spontaneous mouse erythrocyte (Mo) rosettes have been shown to be 
formed by a subpopulation of human B cells (Stathopoulos and Elliott, 
1974; Gupta et al, 1976; Dobozy et al, 1976) which is cytochemically 
unremarkable (Higgy et al, 1977) but seems to be related to the clonal 
expansion of CLL (Stathopoulos and Elliott, 1974; Millard, 1976; 
Forbes and Zalewski, 1976). A report of Mo rosette formation in HCL 
(Catovsky et al, 1975) is often cited as evidence for the B-lymphoid 
nature of HCs although few reports have confirmed the presence of this 
receptor on HCs. 
The literature on spontaneous monkey erythrocyte (MK) rosette 
formation with human leucocytes is confusing, and it has been suggested 
that the species of monkey used may determine the specificity of the 
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rosette (Siegal and Good, 1977). With rhesus monkey erythrocytes, 
Lohrmann and Novikovs (1974) reported that most normal human PB T 
lymphocytes, and the cells from some patients with CLL, formed rosettes. 
In contrast, Pellegrino et al, (1975a) reported that rosette formation 
with Mk was a B-cell marker when employing erythrocytes from the 
Japanese ape (M. speciosa). Rosette formation was only observed with 
PB B cells and with B-cell lymphoidblastoid cell lines. The same authors 
(Pellegrino et al, 1975b) subsequently reported linkage between a 
receptor for Mk on B cells and HLA antigen expression, and this report 
was confirmed by another group (Fellows et al, 1977) but employing 
erythrocytes from the marmoset (C. jacchus). 
This section examines Mo and Mk rosette formation in HCL and 
provides some information bearing on the nature of Mk rosette formation 
by HCs. 
2. MATERIALS AND METHODS 
A description of mononuclear cell isolation from normal individuals 
and patients with HCL and other disorders has been given in the last 
section and, in more detail, in Chapter 2. The characteristics of 
the various cultured cells examined have also been given elsewhere. 
These were washed in serum-free HBSS before testing. 
2. 1 Mo no-o e;t;tv.i 
Blood was collected from the orbital venous plexus of young male 
CBA mice into Alsever's solution. Erythrocytes thus obtained were used 
for a maximum of two days. After collection the Mo were washed 4 times 
in physiological saline and resuspended in HBSS with bovine serum 
albumin (BSA). However, because of the technique recommended by Gupta 
et al, (1976), 5% BSA, rather than the usual 0.2% HBSSA used in other 
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rosette tests, was employed. 
Rosette testing was carried out, with only some modification, 
after the method of Gupta et al, (1976). 6 Leucocytes at 2 x 10 /ml in 
HBSSA were mixed with 1% Mo and incubated at room temperature for 5 min. 
The mixture was centrifuged (150 g for 1 min) and the pellet placed 
on ice until reading of the percentage rosette formation was carried 
out. In this test and in the Mk rosette test below, scoring of viable 
rosette-forming cells was performed by the method of Ramasamy (1974) 
previously described. 
2. 2 Mk. Jto.t, etteo 
Venous blood was obtained from either rhesus or cynomorgus monkeys 
which were under investigation for the effect of lithium on platelet 
function. However, no difference in Mk rosette formation was observed 
either between the two species of monkey, or between Mk obtained from 
animals which had recently received lithium and control animals. 
Erythrocytes were collected into Alsever's solution and used in rosette 
tests for up to 1 week after collection. It was also found that red 
cells stored at -20°c in 3M glycerol were suitable for use. 
Before testing, Mk were thoroughly washed in physiological saline 
and resuspended to 1% (v/v) in Hanks' balanced salt solution. Preliminary 
investigation showed that there was no difference in the percentage 
rosettes formed when testing was carried out in phosphate-buffered 
saline over a pH range 6-10, or whether testing was at room temperature 
0 
or at 4 c. Centrifugation (1 min at 150 g) was required for optimal 
rosette formation between the mixture of leucocytes and erythrocytes; 
if leucocytes and Mk were mixed and incubated at room temperature, or 
in an ice bucket, for 10 min and then read for percentage rosette 
formation, rosettes were seen to have formed but the score was <SO% of 
that' observed after centrifugation. The formed rosettes were very stable 
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and resistant to disruption, and a period on ice following centrifugation 
was not required. Incubation of formed rosettes for 10 min at 37°c did, 
however, reduce the percentage rosettes. 
Scoring of rosettes was carried out by counting viable cells under 
combined u.v. and phase contrast microscopy after the addition of 
fluorescein diacetate (Ramasamy, 1974) and more than 200 cells were 
counted in each determination. 
2.4 An;tu.,e!LCl to C3 and C4 
The specific antisera to human C3 and C4 were kindly supplied by 
Professor P.J. Lachmann, M.R.C. Group on Mechanisms on Tumour Immunity, 
The Medical School, Cambridge. The anti-C3 reagent was whole rabbit 
antiserum which was heat decomplemented before use, and the anti-C4 
reagent was the IgG fraction of a hyperimmune sheep serum separated by 
DEAE chromatography. 
3. RESULTS 
3.1 Mo no~ettv., oonmed by nonma.1 mononuc.lecvr. ceLe..6 
The PB mononuclear cells from 6 normal individuals were examined 
for Mo rosette formation. The results were O (2), 2 (1), 4 (2) and 5 (1)% 
rosette formation. In two cases, T cells were removed by centrifuging 
E rosette-forming cells through a Ficoll-Isopaque gradient and the 
residual non-T cells tested for Mo rosette formation. In both cases 
the percentage rosette formation of the T-depleted cells exceeded that 
of the whole mononuclear cell preparation (0% to 6% and 4% to 10% 
respectively). In another 2 cases, Mo rosette-forming cells were 
isolated by allowing bulk preparations of mononuclear cells to form Mo 
rosettes and isolating the rosettes through a Ficoll-Isopaque gradient. 
Cytochemistry confirmed the relative T-cell depletion in such preparations, 
.... 
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but the Mo-rosette positive cells were themselves cytochemically 
unremarkable and, after lysis of the Mo, they did not reform rosettes 
with fresh Mo. 
The mononuclear cells from a normal spleen were tested for Mo 
rosette formation: 2% of cells formed Mo rosettes. 
3.2 Mo ~o~ettv.i in leukaemia and lymphoma 
PB mononuclear cells from a variety of disorders were examined 
for Mo rosette formation. No increase, above normal, was noted in 
non-Hodgkin's orHodgkin'slymphoma, prolymphocytic leukaemia, acute 
monocytic or acute meylomonocytic leukaemia, or in acute lymphoblastic 
leukaemia. 
One unexpected, and unexplained, result was obtained in a study 
of Gaucher's disease. Gaucher's disease is one of a group of hereditary 
metabolic disorders in which reticuloendothelial cells accumulate 
glucocerebroside due to an enzyme defect (Goldstone et al, 1976). 
The disease has an autosomal recessive mode of inheritance with minimal 
manifestations in the carrier heterocygote. The large storage cells are 
mainly found in the bone marrow and spleen and are assumed to be of 
monocytic origin. When splenic mononuclear cells were examined from a 
patient with Gaucher's disease, 53% of the large Gaucher's cells were seen 
to form Mo rosettes. ox erythrocytes did not adhere to these cells. 
Thirty five days after splenectomy, PB from the. patient (a girl 
of seven), her sister (who also has Gaucher's disease but has not had 
splenectomy), both parents, and a seven-year-old girl as a control was 
examined for a variety of surface receptors. The results are shown in 
Table 3.VIII, and it can be seen that the whole family, including the 
apparently unaffected heterozygous parents, had a marked decrease in 
T cells, and an accompanying increase in the percentage of cells forming 
Mo rosettes. 
·' r 
! 
.L !) .L 
Table 3.VIII Peripheral blood markers in Gaucher's disease 
rosette formation by staining + % Esterase 
mononuclear cells 
Patient Mo E yFc T cell B cell 
Propositus 14 40 58 45 34 post splenectomy 
Sister with Gaucher's 22 53 45 54 35 disease 
Father 22 11 69 ND ND 
Mother 25 27 59 ND ND 
++ Normal 7-year- 4 71 24 ND ND 
old girl 
+ Staining and interpretation by the method of Higgy et al, (1977) 
++ Tested at the same time with the same reagents 
ND Not done 
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The lymphocytes from 14 cases of CLL were examined for Mo rosette 
formation. In all cases some rosettes were observed, but the percentage 
varied from case to case: mean 30%, range 4-63%, s.d. 18%. No 
particular surface marker particularly correlated with a high or low 
Mo rosette formation. 
Sixteen cases of HCL were tested for Mo rosette formation, several 
on more than one occasion. Of these cases, 8 never expressed >5% 
rosette formation by PB mononuclear cells on any occasion of testing. 
Of the remaining cases, 3 were generally <5% but occasionally yielded 
Mo rosette formation up to 17%. More often than not, however, PB cells 
from these 3 cases were virtually Mo negative. Five cases yielded Mo 
rosettes as follows: KD, 20%; HD, 15%, 12%; LS, 17%; FW, 10%; RR, 11%. 
Splenic cells from 6 cases of HCL were also tested for Mo rosette 
formation. The% scores were as follows: DC, 4; LP, 19; LH, 47; NW, 30; 
HR, 39; AB, 8. Thus the capacity for HCs to form Mo rosettes appears 
to be a feature of splenic, rather than PB, HCs. However, another 
feature of Mo rosette formation by HCs appears to be a correlation with 
the Sig phenotype. As will be presented in Chapter 4, Sig expression in 
HCL can be divided into types, arbitrarily numbered I, II and III. All 
but one of the patients never expressing Mo rosettes in the PB belong 
to Sig type I (IgG only), whereas all but one of the Mo-positive patients 
tested for Sig belong to Sig type II (multiple heavy chain isotype). 
The two patients with low Mo rosette expression by splenic HCs (DC and 
AB) belong to Sig type I, and the other patients with high splenic Mo 
rosette scores belong to Sig type II. The single exception to type I 
by PB cells never expressing Mo is patient LP, and it can be seen above 
that this Sig type II patient, although above normal, had rather poorer 
Mo rosette formation by splenic cells than the other three type II patients. 
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After two weeks of culture, cells from the prima
ry HC culture 
established from the spleen of patient HR (Mo rosettes, 39%) 
did not 
form any Mo rosettes. At this time, the cultured
 cells continued to 
express Sig, yFc, µFe and Mk receptors. 
The established monoblastoid cell line (L230, Karpas et al, 
1978a) 
formed 3%, weak, Mo rosettes. A B-cell line test
ed did not form Mo 
rosettes. 
Normal mononuclear cells Mononuclear cells from 
the PB from 7 normal 
volunteers was tested for Mk rosettes. A mean of
 14% (range 2-22, SD 
7%) rosette formation was obtained. The rosette-forming cel
ls, in 
each case, resembled monocytes when cytocentrifug
e preparations were 
stained with Giemsa. 
B-cell leukaemias The results obtained for Mk ros
ette formation in 
a variety of B-cell leukaemias are given in Table
 3.IX. The case of 
acute lymphoblastic leukaemia was of the non-T va
riety, and it is 
clear that some blasts form Mk rosettes. Most ca
ses of CLL studied 
had a small percentage of leukaemic cells which r
osetted with Mk, but 
only l case had a major proportion of cells forming Mk rosettes
 (42%), 
and this case is considered in further detail bel
ow. The case of 
Waldenstrom's-type mixed lymphoid-plasmacytoid pr
oliferation, and the 
case of plasma-cell leukaemia given in Table 2.X,
 both make it clear 
that mature, immunoglobulin-secreting, lymphocyte
s and plasma cells 
can form Mk rosettes. However, although only th
ese two cases are 
presented to illustrate this point because of the
 high proportion of 
pathological cells in the PB in both cases, a hig
h percentage of Mk 
rosette-formation was observed in the PB and marr
ow of all of a wide 
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variety of myelomas studied for this marker. In some of these cases 
the plasma cell involvement was not high, and it was clear that in 
myeloma, myeloid precursors and monocytes, as well as a high 
proportion of PB lymphocytes, formed Mk rosettes. 
Myeloid leukaemias Leukaemic myeloid cells at all stages of maturation 
from myeloblasts to neutrophils formed Mk rosettes. These results are 
shown in Table 3.X. The results indicate that in each of the conditions 
studied, the vast majority of leukaemic myelocytes present form Mk 
rosettes. 
Leukaemias in remission Table 3.XI illustrates that in patients 
undergoing treatment for leukaemia and lymphoma, even when the PB 
appears to be returning to more normal cell proportions, the percentage 
of cells forming Mk rosettes remains high. In these cases, Mk rosettes 
are formed by morphologically normal T lymphocytes. In addition, a case 
of HD without morphological PB involvement was examined (Table 3.XI), 
and this too showed Mk rosette formation by T cells greatly in excess 
of the normal range. 
Cultured cell lines Seven cell lines were examined for Mk rosette 
formation (Table 3.XII). It is clear that cultured B lymphoblasts, 
T lymphoblasts (although to a lesser extent), monoblasts and HCs all 
form Mk rosettes. Further, Mk rosette formation does not depend upon 
the la-like antigen, Sig, complement receptors or Epstein-Barr virus 
transformation. 
HCL The cells from 20 patients with HCL were examined for Mk rosette 
formation, many on several occasions. The results of some of these 
studies are shown in Table 3.XIII. It can be seen that most HCs 
invariably formed Mk rosettes and that in some cases, but not always, 
a proportion of the T lymphocytes in HCL formed Mk rosettes. The firm 
case 
1 
2 
3-14 
15 
16 
Table 3.IX Mk rosette formation by leukaemic B cells 
Disease 
Acute lymphoblastic leukaemia 
Prolymphocytic leukaemia 
Chronic lymphocytic leukaemia 
Mixed (Waldenstrom-type) 
proliferation with IgA para-
protein and leukaemic involvement 
IgG plasma cell leukaemia 
. l++ Materia 
PB 
BM 
PB 
PB 
PB 
PB 
Predominant cell type (%) 
lymphoblast (>95) 
lymphoblast (>95) 
pro lymphocyte (>95) 
lymphocyte (>80) 
lymphoid-plasmacytoid 
cells (80) 
plasma cell (70) 
++ PB= peripheral blood 
BM = bone marrow 
Mk rosettes (%) 
20 
22 
3 
Mean 17 
(0-42; SD 13) 
t-' 
(Jl 
73 (Jl 
85 
Table 3.X Mk rosette formation by leukaemic myeloid cells 
Case Disease Material Predominant cell type (%) Mk rosettes (%) 
-
PB myeloblast (>90) 70 1 Acute myeloid leukaemia BM myeloblast (>90) 95 
2 Acute promyelocytic 
BM promyelocyte (70) 73 leukaemia I-' 
(.Jl 
O'I 3 Acute promyelocytic PB promyelocyte (60) 72 leukaemia 
4+ Acute monocytic leukaemia PB monoblast (70) 69 
5 Chronic myelomonocytic PB monocyte (60) 84 leukaemia 
6 Chronic myelomonocytic PB neutrophils and metamyelocytes 90 leukaemia (60), monocytes (20) 
BM metamyelocytes and neutrophils (80) 85 
+ Following 1 day of treatment 
Table 3.XI 
++ 
b. 
0 
* 
Mk rosette formation by peri~heral blood T cells in ratients with leukaemia++ and Hodgkin's disease 
% rosette formation 
Case Disease being treated i':, Mk 
1 Waldenstrom's macroglobulinaemia 48 72 
2 Acute myelomonocytic leukaemia 88 42 
3 IgM myeloma a) in remission 70 85 
b) in relapse 0 42 92 
* 4 Hodgkin's disease 36 + 66 53 
In each case the patient had received treatment and was not leukaemic at the time of testing 
T lymphocytes as measured by spontaneous sheep erythrocyte rosettes 
36% cytoplasmic Ig+ lymphoid/plasmacytoid cells present 
Increase in E rosettes after overnight culture in medium containing 10% foetal-calf serum 
f-' 
V1 
-...J 
I 
Table 3.XII Mk rosette formation by cultured human cell lines 
C<fll line Nature of cells Mk rosettes 
"' 
(%) Cell phenotype ++ 
Raji B lymphoblasts 92-100 + + ·i -EBNA CR y'FcR·i:'/ ·Sig 
150 B lymphoblasts 70 + + - + EBNA CR yFcR Sig 
P2 B lymphoblasts 80 EBNA+ 
241 B lymphoblast 79-83 EBNA Sig + 
+ + + + 281 Primary hairy cell culture 92 EBNA CR y'FcR µFcR Sig Ia 
230 monoblasts 80-98 EBNA Sig Ia + 
45 T lymphblasts 32-42 + E EBNA CR Sig Ia 
++ Constant features of the cell lines. EBNA, Epstein-Barr nuclear antigen; CR, 
receptors for the third components of fixed complement; y'FcR, receptors for the Fe of IgG; µFcR, 
receptors for the Fe of IgM; Sig, surface membrane irorounoglobulin; E, spontaneous sheep erythrocyte 
receptors; Ia, the antigen staining with an antiserum to the human Ia-like antigen complex, p29,34. 
__ :,_,··,.,__ --=-···--=-
I-' 
lJ1 
O'.l 
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Table 3.XIII Mk rosette formation by PB cells in HCL 
% of mononuclear cells 
Patient Date 
Mk rosettes T cells HCs 
KD 18. 1. 78 95 5 91 
PS 6. 2.78 36 52 47 
MH 8.10. 77 76 56 30 
RH 29. 4.77 46 87 
13 
30.10. 77 52 76 24 
29. 4.77 40 94 6 
DC 18. 5. 77 43 
85 15 
5. 8.77 2 88 10 
13.10.77 34 75 25 
FB 17. 6. 77 80 50 50 
AD 23. 1. 78 40 30 40 
18. 5. 77 76 50 50 
LH 30. 6. 77 84 40 60 
6. 2.78 37 70 30 
FW 23. 6. 77 61 
34 68 
19. 1. 78 39 8 70 
BN 16. 6. 77 39 44 56 
NW 17. 6.77 13 87 13 
RR 4 .10. 77 90 44 56 
HR 5.10.77 94 19 
81 
26.10.77 85 22 78 
29. 9. 77 77 54 46 
AB 22.11. 77 64 32 68 
23.11.77 91 0 98 
19.12.77 70 43 47 GH 24. 1.78 55 46 40 
TN 15. 1. 78 74 30 70 
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Table 3.XIII continued 
% of mononuclear cells 
Patient Date 
Mk rosettes T cells 
LK 18. 1. 78 56 20 
DA 2. 3.78 21 26 
BC 14.12.77 40 54 
CJ 5. 8.77 66 7 
HCs 
78 
70 
40 
89 
1 
'. i 
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rosette formation between Mk and HCs which was generally observed is 
illustrated in Figure 3.5 
Chemical reagents When mononuclear cells freshly isolated from 
patients with CLL or HCL were treated with sodium azide (10-lM) or 
cytochalasin B (20 µg/ml), which affects microfilaments, no effect 
on Mk rosette formation was observed. The chelating agent EDTA, on the 
-3 other hand, markedly inhibited Mk rosette formation, even at 10 M. 
Neither pH or the suspending medium appeared to influence Mk rosette 
formation, but the EDTA tests were carried out in phosphate-buffered 
saline at pH 7.o. 
C3 on the leucocyte surface membrane Deposits of C3 on the leucocyte 
membrane in CLL and HCL were sought using direct immunofluorescence 
with a rabbit anti-C3 serum. One case of CLL and both cases of HCL 
were shown to have membrane-associated C3 by this relatively 
insensitive method. Since F(ab) 2 fragments of antiserum were not used, 
yFc-binding of the reagent may be invoked as a possible reason for the 
positive results; however, this seems unlikely since the 2 cases of CLL 
which were negative with this reagent also had strong yFc receptors. 
As is shown in Table 3.XIV, the% cells staining with anti-C3 bore 
some relationship to the% cells forming Mk rosettes. Although these 
two tests give different %-positive cells, the two CLL cases negative 
for C3 were also negative for Mk rosettes. 
Pretreatment of Mk with cobra venom factor (CVF) Erythrocytes were 
pretreated with CVF with and without serum, and in the presence or 
absence of EDTA as shown in Table 3.XV. Subsequent testing of the 
treated Mk revealed that blocking of the Mk immune adherence receptor 
(C3b receptor) with alternative pathway-activated complement considerably 
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Figure 3.5 Rosette formation between a HC and Mk erythrocytes 
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Table 3.XlV The relationship between C3 staining and Mk 
rosette formation in CLL and HCL 
++ 
T cells B · cells 
* Patient + + Anti-C3 Mk 
E la Slg 
CLL 0 100 
6 0 0 
CLL 8 95 89 94 42 
CLL <l 90 80 4 6 
HCL (LH) 49 50 50 57 76 
HCL(DC) 86 16 16 10 43 
++ la-positive and Slg-positive cells are given as an estimate 
of pathological cell involvement. 
la+ from cells staining with the anti-la-like antiserum to p29,34. 
+ . Slg from cells forming rosettes with a single light chain type. 
* Cells stained with a direct FlTC-labelled technique using 
rabbit anti-C3 antiserum diluted 1/10. 
Not done 
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Table 3.XV The effect of treating Mk erythrocytes 
6 with cobra venom factor (CVF) on subse$Lllent 
Mk rosette formation 
* Reagent 
Patient Mk rosettes (%) CVF EDTA NHS 
76 
HCL + 77 
(LH) + + 35 
+ + + 76 
66 
+ 66 
+ + 37 HCL 
+ + + 68 (LH) 
+ 38 
+ + 65 
43 
HCL + 31 
(DC) + + 15 
+ + + 35 
6 
+ 5 CLL 
2 + + 
+ + + 4 
42 
+ 42 CLL 
11 + + 
+ + + 40 
41 
+ 40 
+ + 13 CLL 
+ + + 37 
+ 14 
+ + 42 
-
6 20 µl packed erythrocytes incubated with 50 g1 CVF in CFT buffer with or without serum (0.2 ml) for 20 min at 37 c. In some cases 10 mM EDTA was added and PBS replaced the CFT buffer. The Mk were then washed and rosette tested in the usual way. 
* NHS= normal human serum 
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reduced Mk rosette formation by HCL and CLL cells. Blocking by 
CVF alone, in the absence of serum, indicated that the Mk immune 
adherence receptor binds CVF (cobra C3b). Also, since EDTA blocked 
this binding reaction, as well as C3b binding by Mk in the presence 
++ ++ of serum, it would appear that Mg andjor Ca ions are required for 
immune adherence binding by Mk. 
Pretreatment of cultured cells with anti-complement components 
from various cultured lines were treated with antisera to C3 or 
Cells 
C4, or both, in attempts to block Mk rosette formation (Table 3.XVI). 
Pretreatment of Mk with these reagents did not affect rosette 
formation. The results show that high concentrations of either anti-
C3 or anti-C4 do block Mk rosette formation to some extent, but not 
completely. A combination of anti-C3 + anti-C4 was more effective at 
blocking than either of the antisera alone, although at the dilutions 
used complete inhibition of rosette formation was not obtained. Higher 
concentrations of the antisera tended to agglutinate the leucocytes. 
The results also show that the T-cell line 45 (Table 3.XVI) produces 
some C3 and, or, C4 although less than the other lines. Some lines 
appear to produce proportionally more C4 to C3 (line P2) than others 
(Raji, 241). In a control experiment, an antiserum to hairy cells, 
rendered specific by absorption (Section IV) did not block Mk rosette 
formation by hairy cells when used at a concentration which strongly 
stained the cells when tested by indirect immunofluorescence. 
Detection of complement deposited by immune comp lex formation A 
different approach was employed both to show that Mk rosette formation 
was detecting deposited complement and to demonstrate the flexibility 
and potential use of this technique. In preliminary experiments 
(Table 3.XVII) complement was activated by immune complex formation 
* 
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Table 3.XVI The effect of pretreatment of cultured 
leucocytes with anti-complement antibodies 
on subsequent Mk rosette formation 
* Cell line Treatment Mk rosettes 
96 
Anti-C3 (1/2) 46 
Anti-C3 (1/5) 68 
Raji Anti-C3 (1/10) 82 Anti-C4 (1/2) 74 
Anti-C4 (1/10) 82 
Anti C3 + C4 (1/10) 74 
80 
P2 Anti-C3 (1/5) 43 
Anti-C4 (1/5) 55 
Anti C3 + C4 (1/10) 34 
76 
241 Anti-C3 (1/5) 54 
Anti-C4 (1/5) 79 
Anti C3 + C4 (1/10) 69 
32 
45 Anti C3 + C4 (1/10) 13 
(%) 
Washed cells were incubated with antiserum at the dilution 
indicated for 30 min at room temperature with occasional mixing. 
The cells were then washed and tested for Mk rosette formation. 
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Table 3.XVII The use of Mk rosettes for the detection 
of immune complex formation between Ia-like 
antigens and monospecific anti-p29,34 antiserum 
* Treatment 
Mk rosettes ( %) anti-Ia + complement anti-C3 anti-C4 
* 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
(heat 
treated) 
+ 
+ 
+ 
+ 
+ 
13 
15 
12 
15 
27 
5 
19 
Normal human lymphocytes were incubated (30 min at room temperature) with (a) anti-p29,34 serum (at 1/100), and washed. They were then incubated (b) with zymosan-absorbed normal human serum (1/10) (5 min 0 at 37 C) as a source of complement. (c) Some tests were then incubated with either anti-human C3 or C4 serum and washed. Control experiments were incubated with steps (a) or (b) alone. 
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between normal blood lymphocytes and an antiserum to the Ia-like 
antigen, p29,34. The dilution of antiserum used was outwith the 
plateau region of this serum when used in indirect fluorescent studies. 
As can be seen from the table, cells bearing the Ia-like antigen were 
readily detected by Mk rosette formation and this reaction could be 
inhibited by antiserum to C3. 
4. DISCUSSION 
Spontaneous rosette formation with mouse erythrocytes is a 
marker for a subpopulation of B lymphocytes (Siegal and Good, 1977) and 
the capacity of HCs to form Mo rosettes has been used as evidence for 
the B-cell origin of HCL (Catovsky et al, 1975). In this report it is 
shown that Mo rosette formation is, by no means, a consistent feature of 
HCs. The rosette test used here is no less sensitive than that of 
Catovsky et al since a generally higher percentage rosette formation 
was obtained in CLL than was obtained by these workers. Also, of the 
only two other studies of Mo rosette formation by HCs which has been 
reported, one group found them to be negative (Matre et al, 1977), and 
the other study obtained one case which was negative and two which were 
positive (Rozenszajn et al, 1976). 
These apparently conflicting results are resolved by the demonstration 
here that Mo rosette formation may depend upon the Sig phenotype. 
Siegal and Good (1977) have reported that all normal mouse resetting 
cells have SigM and SigD, and the findings here suggest that this may 
also be substantially true in leukaemias. Thus, most CLL cells have 
both SigM and SigD and are Mo positive, whereas, with few exceptions, 
SigG cases of HCL are Mo negative. Cases of HCL in which the cells bear 
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SigD in addition to SigG (multiple isotype group, Chapter 4) are, in 
general, Mo positive. The reason why splenic HCs are much more 
Mo positive than their PB counterparts is not at all clear, but the 
results suggest that a factor provided by the spleen enhances Mo rosette 
formation; whether this is also true of CLL cells, and whether it 
suggests that Mo-positive cells have recently circulated through the 
spleen, awaits further study. 
The results presented in this section show, for the first time, 
that HCs have a 'receptor' for monkey erythrocytes. They also suggest 
that previous reports (Lohrmann and Novikovs,1974; Pellegrino et al, 
1975a) suggesting that Mk rosettes are markers for particular cell 
types are wrong, and that, contrary to one opinion (Siegal and Good, 
1977), Mk rosette formation does not depend upon the species of monkey 
used. 
Thus, in this study it is shown that Mk rosette formation with 
human leucocytes is probably a function of the Mk IA receptor (Cooper, 
1969) detecting complement components on the leucocyte membrane. By 
blocking the Mk IA receptor with CVF, rosette formation with leukaemic 
cells from HCL and CLL was considerably reduced, and treating cultured 
lymphoblastoid cells with antisera to complement components also reduced 
Mk rosette formation. Mk rosette formation by HCs, on the other hand, 
was not reduced by treatment with an anti-hairy cell serum (Section IV, 
Chapter 3) indicating that blocking by antisera was not simply steric 
hindrance. Morever, in v,l.:t;Jio complement deposition by immune complex 
formation with normal human lymphocytes enhanced Mk rosette formation 
and this could be inhibited with antiserum to C3. 
This being so, it is of interest that the incidence of membrane 
associated complement on human leukaemic cells is much higher than has 
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been previously suspected. Several mechanisms can be envisaged for 
the presence of complement on leukaemic leucocytes. The anti-lymphocytes 
antibodies known to be present in some malignancies including Hodgkin's 
disease (Siegal, 1976), CLL, and chronic myeloid leukaemia (Metzgar 
et al, 1975) might lead to complement activation leaving C3 deposited 
on the cell membrane. Also, the high incidence of Mk rosettes with the 
macroglobulinaemia cells and in myeloma suggest a role for immune complex 
formation since, in many cases, the paraproteins of these diseases have 
autoantibody activity (Seligmann and Brouet, 1973). The process of 
complement deposition would not necessarily lyse the leukaemic cells 
since human lymphocytes are resistant to cytolysis and CLL cells, at 
least, are particularly resistant (Logue and Huang, 1978). Passive 
uptake of serum C3 seems unlikely since many of the leukaemic cells 
investigated, including myeloblasts (Ross et al, 1978), HCs (Burns et al, 
1977c), most acute lymphoblastic leukaemia cells (Tsubata et al, 1977) 
and myeloma plasma cells (McConnell, 1975) all lack complement 
receptors, although it is possible that these cell types have picked up 
serum C4 either via the C4 receptor (Bokisch and Sobel, 1974) or even 
attached to the C4-binding protein recently described in man (Scharfstein 
et al, 1978). 
Human lymphoblastoid cell lines can activate the alternative 
pathway of complement when incubated in autologous serum (Okada and 
Baba, 1974; Budzko et al, 1976), and complement deposition on the 
lymphoblasts does not depend on the presence of a C3 receptor. Although 
this method of complement activation has only been demonstrated with 
cultured cells, it is possible that in some types of leukaemia alterations 
to the cell membrane during transformation could cause 1n vlvo 
alternative pathway activation. However, CLL cells do not activate 
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complement in this way (Budzko et al, 1976) and also Epstein-Barr virus 
infection is probably associated with this type of transformation 
(McConnell et al, 1978). With this type of complement activation, C3 
deposition can be detected by the IA receptor of human group O erythrocytes 
suggesting that rather more complement is deposited (see below). It 
is of interest that in infectious mononucleosis, which is associated with 
Epstein-Barr virus-infected B cells, an increase in spontaneous 
autorosette ~o-called H-rosette formati0n)has been recorded (Sheldon and 
Holborow, 1975). 
The above mechanisms cannot account for Mk rosette formation by 
cultured cells, and in these cases it is possible that Mk rosettes are 
detecting C3 and C4 synthesised by the rosette-forming cells. It has 
been suggested that C4 is synthesised by human lymphoblastoid cell 
lines, including Raji (Ferrone et al, 1976), and human monocytes, both 
normal and leukaemic, can synthesise C3 (Lai A Fat and Furth, 1975; 
Einstein et al, 1977). The present section suggests that a variety of 
cell lines can produce both C3 and C4, and that the cultured cells from 
HCL can manufacture complement components. The detection of complement 
synthesised by cells also accounts for the reported linkage between Mk 
rosette formation and the expression of HLA antigens in man-mouse 
hybrid cells (Pellegrino et al, 1975b; Fellous et al, 1977) in view 
of the association between HLA and C4 production (Jersild et al, 1976) 
and of the close spacial association of C4 with HLA determinants on 
the cell membrane (Ferrone et al, 1976). Also, the apparent synteny 
between Mk rosette formation and the P blood group system (Fellous et al, 
1977) might be tied in with the association between C3 gene expression 
and certain other human red cell blood groups (Jersild et al, 1976). 
The detection of minute quantities of complement demands that the 
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IA receptor on Mk be very sensitive, more sensitive than the receptor 
on human group O erythrocytes which are IA negative with untreated 
Raji cells (Theofilopoulos et al, 1974; Budzko et al, 1976) and with 
most human leukaemic cells (Sheldon and Holborow, 1975). The measurement 
of C4 on Raji cells by sensitive absorptive methods (Ferrone et al, 1976) 
gives an estimate of 487 molecules of C4 per cell, and the IA receptor 
on human erythrocytes (Hu) requires about 2,500 molecules per cell for 
adherence (Cooper, 1967). The Mk IA receptor ~ppears, therefore, to be 
about five times more sensitive than its human counterpart. This 
report also shows other differences between the IA receptor on Mk and Hu. 
EDTA abolishes IA rosette formation, and the binding of fluid-phase 
C3b or CVF, by Mk but not by Hu (Cooper, 1967). A similar difference 
in cation requirement between the IA receptors of monocytes and 
polymorphonuclear leucocytes and those of lymphocytes has been observed 
by Lay and Nussenzweig (1968). Again, the Mk IA receptor clearly binds 
CVF whereas the Hu receptor does not (McConnell and Lachmann, 1976). 
CVF is the cobra C3b (Alper and Balavitch, 1976) and it is therefore 
not surprising that this reagent can bind to Mk but not Hu since such 
variations in the binding of xenogeneic C3b by IA are frequent. Thus, 
mouse C3b binds human IA receptors (Ross and Polley, 1976) but fixed 
rabbit C3b binds poorly (Pepys, 1976). Human C3b, on the other hand, 
does not bind to mouse IA receptors, also, human CLL cells possess weak 
IA binding with CVF (McConnell and Lachmann, 1976). 
Finally, mention should be made of the possible value of these 
observations on Mk rosette formation. Rosette formation with Mk 
provides an exquisitely sensitive and very simple tool for the 
detection of immune complex formation and deposition of complement in, 
for example, the leukaemias. The method does not depend upon metabolic 
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activity of the leucocyte, or even apparently leucocyte viability, 
and might be used to detect complement deposition in tissue sections. 
Since yFc-binding of antiserum by leucocytes does not effect 
complement activation, the method might also be used as an alternative 
to fluorescent staining in some situations. 
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IV T l ymphocytes and B l ymphocytes in HCL 
1. INTRODUCTION 
Except for two reported cases (Burns et al, 1977d; Saxon et al, 
1978a) HCs do not form spontaneous sheep erythrocyte (E) rosettes. 
E-rosette formation is therefore a reliable indicator of T-cell 
proportions in HCL, as in normal blood (Jondal et al, 1972), and 
the use of AET-treated E (Kaplan and Clark, 1974) avoids the problems 
of weakly-avid T cells occasionally found in chronic leukaemias (Nath 
et al, 1975; Wenzel and Ichiki, 1977). 
Until recently, T cells had not been subclassified because of the 
paucity of markers, but Moretta et al, (1977b) divided these cells into 
TM and TG depending on whether the cultured T cells had receptors for 
IgM or IgG respectively. T cells are probably helper T cells and T M G 
cells suppressor cells, and there is a small population of T cells with 
neither receptor, T null, of unknown function. Imbalances in the 
distribution of circulating TM and TG cells occur in patients with both 
congenital and acquired immunodeficiencies (Cooper and Seligmann, 1977), 
and because of the high incidence of infectious disease in HCL 
(Katayama and Finkel, 1974; Bouza et al, 1978) it was of interest to 
study T-cell subpopulations in this disorder. 
Increasingly, it is being recognised the B-cell neoplasms are 
characterised by an almost complete replacement of the normal B-cell 
series by the monoclonal proliferation. Frequently, this replacement 
is only detectable immunologically since cells involved in the monoclonal 
proliferation are morphologically normal in such diseases as myeloma 
(Mellstedt et al, 1974), Waldenstrom's macroglobulinaemia (Preud•homme 
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and Seligmann, 1972) and non-Hodgkin's lymphoma (Garrett et al, 1977). 
In this section evidence is presented that the same process occurs in 
HCL. 
2. MATERIALS AND METHODS 
Details of the patients have been given in Chapter 2. In HCL, 
the proportions of HCs in the PB varies widely and on some occasions 
virtually no HCs can be morphologically identified. This phenomenon 
has been described as spontaneous remission (Bouroncle, 1978), but 
immunological evidence (Chapter 4) reveals that there are always some 
HCs persisting in the PB. Also, bone marrow biopsy carried out at the 
time of apparent remission clearly reveals abundant HC involvement 
(J.C. Cawley, personal communication). However, for the purpose of T 
cell evaluation in HCL, patients were selected who had undergone 
apparent remission and in those cases the percentage T cells was very 
high. 
Isolated mononuclear cells were tested for the proportions of TM 
and TG by the method of Moretta et al, (1975). Briefly, the cells 
were cultured overnight in tissue culture medium (TC 199) with 10% 
foetal calf serum. After this time the cells forming spontaneous E, 
EAM and EAG rosettes were counted. The reagents for EAM and EAG were 
th d 'b d · l On some occasi'ons Sig+ B cells (and e same as escri e previous y. 
HCs) were first removed by rosette formation with anti-light chain-
coupled red cells (Ling et al, 1977) followed by Ficoll-Isopaque 
centrifugation. 
:1 
j, 
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2. 3 Anti-hcu.Jty-c.ill 1.> e/1.wn (AHS l 
Details of the preparation of this serum have been given in 
Chapter 2. HCs staining with this AHS were scored by indirect fluorescence 
with FITC-coupled goat anti-rabbit IgG serum (Nordic pharmaceuticals). 
Positive cells were also examined at the ultrastructural level with 
either peroxidase- or ferritin-conjugated goat anti-rabbit IgG antiserum 
(Nordic pharmaceuticals). In all cases the control was preimmunisation 
serum from the same rabbits. 
2.4 SWtoac.e maJtRe/1.,6 and electlton mic.Jto1.>c.opy 
The surface marker tests and the processing for electron microscopy 
were carried out as described previously. 
2 • 5 EM:.e/1.M e c.y:to c.hemi!.>:tJty 
For cytochemical studies either air-dried smears of PB buffy 
coats or cytocentrifuge preparations of mononuclear cells were used. 
The method of Higgy et al, (1977, 1978) with a-napthyl butyrate was 
employed. Fresh air-dried preparations were fixed in formalin vapour 
for 4 min, washed, and exposed to a-napthyl butyrate (pH 8.0) in low 
concentration and Fast blue BBN as a diazonium salt capture agent for 
15-30 min. The slides were then washed briefly in distilled water and 
counterstained in haematoxylin for 5 min. This method stains T cells 
with a dense localised positivity made up of l to 4 course granules 
(Higgy et al, 1977) while B cells contain no activity. In contrast, 
HCs often show a highly distinctive pattern of reaction positivity 
which is not inhibited by fluoride; this positivity is readily 
distinguished from that of monocytes where the strong granular positivity 
is scattered throughout the cytoplasm and is inhibited by sodium fluoride 
(Higgy et al, 1978). The distinctive HC esterase pattern is not observed 
in a wide variety of other pathological states (Higgy et al, 1978). 
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3. RESULTS 
While examining the surface marker characteristics of HCs, it 
was often observed that the sum of the% cells forming yFc rosettes 
and those forming E rosettes exceeded 100%. Some examples are shown 
in Table 3.XVIII. In these cases, the morphological HCs were not 
forming E rosettes and this suggested that possibly some T cells were 
G 
expressing the yFc receptor even without culture. 
The cells from 3 patients with HCL and from 4 normal volunteers 
were cultured overnight in TC 199 and then tested for EA, EA and E M G 
rosette formation. The findings are given in Table 3.XIX. The results 
are difficult to interpret since HCs, almost invariably, have receptors 
for both EAM and EAG and therefore the contribution made by T cells 
cannot be readily assessed. The results from patient NW (who had a 
very high proportion of T cells at this time) however, suggest that 
most of his T cells had receptors for neither IgG nor IgM but belonged 
to the T null subgroup. 
To resolve this question of T cell contribution to EAM and EAG 
rosette formation, the mononuclear cells from the PB of 2 of the cases 
were enriched for T cells. HCs possess monoclonal Sig (Chapter 4), 
and thus it was possible to remove HCs by allowing them to form Sig 
rosettes and then removing the rosetted cells by centrifugation over 
Ficoll-Isopaque. The T cells remaining on the interface were then 
cultured overnight, as previously, and tested for rosette formation. 
This test was carried out on 2 of the same patients as previously, but 
on different dates. The results obtained (Table 3.XX) show that patient 
DC - who appeared to possess TM and TG cells on the previous occasion 
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Table 3.XVIII The sum of% rosette formation 
with EAC and Eby mononuclear cells from cases of HCL, 
without culture 
% rosette formation 
Patient sum 
E EAG 
FB 50 82 132 
AD 31 82 113 
LP * 
(spleen) 18 94 112 
RR 60 63 123 
HR 10 95 105 
AB 54 64 118 
TN 30 92 122 
* The%. mononuclear cells staining with a specific anti-T cell 
serum (Chapter 5) was 21. 
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Table 3.XIX The effect of culture on E, EA and EA rosette 
formation b y the PB mononuclear cells by HCL 
% rosette • formation 
Patient 
E EA EAG M 
Before culture 
DC 85 24 23 After culture 89 58 35 
Before culture 
LH 49 24 79 After culture 54 45 65 
Before culture 
NW 87 12 15 After culture NT+ 12 16 
Before culture 6. 63 3 28 After culture Normal 58 32 27 
+ NT, not tested 
Mean value of 4 individuals 
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Table 3.XIX The effect of culture on E, EA and EA rosette 
i formation by the PB mononuclear cells by HCL ;f, 
;1 
Ii 
!I 
! 
% rosette formation 
Patient 
E EA EA M G 
Before culture 
DC 85 24 23 After culture 89 58 35 
Before culture 
LH 49 24 79 After culture 54 45 65 
Before culture NW 87 12 15 After culture + 12 16 NT 
Before culture /), 63 3 28 After culture Normal 58 32 27 
+ NT, not tested 
Mean value of 4 individuals 
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of testing (Table 3.XIX) - now had no T cells and only a proportion M 
of TG cells. Like patient NW (Table XIX), most of DC's T cells 
appeared to belong to the T null subgroup. Patient LH, on the other 
had, showed about normal TM cell proportions, but greatly elevated 
TG cells. 
A different method of T-cell evaluation is by esterase staining. 
However, this method probably only detects TM cells and the results. 
obtained from 5 patients with HCL (Table 3.XXI) make it clear that 
the proportions of TM cells are often reduced in this disease. 
Romanowsky morphology Typical HCs were identified by the presence of 
prominent cytoplasmic hairs and an eccentrically-placed nucleus 
which contained largely non-condensed chromatin and frequent single 
nucleoli. Cells were also identified as HCs when they contained the 
typical nucleus and possessed the characteristic slate-blue cytoplasm, 
even when the surface hairs were inconspicuous. The percentage of 
mononuclear cells scored as HCs using these criteria are listed in 
Table 3.XXII. 
Electron microscopX In addition to typical HCs (Figure 3.8), a 
variable percentage of cells was observed which in many respects 
resembled small nature lymphoblasts (Figure 3.6), but were seen to 
contain the ribosome lamellar complex which has come to be regarded as 
largely diagnostic of HCs (Katayama et al, 1972a; Catovsky, 1977). 
Cells of this type were particularly prominent in patient WH (Table 3.XXII). 
Since the ribosome lamellar complex has not been found in normal 
lymphocytes, cells containing it are likely to be involved in the 
leukaemic process. 
Esterase c ytochemistry The percentage of cells from a number of 
11 
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Table 3.XX E, EA and EA rosette formation by negatively ______ ,-;._...;-M G;-----------=----------
enriched T cells from 2 cases of HCL 
before and after culture 
% rosette formation 
Patient 
E EAM EA G 
* Before culturl DC 92 0 16 After culture 75 0 22 
Before culture 96 0 28 
After culture6 LH 96 43 47 
* The same EAM reagent formed rosettes with HCs before T-cell 
enrichment. 
Ll Results for EAM and EAG were comparable after 12 h, 18 hand 
24 h of culture. 
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Ta~le 3.XXI Comparison of% T cells by E rosette formation 
and esterase pattern 
T cells 
Patient 
E rosette Esterase 
PS 42 10 
MH 36 20 
HD 24 10 
FB 44 25 
FW 45 20 
Normal 63+ 67++ 
+ Mean value of 4 normal individuals 
++ Mean value of 11 normal individuals 
Table 3 .XXII Studies of PB leucocxtes in HCL 
% of total mononuclear cells 
Total WBC HC numbers by different methods Normal B lymphocytes T cells Monocytes Patient cou~t Roman ow sky 
Y-C3b (x 10 /nmi3) EA esterase Sig esterase Sig E Esterase morphology M 
DC 2.5-3.4 40 40 41 ND <l 16 ND ND 0 
HD 3.8-5.5 25 20 89 ND 2 5 ND 24 0 
WH 3.0-5.2 7 23 65 55 (K) ND 15 O(A) 36 0 
PS 2.8-5.9 35 30 88 62()1.) 0 2 4 (K) 42 0 I-' ro 
w FW 3.3-7.2 24 52 79 57(A) ND 1 0 (K) 45 <l 
-FB 3.0-4.0 17 37 67 57 (K) ND 7 2(1,.) 44 0 
LP 10.0-21.0 60 78 88 70 ()I.) ND 2 3 (K) 17 0 
KD 10.1-14.6 49 51 55 85(1,.) ND 9 0 (K) 15 0 . A 
--AD 5.8-10.0 60 71 ND 66(1,.) <l ND <l (K) 18 ND 
ND= not done 
- - ~ ,_.c-'-~= ..•.. =-,1 
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cases of HCL which showed the distinctive HC esterase pattern 
(Figure 3.7) is given in Table 3.XXII. It can be seen that this 
percentage generally exceeded considerably the percentage of cells 
with typical HCs Romanowsky morphology. This finding suggests that 
many cells with apparently normal lymphocyte morphology, in fact, 
belong to the leukaemic clone. 
On the other hand, whereas in most cases virtually all the 
morphologically recognisable HCs, as well as some morphological 
lymphocytes, showed the HC esterase pattern, in some cases, notably 
patients DC and WH, morphologically obvious HCs could be found with 
negative esterase reaction (Figure 3.7). Such cells are recorded 
under 'Normal B lymphocytes' in Table 3.XXII since B lymphocytes 
are characteristically negative with this esterase stain. 
AHS The absorptions used during the preparation of the AHS have been 
described in Chapter 2. Before absorption, the serum was exceedingly 
potent, and stained the HCs from a variety of patients with HCL, in 
an indirect fluorescent technique, to a dilution of 1/1600. However, 
after extensive adsorption with a variety of tissues, specific 
immunofluorescent staining was something of a compromise. Normal PB 
and splenic (also l spleen from a patient with Hodgkin's disease and 
l from a patient with Gaucher's disease) lymphocytes, erythrocytes and 
most polymorphs completely failed to stain, even at a dilution of 1/5. 
The end of the plateau region of staining in cases of HCL varied, but 
in some cases it was about 1/15, in other cases the cells stained at a 
dilution of 1/100. At a dilution of 1/10, however, the cells from some 
cases of CLL stained weakly, and the monocytes from a case of acute 
monocytic leukaemia and from a case of acute myelomonocytic leukaemia 
also stained weakly at this dilution. At the time of testing the AHS, 
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Figure 3.6 (x 11,400) This cell is not readily distinguishable 
from a normal lymphocyte - there are no typical surface projections 
and the nucleus contains moderately heavy peripheral chromatin · f 
condensation. However, the presence of a ribosome lamellar complex 
(sectioned largely transversely) indicates that the cell is involved 
in the leukaemic proliferation. 
186 
Figure 3.7 HCL, PB buffy coat preparation; a-napthyl butyrate esterase. 
A group of 8 HCs are seen together with a single mature small lymphocyte. 
Seven of the HCs show the distinctive reaction pattern with a mixture 
of fine scattered granule together, in some instances, with coarser 
granules located in a crescentic configuration. A single HC is 
virtually negative. The small lymphocyte shows a single block of 
coarse positivity which is typical of normal T lymphocytes. 
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F(ab) 2 fragments had not been made, and it was considered that yFc 
binding might be causing non-specific staining. Acetone-fixed cells 
from a case of CLL and from a case of chronic myelomonocytic leukaemia 
CMML were then tested, in parallel with cells from cells from a case 
of HCL which had been stored as a cytocentrifuge preparation at -20°c 
for 6 months. Some 10% of the CMML cells stained faintly at a 1/10 
dilution of serum, and 5% of CLL cells stained quite strongly at 
this dilution; 73% of the mononuclear cells from the case of HCL 
stained with a strong membrane and cytoplasmic fluorescence. 
Some of the blocking studies with this serum are of passing 
interest. The exquisite sensitivity of the µFe receptor (and of the 
apparent C3 receptor) of HCs to blocking by AHS has been described in 
a previous section. However, EAM rosette formation by T cells was 
not blocked by a 1/100 dilution of serum (HCs were regularly blocked 
to a 1/400 dilution), and in a case of CLL tested with AHS at 1/10, 
EAM rosette formation was reduced fro~ 55% to 22% by this treatment. A 
1/25 dilution of serum did not block E rosette formation by normal T 
cells, nor did it block Sig rosette formation (Chapter 4) or EAG rosette 
formation by HCs. Mouse rosette formation by splenic HCs, from one 
case of HCL tested, was only partly blocked by AHS at a dilution of 
1/25. 
Nevertheless, because normal leucocytes do not stain with the 
absorbed AHS, it was considered a valuable tool for the estimation of 
HC numbers within a given case of HCL. This is particularly true 
because of the virtual absence of monocytes in HCL (confirmed by the 
esterase staining in Table 3.XXII). The results obtained when 
percentage scores were made in 3 patients are given in Table 3.XXIII, and 
the results in this table extend the general theme that normal B cells 
Patient 
ocl:i 
AD 
PS 
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Table 3.XXIII Staining of HCs b y the AHS 
and the correlation with other surface markers 
T cells 
AHS dilution % stain 
* Anti-T E yFc 
1/100 23 ND 83 12 
1/15 80 24 31 82 
1/10++ 73 ND 42 73 
Sig 
8 
ND 
73 
+ The anti-T cell serum (Chapter 5) was used in an indirect 
fluorescent method. 
* 
* 
The% cells resetting with a single light chain type of anti Ig. 
L:i This patient had 10% plasmacytoid cells in his mononuclear cell 
preparation. 
++ Acetone-fixed slide used. 
ND Not done on this date 
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are virtually absent from the PB of patients with HCL. Also, of 
special interest are the results from patient DC. At the time of 
study, this patient had an infection and some 10% of his PB cells 
had a transformed, plasmacytoid, appearance. These cells did not 
possess any of the surface markers examined, but they did stain with 
the AHS. 
Figure 3.8 illustrates a hairy cell stained with the AHS at EM 
level by the 2 methods used. Non-specific staining was more of a 
problem at the EM level than it was by light microscopy. 
Other marker studies The extra data added to Table 3.XXII: Sig; 
Yeast C3b (Y-C3b); EAM; and E rosettes are taken from the results given 
in other chapters. 
The Sig results tabulated refer only to the light chain findings 
with a rosette method (Chapter 4), but the percentage of heavy chain 
rosettes (not tabulated) closely paralleled the percentage rosettes 
obtained for the predominant light chain type, although the class 
varied from case to case. 
In the 5 cases tested for Sig by immunofluorescence the percentage 
of mononuclear cells staining either for the predominant light chain 
type or for the particular heavy chain class present, in each case 
closely approximated to that found by the rosette method. In contrast, 
by immunofluorescence, no cells bearing the non-predominant light chain 
type, which presumably reflect normal B cell numbers, were detected. 
In the 4 cases tested for complement receptors by the Yeast-C3b 
method (Table 3.XXII), virtually no cells bearing this receptor were 
observed, although this method detects normal C3b-receptor-bearing 
lymphocytes (Section II). 
As can be seen from Table 3.XXII, the sum of cells forming E and 
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Figure 3.8 Staining with AHS; immunoelectronmicroscopy with an 
indirect method using ferritin- (inset) and peroxidase-labelled 
antibody (x 10,000; inset x 22,000). This typical HC shows strong 
peroxidase activity at its surface indicating the presence there of 
antibody. In the inset, the presence of AHS is shown by the 
alternative ferritin method. 
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monoclonal Sig rosettes approximated to 100%. 
4. DISCUSSION 
The limited studies of T cell subpopulation in HCL reported in 
this section suggest that there are imbalances in the T, T and M G 
T null populations. The techniques used to identify TM and TG cells 
cannot account for this imbalance (particularly the reduced proportion 
of TM cells) since the values obtained with normal mononuclear cells 
with the same reagents closely agree with the findings of others 
(Moretta et al, 1975; McConnell and Hurd, 1976). Moreover, comparison 
of the percentage of E-rosette forming T cells with the value obtained 
for T cells by esterase staining, shows that the latter method identifies 
far fewer T cells in HCL. The identification of T cells by the single 
block pattern obtained with non-specific esterase stains was 
independently reported from several laboratories (Ranki et al, 1976; 
Sher et al, 1976; Higgy et al, 1977; Kulenkampff ,et al, 1977). In 
normal blood the difference in percentage scores between this method 
and E rosette formation for the identification of T cells is small 
(Ranki et al, 1976; Higgy et al, 1977), but recently Grossi et al, (1978) 
have shown that this small difference is significant since only T, and 
M 
not TG 1 cells have the characteristic T-cell esterase pattern. Thus 
the esterase results obtained here in ECL probably support the surface 
marker data in showing a reduced TM cell subpopulation in this disease. 
The significance of this finding, however, awaits further study. 
Evidence will be presented in the next chapter that HCs bear 
monoclonal Sig, and HCL can therefore be classified as a B-cell 
neoplasm. In common with other B~cell proliferations (Mellstedt et al, 
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19741 Preud 'homme and Seligmann, 1972), it is shown here that the 
proliferative monoclonal cells of HCL almost completely replace the 
normal circulating B cell component. Thus, although the majority of 
cases of HCL had less than 50% morphologically identifiable HCs, 
several other pieces of evidence indicated that many more circulating 
lymphoid cells were involved in the leukaemic process. For example, 
electron microscopy revealed that ribosome-lamellar complexes, in 
addition to being present in HCs, were also observed in cells that 
would otherwise be regarded as normal lymphocytes. EAM rosette formation, 
without culture, frequently suggested the presence of a higher number of 
abnormal cells than was apparent by simple morphology. Also, both the 
esterase pattern defined as specific for HCs (Higgy et al, 1978), and 
the limited serological studies using the anti-hairy-cell serum, again 
revealed many more pathological cells than were immediately apparent. 
Finally, the Sig results further substantiated this theme, since the 
percentage of cells being the same light chain type as the morphologically 
unequivocal HCs was in close agreement with the number of leukaemic 
cells by other methods. 
As a corollary to this concept, the results presented here 
demonstrated a profound depression of circulating normal B lymphocytes 
in HCL. The evidence supporting this conclusion includes: the very low 
numbers of cells bearing Sig of the light chain not involved in the 
monoclonal proliferation; the exceedingly small percentage of cells 
forming rosettes with Yeast-C3b - since normal B lymphocytes have a 
receptor for C3b (Bianco et al, 1970); and the generally small numbers 
of cells showing the lack of esterase activity typical of normal B cells 
(Higgy et al, 1977). 
The number of cells bearing Sig light chains of the type not 
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involved in the leukaemic process was strikingly low, even when a 
highly sensitive rosette method was employed (Ling et al, 1977; 
Haegert et al, 1978). With the traditional direct immunofluorescent 
method, no cells bearing the non-predominant light chain were 
demonstrable: this observation is in accord with previous reports where 
this finding was recorded but not commented upon (Fu et al, 1974; 
Haegert et al, 1974; Deegan et al, 1976). 
The esterase evidence, however, was weakened in a number of cases 
by a variable number of morphological HCs which failed to stain and this 
therefore resulted in an artificially high 'normal' B lymphocyte count 
being recorded in these cases. The esterase cytochemistry also, 
incidentally, confirmed the virtually complete absence of monocytes 
recently reported as a feature of HCL (Seshadri et al, 1976). This 
monocytopenia is an interesting, and curious, finding, but it cannot 
now be used as evidence favouring a monocytic evidence for HCs 
(Sehadri et al, 1976; Branda, 1976) in view of the similar B-lymphocytopenia 
in the disease reported here. 
The difficulties which were observed with the extensively 
absorbed heteroantiserum to hairy cells deserve comment. The 
immunogenicity of HCs, and the method of immunisation, appeared to be 
perfectly adequate since the pre-adsorption serum even agglutinated HCs 
to very high titre. It is probable that entirely monospecific 
heteroantisera can never be fully achieved by adsorption, and for such 
sera to be useful this must be recognised. Thus, in immunofluorescent 
tests, such antisera must be employed at the very end of the plateau 
region of staining, and more sensitive techniques such as imrnunoelectron 
microscopy should probably be avoided. This technique is so sensitive 
that the slightest cross-reactivity in the serum becomes immediately 
I . 
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apparent, and one published report of an anti-monocyte serum illustrates 
'specific' staining with a cell of the wrong type (Stuart et al, 1976). 
To conclude the evidence presented here indicates that HCL is a 
B-cell neoplasm in which the leukaemic cells are invariably present 
in the PB in much larger numbers than has been previously recognised and 
in which circulating normal B lymphocytes are profoundly depressed. 
Within the T cell population, the TM subpopulation is also considerably 
reduced, at least in some cases. This depression of both normal B 
lymphocytes and of T lymphocytes is all the more striking when considered M 
in absolute numbers rather than as a percentage, since the majority of 
patients studied (Table 3.XXII) showed the leucopenia characteristic 
of HCL. 
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THE NATURE OF HAIRY CELLS 
I Monocytic properties 
1. INTRODUCTION 
The hairy cell was originally thought to arise from a primitive 
reticuloendothelial cell whose normal progeny included both lymphoid 
cells and cells of the monocyte-macrophage system (Bouroncle et al, 
1958; Mitus et al, 1961). However, more recent concepts of cell 
kinetics suggest that lymphoid and macrophage cell lines develop 
independently. Nevertheless, various studies of HCL document that 
HCs share characteristics with normal B lymphocytes, normal monocytes 
or combinations of the two cell lines. 
Several of the monocytic features of HCs have been described in 
previous chapters, and these, together with some of the morphological, 
cytochemical, and immunological, aspects of HCs have led several recent 
groups to declare that HCs derive from the monocyte-macrophage series 
(Jaffe et al, 1974; Polliack et al, 1974; King et al, 1975; Seshadri 
et al, 1976; Rozenszajn et al, 1976; Kass, 1977; Banerjee et al, 1978; 
Reyes et al, 1978). 
In this section, some of the monocytic characteristics of HCs are 
examined and then the evidence favouring a monocytic lineage for HCs is 
discussed in relation to the literature. 
2. MATERIALS AND METHODS 
2.1 Sephadex G-10 6).J,;t)ia;tion 
The mononuclear cells isolated from a case of HCL by Ficoll-Isopaque 
~ 
' 
11 I 
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centrifugation were passed through a column of Sephadex G-10 following 
the technique of Ly and Mishell (1974). A small column of Sephadex 
G-10 (4 ml, 6 x 1 cm) was thoroughly washed with HBSSA and then HBSS + 
10% foetal calf serum (FCS). To this was added 1 ml of the mononuclear 
cell preparation at 4 x 106 cells in HBSS + 5% FCS. The column was 
incubated for 60 min at 37°c and non-adherent cells were then eluted 
with several bed volumes of HBSS + 10% FCS. Weakly adherent cells were 
-3 
eluted with PBS + 10 M EDTA. Fractions eluted were cytocentrifuged 
and examined after staining with Giemsa. 
To investigate the phagocytic potential of HCs, 1 ml of cell 
6 
suspensions at 4 x 10 /ml in HBSSA, with and without 10% autologous 
plasma, was incubated for 1 hat 37°c in a shaking water bath with 1 
drop of a suspension of latex particles (1.1 µ). After this time the 
cells were washed in HBSSA and phagocytosis was assessed by phase 
contrast microscopy and by the examination of Giemsa-stained cytocentrifuge 
preparations. Cells were also examined for phagocytosis by transmission 
electron microscopy. 
Mononuclear cell preparations from cases of HCL were incubated with 
ox erythrocytes, or ox erythrocytes sensitized with IgM (EAM), IgG (EAG) 
or IgM + complement (EAC) prepared as described previously. The 
leucocytes at 4 x 106 cells/ml were mixed with the erythrocytes (1%) and 
incubated on a shaking water bath at 37°c for up to 3 h. After this 
time, non-phagocytosed erythrocytes were lysed with distilled water and 
cytocentrifuge preparations were stained with Giemsa. In one case 
(MB) erythrophagocytosis was also examined by transmission electron 
microscopy. 
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3. RESULTS 
3.1 Sephadex G-10 0..i.i..:t:Jta;t[on 
The test was carried out on cells from patient LS at a time when 
this patient had a very high proportion of morphological HCs in his PB 
mononuclear cell preparation. Very few cells passed through the column 
when it was eluted with HBSS + 10% FCS, and these had the morphology 
of small lymphocytes. HCs did not pass through the column, even when 
-3 it was eluted with 10 M EDTA. 
Most of the patients available for study were tested for 
phagocytosis of latex at some time. In all cases, phagocytosis was 
observed by a proportion of the HCs. At the level of the electron 
microscope (Figures 4.1 and 4.2), two or more latex particles were 
frequently observed to be enclosed within phagocytic vacuoles in any 
one cell. 
3. 3 Phago c.y.to-6M o 6 -6 en1.i,U,i,zed eJl..y.tlvw c.y.tu 
Ten patients were tested for erythrophagocytosis, and in only 
1 patient (MB, Figures 4.3 and 4.4) was a high degree of phagocytosis 
observed. Only erythrocytes opsonised with IgG were phagocytosed; 
unsensitized ox erythrocytes were not ingested and neither IgM, nor 
IgM and complement, were active as opsonins. In the other 9 patients, an 
occasional HC could be observed which had internalised a single IgG-coated 
erythrocyte (Figure 4.5), and such cells were only observed after at 
least 2 h of culture. Control preparations from patients with acute 
monocytic leukaemia rapidly phagocytosed EAG within 30 min but did not 
ingest unsensitized erythrocytes or EAM. 
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Figure 4.1 HC phagocytosing latex TE.M 
Figure 4.2 HC phagocytosing latex TEM. Two (L) and possibly 3 (?L) 
latex particles are seen enclosed within phagocytic vacuoles. 
M = membrane whorl. 
I., 
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Figure 4.3 Phagocytosis of IgG opsonised ox erythrocytes by the 
HCs of patient MB. 
--- --
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Figure 4.4 Electron micrograph of the phagocytosis of two IgG 
opsonised erythrocytes by a HC from patient MB. 
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• 
Figure 4.5 HC phagocytosing a single IgG-opsonised erythrocyte. 
This cell is from patient LS. 
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4. DISCUSSION 
The monocytic properties of HCs are still the subject of some 
controversy (Catovsky, 1977): this probably results both from 
variations in the techniques used and from variations from case to 
case. Adherence to glass slides by HCs was shown in the last chapter, 
and glass and plastic adherence by HCs is the experience of most 
workers (Flandrin et al, 1973; Catovsky et al, 1974b; Debusscher et al, 1975; 
King et al, 1975; Boldt et al, 1977; Rieber et al, 1977; Palutke et al, 1978; 
Jansen et al, 1978). Rieber et al, (1977) assessed the glass adherence 
of HCs from three patients quantitively and found the adherent HCs to be 
more resistant to EDTA-trypsin treatment than normal monocytes. There 
are, however, reports claiming that HCs do not adhere to glass or 
plastic (Trubowitz et al, 1971; Rozenszajn et al, 1976; Matre et al, 1977). 
Another report of a single case (Ruben et al, 1969) showed that HCs 
passed through nylon fibre columns, but two other groups (Yam et al, 1968; 
Boldt et al, 1977) both tested a case of HCL by this method and found 
that the HCs were retained. In this section it was shown that HCs from 
a single case were also retained by Sephadex G-10 beads which is generally 
considered to remove monocytes (Ly and Mishell, 1974; Alonso et al, 1978). 
However, these techniques probably also remove some B lymphocytes, 
particularly those cells which bear Sig of the IgG or IgA type (Alonso 
et al, 1978). 
Again, with few exceptions (Schrek and Donnelly, 1966; Yam et al, 
1968; Matre et al, 1977), there is almost complete agreement that HCs 
can phagocytose latex (Flandrin et al, 1973; Fu et al, 1974; Catovsky 
et al, 1974b, 1977; Haegert et al, 1974; King et al, 1975; Rozenzajn et al, 
1976; Boldt et al, 1977; Utsinger et al, 1977; Zidar et al, 1977; 
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Rieber et al, 1977; Jansen et al, 1978; Palutke et al, 1978) and this 
is confirmed in the present section. There is less agreement about 
phagocytosis of anything other than latex, and, as shown in the present 
report where only one case effectively phagocytosed opsonised erythrocytes, 
this ability probably varies from case to case. Ferritin was phagocytosed 
weakly (less than monocytes) in a single case (Schmalzl et al, 1975), 
but in most cases carbon black, yeast and bacteria, whether opsonised or 
not, are not phagocytosed by HCs (Yam et al, 1968; Ruben et al, 1969; 
Berg and Brandt, 1970; Haak et al, 1974; Fu et al, 1974; Debusscher 
et al, 1975; King et al, 1975; Kitani, 1977). One report claims weak 
engulfment of yeast followed by mycocidal activity (Catovsky et al, 1974b), 
but this was countered by a major study of eight cases (Jansen et al, 1978) 
which demonstrated that apparently phagocytosed staphylococci were cell 
associated, rather than internalised, and could be destroyed by 
lysostaphin which cannot permeate the leucocyte membrane. The single 
case in this section which phagocytosed opsonised erythrocytes is, 
however, supported by occasional such cases in the literature and Zidar 
et al, (1977) (1 of 7 cases) and Boldt et al, (1977) have each reported 
a similar case. Palutke et al, (1978) reports that most cases will 
phagocytose erythrocytes, and Rieber et al, (1977) demonstrate occasional 
erythrophagocytosis of opsonised cells in most cases. 
Phagocytosis is not a property exclusive to the monocyte-macrophage 
series. When using CLL cells as a control, Zidar et al, (1977) 
observed that two cases adhered to glass and one of these phagocytosed 
latex, but other groups have failed to demonstrate phagocytosis by 
CLL cells (Fu et al, 1974; Rieber et al, 1977). Catovsky et al, (1977) 
demonstrated that all of nine cases of CLL, and three cases of 
prolymphocytic leukaemia, phagocytosed latex, and claimed that serum was 
'I 
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required in the incubation mixture. In the present report, the 
presence of serum in the mixture of latex and HCs was found to be 
unnecessary and Fu et al, (1974) considered that the presence of high 
concentrations of serum in the initial mixture inhibited phagocytosis 
by HCs. In some cases of acute lymphoblastic leukaemia, the lymphoid 
blast cells can occasionally phagocytose erythrocytes (Foadi et al, 
1978), and normal T lymphocytes bearing yFc receptors have been 
demonstrated to phagocytose opsonised erythrocytes (Grossi et al, 1978). 
The other evidence for a monocytic origin for the HC mainly rests 
on the nature of the yFc receptor - and thus of the intrinsic nature 
of Sig - and on cytochemical staining. The monocytopenia in HCl used 
as evidence by Seshadri et al, (1976) was shown in the last section to 
be no more marked than the lymphopenia. 
It will be shown conclusively in the next section that the Sig 
on HCs is intrinsic and not acquired either by the yFc receptor (Jaffe 
et al, 1974; King et al, 1975) or as autoantibody (Banerjee et al, 1978) 
as has been suggested. Nevertheless, the yFc receptor on HCs bears 
many resemblances to that of monocytes (Chapter 3), and it is fair to 
describe this receptor as a monocytic feature of HCs. However, the 
UCG (unclassified cell group - null cells, K cells, L cells) also have 
an exceedingly avid yFc receptor, and some of these cells are B cells 
as evidenced by il!UUunoglobulin synthesis and secretion (Chess and 
Schlossman, 1977). 
Hairy cells possess non-specific esterase (NSE) enzymes 
(Rozenszajn et al, 1976; Kass, 1977; Higgy et al, 1978) which are more 
characteristic of monocytes than of lymphocytes (Li et al, 1973). One 
group has consistently used this feature as evidence for a monocytic 
origin for the HC (Kass and Schnitzer, 1973; Kass, 1977) and claims 
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that the esterase staining is markedly inhibited by sodium fluoride. 
This last point is crucial since it has recently been demonstrated 
that some T lymphocytes and null cells also have NSE activity (Higgy 
et al, 1977), but complete fluoride inhibition is a feature of the 
monocyte enzyme. However, in a study of 14 cases of HCL, Higgy et al, 
(1978), whilst observing a distinctive pattern of NSE staining (quite 
different from that of monocytes), did- not find that the enzyme was 
inhibited by fluoride. Moreover, NSE activity which was inhibited by 
fluoride has been recorded in megaloblasts and normoblasts in patients 
with anaemia (Kass and Peters, 1977), and therefore this reaction is 
probably not entirely specific for monocytes. 
Several other features of HCL are very unusual, and by being almost 
invariably present in HCL, but rarely in other conditions, they are 
useful as diagnostic aids. However, none of these distinctive features 
is diagnostic of HCL since one or more may be absent in any particular 
case and since any may occur in other pathological states. Thus, the 
tartrate-resistant isoenzyme 5 of acid phosphatase in HCL (Yam et al, 
1971) is also found in some cases of Hodgkin's disease and in CLL 
(Katayama et al, 1972b; Katayama and Yang, 1977). Both the receptor for 
IgM on HCs (Burns et al, 1977a), and the distinctive ribosome-lamellar 
complex (Katayama et al, 1972a), can be found in CLL (Cawley et al, 1975; 
Burns et al, 1977b; Pichler and Knapp, 1977) as can a high leucocyte 
alkaline phosphatase score (Hayhoe et al, 1977). 
There remain other findings which appear to be restricted to 
the HC and thus add to the interest of HCL. The cytoplasmic projections 
both at light and electron microscopy level which give the cell its 
characteristic hairy appearance are not commonly found in other conditions, 
nor is the hybrid-type appearance of both microvilli and ruffles on the 
- - --- - -
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cell surface as viewed under scanning electron microscopy (Polliack 
et al, 1974). Unlike the cells from most chronic leukaemias (Revesz 
et al, 1976), HCs do not bind cholera toxin (Revesz et al, 1976), and 
very recently, Reyes et al, (1978) have described a newly discovered 
peroxidase activity in HCs which is not associated with granules. 
In conclusion, while the HC remains an unusual and interesting 
cell type, the weight of evidence does not appear to necessarily 
suggest a monocytic origin for HCL. 
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II Surface imrnuno2l()bulin .on HCs 
1. INTRODUCTION 
The strong yFc receptor on HCs has often been invoked to account 
for the varied, and frequently multiple, heavy chain isotypes of 
surface immunoglobulin (Sig) on these cells (Jaffe et al, 1974; King 
et al, 1975; Seligmann, 1977; Catovsky, 1977), and these continues to 
be uncertainty about the heavy chain phenotype of HCs. 
A detailed study of the complete Sig phenotype of the cells from 
a large series of cases of HCL was therefore undertaken, both to 
clarify this previous uncertainty and to place HCL firmly within the 
B-cell disorders. 
2. MATERIALS AND METHODS 
Twenty four patients with clinically and morphologically typical 
HCL were studied. The diagnostic criteria used for most of these 
patients has been given in Chapter 2. In brief, in all the patients, 
the bone marrow aspirate or trephine biopsy was extensively infiltrated 
with HCs, and in all the 15 patients splenectomised, the spleen was 
diffusely replaced by HCs. In all instances, the diagnosis was 
confirmed by the demonstration of tartrate-resistant acid phosphatase 
(Li et al, 1970), of a typical ultrastructure (Daniel and Flandrin, 
1974) and of a surface receptor for IgM (Burns et al, 1977a). Only 
1 of the patients (FE) had a paraprotein, and this patient is discussed 
in more detail in the next section. 
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In most cases the PB was examined sequentially for periods of 
up to 15 months. Splenic (8 patients), bone marrow (_4 patients}, and 
lymph node (1 patient) cells were also examined. In order to 
determine the possible effect of splenectomy in PB populations in HCL, 
in two patients blood was studied daily in the immediate post-splenectomy 
period. 
For comparison, the PB of 25 patients with typical chronic 
lymphocytic leukaemia (CLL) was also examined. 
2.2 MononucleaJL ee,ll ,[}.,olcition 
Mononuclear cell suspensions were prepared from the various tissues 
as described previously. In all instances, the viability by trypan-blue 
dye exclusion was greater than 95%, and the virtual absence of monocytes 
characteristic of HCL was always confirmed by non-speqific esterase 
staining of cytocentrifuge preparations. 
In all experiments, before testing for Sig, the isolated and 
0 
washed mononuclear cells were incubated for 2 hat 37 c, and in some 
cases overnight, in serum-free medium in order to remove cytophilic IgG 
(Winchester and Fu, 1976). A modified rosette method (Molinaro and 
Dray, 1974; Ling et al, 1977) was used: this employs chromic chloride 
coupling to indicator ox erythrocytes of purified sheep IgG antibody, 
monospecific for human heavy and light chains. The antisera used were 
a gift from Dr. N. Ling, Department of Experimental Pathology, University 
of Birmingham, and details of their specificity have been given by 
him (Dhaliwal et al, 1978). In addition, the purity of the antisera 
was confirmed by the specific staining in indirect fluorescent preparations 
from cases of IgG, IgA, IgM, and IgD myelomas (Burns et al, 1978d) • In 
particular, the anti-IgG and anti-IgA antibodies did not stain the 
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cytoplasm of either of two cases of IgM myeloma or of the two cases 
of IgD myeloma tested; the anti-light chain antibodies were monospecific 
for the appropriate light chain type of each myeloma studied. Sheep 
IgG does not readily bind to t?e yFc receptor of human cells (Alexander 
and Sanders, 1977), but this possibility was controlled to non-immune 
sheep IgG; in all instances rosette formation with this reagent was 
less than 1%. It was also observed that the percentage of cells rosetting 
with the non-predominant light chain type was negligible. Furthermore, 
the possibility of soluble complex formation with residual serum Ig 
causing apparent Sig by yFc-binding of the anti-lg reagent (Winchester 
and Fu, 1976) is not a problem with the rosette method (see Discussion). 
In some patients, a direct fluorescent staining technique 
employing FITC-coupled, affinity purified, monospecific rabbit or sheep 
anti-human Ig was used to detect Sig. The antisera were purchased from 
Dr. J.L. Smith, Immunology Unit, Tenorus Research Laboratory, Southampton, 
and details of their preparation have been published (Gordon and Smith, 
1978). The antisera were ultracentrifuged immediately before use, and 
an FITC-coupled normal rabbit serum control was negative in each test. 
2.4 Cytopla.6miQ Ig 
Cytocentrifuge preparations of washed mononuclear cells, which 
had been pre-incubated for 2 hat 37°c to remove extrinsic Ig, were 
fixed in acetone at -20°c overnight and stained with FITC-coupled, 
affinity purified, monospecific rabbit anti-human Ig immunoglobulin. 
These antisera were all monospecific for the appropriate myeloma cell 
types. A normal rabbit serum used as a control was in each test 
completely negative. For the staining procedure, a method employing 
very small quantities of antisera and a cytoplasmic counterstain was 
used (Worman, 1978). In brief, this method involved placing a 3\ drop 
I r 
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of antiserum on a coverslip which was then inverted onto the 
cytocentrifuged cells. After incubation and thorough washing, the cells 
were counterstained by incubation for 5 min at room temperature with 
0.2% Evan's Blue dye in physiological saline. The counterstain was 
washed off and the slides read under combined phase contrast and u.v. 
epifluorescence. The cytoplasm of negative cells fluoresced a bright 
red thus greatly facilitating percentage cell counts. Positive (green) 
plasma cells were only red around the Golgi region and the Evan's blue 
counterstain in no way interfered with specific immunofluorescence. 
2. 5 Cui;tWLe. 
Splenic cells from. one case of HCL were established in culture 
for more than 60 days by methods described elsewhere. During this 
time, the cells consistently maintained a hairy cell morphology and 
continued to display tartrate-resistant acid phosphatase activity. They 
retained the same surface membrane marker phenotype as before culture 
and, in particular, remained negative for the Epstein-Barr nuclear 
antigen. 
2. 6 O.theJt .6WL6ac.e. mMk.eJL-6 
E rosette formation and yFc receptor expression were determined 
as described previously. 
3. RESULTS 
3.1 VL5bubux).on. 06 Slg 
The results are shown in Table 4.I. The pathological cells in 
all 24 cases expressed only a single light chain type (16K, 8\), 
thus showing the probable monoclonality of HCL and, incidentally, 
demonstrating a 2:1, K:A ratio. As regards heavy chain isotype expression, 
Table 4.I Distribution of sr2 on isolated mononuclear cells in HCL 
Sig method % Sig~ positive cells 1. Rosette % % Patient Date Tissue 2. Fluoresc- E rosettes Comments Type yFc rosettes 
ence K >.. µ 0 y a 
* 2. 2. 77 PB* 1 0 73 41 70 85 - 10 93 After overnight culture II 
PB 1 0 69 37 70 73 KD 18. 1. 78 PB 1 2 86 55 75 79 2 5 91 
13. 4.78 PB 1 0 83 9 78 70 0 10 93 
* 24. 9.76 Spleen 2 0 90 5 0 90 0 3 78 After overnight culture I 
4. 2.77 PB 1 5 41 0 0 60 - -
- -
~ MB 24 48--- - 6 95 t-4. 3.77 PB* 1 0 0 0 t... 
PB 1 0 66 0 0 70 
30. 9. 76 PB 2 0 60 41 
-
64 0 44 64 II 
19.10.76 Spleen 2 0 86 51 - 85 0 13 91 PS 19. 2.77 PB 1 4 62 45 48 73 - 42 73 
6. 2.78 PB 1 0 35 10 43 25 0 52 47 
* 6. 7.77 PB* 2 55 0 0 0 48 0 36 60 Many plasmacytoid cells I MH 8.10.77 PB 1 11 0 0 0 18 0 56 33 present. Sig persisted after 
overnight culture 
HD 13. 4.78 PB 1 36 0 10 43 5 0 40 70 II 
-
* 29. 4.77 PB 1 6 0 0 0 6 
- 87 14 This patient had previously I * RH 28. 4.78 PB 1 3 0 0 0 4 0 58 46 demonstrated 87% polyvalent 
28. 4. 78 BM 1 9 0 3 0 12 0 46 so anti-Ig staining when E = 16; 
yFc == 88 (18.9.75) 
~---~-- ........:.-:_: ... 
Table 4.I continued 
Sig method 
% Sig- positive cells 1. Rosette % % Patient Date Tissue 2. Fluoresc- E rosettes Comments Type yFc rosettes 
ence K A µ cS y a 
* 14. 1. 77 PB 1 68 1 8 0 65' 
-
30 72 Sig persisted after 4 I DC 14. 1.77 Spleen 2 90 0 0 0 90 9 22 90 days in culture 
* 
* 21. 1. 77 PB 2 47 0 2 3 53 0 50 62 This patient has a I FB 20. 8.78 PB 1 40 0 0 0 40 0 43 63 paraprotein (see Section III) 
* * 25. 1.77 PB 1 0 66 1 2 63 
-
18 78 Sig persisted after overnight AD f\.) 23. 1. 78 PB 1 0 38 3 0 40 0 50 40 culture I I-' 
.i:,. 
* * 28. 1.77 PB 1 3 64 18 70 24 
- 17 83 G and D capping+ synthesis 
LP 28. 1.77 PB 2 - - - 70 4 0 experiments performed II 
3. 2.77 Spleen 1 0 74 14 85 71 - 18 94 
* 12. 1.77 Spleen 1 
- - 3 78 - - 73 96 The HCs in this case had II 
* 12. 1. 77 Spleen 2 78 0 5 82 - 0 combined Band T cell LH 12. 2.77 PB 1 52 4 11 44 10 79 65 features (Chapter 5) -
24. 2. 78 BM 1 50 1 15 55 10 0 33 65 
* 5. 2.77 PB 1 0 50 10 57 32 
-
43 60 Many normoblasts present in II 
23. 6.77 PB* 1 1 67 11 66 28 - 34 74 mononuclear cell preparations 
19. 1. 78 PB 1 <l 40 59 57 27 1 8 73 FW 27. 1.78 PB 1 0 29 7 30 13 0 8 65 
2. 2. 78 PB 1 0 17 4 23 15 0 56 46 
9. 2. 78 PB 1 0 0 2 5 2 0 63 48 
-.--=~~--~ ~~~ ... ....,;..;._.....,:· 
.-------___ --------------------.--- ·· - ~-- ---- ------·-------------~---~----- -_-- ____ -_- --~ .. ------------ - ,. -_-,-. - --- ~~ ~-=-- --
Table 4.I continued 
Sig method 
% % Patient Date Tissue 1. Rosette % Sig- positive cells E rosettes yFc rosettes 2. Fluoresc-
Comments Type ence K 
" 
]J 0 y Cl 
BN 16. 6. 77 PB 1 37 5 0 5 52 
- 42 56 I 
* 
* 3. 9. 77 PB 1 42 0 0 0 41 0 60 63 Sig persisted after I 
RR 
4.10. 77 PB 1 25 0 0 1 37 
- 44 68 overnight culture 
* 
5.10.77 PB 1 58 2 1 67 5 8 19 88 See Sig kinetic II 5.10.77 PB* 1 44 3 4 55 6 
- 15 85 experiments 
N 
11.10. 77 PB 1 70 2 39 80 29 65 19 89 
~All Sig classes persisted t-' 
:E 
lJl 
HR 11.10. 77 Spleen 1 83 5 53 83 36 84 6 91 
after overnight culture 
15.10.77 PB 1 31 3 17 47 10 31 20 83 22.10.77 PB 1 49 1 2 69 40 66 18 85 22.10.77 PB 2 44 2 15 45 17 26.10.77 BM 1 66 0 0 "64-~ -- 9 80 13 85 
* 
* 
29 •. 9. 77 PB 1 52 0 0 0 55 
- 54 64 Sig persisted after 2 I 16.ll.77 PB 1 68 0 1 2 67 1 26 80 days in culture AB 22.ll.77 PB 1 31 0 <l 1 47 1 32 75 22.ll.77 Spleen 1 74 0 0 1 81 0 ll 90 22.ll.77 BM 1 27 0 0 1 45 0 18 73 22.ll.77 LN 1 4 0 0 0 8 0 _,,,. 31 76 
* 
19.12.77 PB* 1 31 0 4 3 36 
- 43 58 Many plasmacytoid cells I 
GH 
24. 1.78 PB 1 8 1 1 1 22 5 46 53 present following a systemic 
candida infection 
~ 
Table 4.I continued 
Sig method 
Patient Date Tissue 1. Rosette % Sig'.'." positive cells % % 
2. Fluoresc- E rosettes yFc rosettes 
Conunents Type 
ence K A µ 0 y a 
TN 15. 1. 78 PB 1 72 <l 80 73 4 1 30 92 III 
LK 18. 1. 78 PB 1 65 0 56 67 43 70 20 78 II 
2. 3. 78 PB 1 48 0 7 8 55 7 26 70 I DA 6. 4.78 PB 1 21 2 <l 1 31 0 51 43 [\. 
I-
(j 
JC 27. 4.78 PB 
1 0 72 0 0 80 0 9 91 I 
9. 5.78 PB 1 0 98 0 0 99 <l <1 96 
BC 14 .12. 77 PB 1 <l 23 16 28 28 2 54 47 II 
CJ 12. 5.78 PB 1 65 0 0 0 67 0 12 92 I 
* 15. 6.78 PB 1 65 <l 0 63 32 0 26 80 Sig persisted in culture II 
26. 7.78 PB 
* 
1 52 <l 0 40 2 5 52 50 for 14 days 
27. 7.78 Spleen 1 94 0 0 94 0 3 5 95 AF 2B. 7.78 PB 1 90 0 0 73 0 2 15 95 
2. 7. 78 PB 1 90 0 0 67 35 22 17 84 
8. 8.7B PB 1 57 0 <l 43 10 6 36 74 
11. 8. 78 PB 1 65 0 2 44 5 4 
· ·~ 
S-"7""-=a-;-·,f::. 
{'---~~:ii;.;_ .~~~..;.;.• -- ~ - ..:.=::::.::::=.::_:::.:2-
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the cases fell into two, or possibly, three groups. In 13 cases the 
cells expressed only IgG (lOK, 3A) - type I. The cells in all the 
other cases displayed multiple heavy chain isotypes, but invariably 
showed restricted light chain expression. Ten cases (SK, SA) had 3, 
or 4, heavy chain isotypes (type II) which always included IgD, and 
usually, IgM. The low level of IgM expression in nearly all of the 
type II cases of HCL was a constant feature, and parallel tests with 
the cells from cases of CLL (Table 4.II) demonstrated that this was 
not due to the anti-IgM antibody. 
The combination of Mand D alone (type III) was observed in only 
one case (K). In all these mixed cases, the sum of two or more of 
the heavy chain isotypes greatly exceeded both the percentage of cells 
+ -bearing the exclusive light chain type and the percentage of Fe E 
(non-T) cells. This indicates that two or more heavy chain isotypes 
were simultaneously expressed on the same cell. The light chain 
restriction observed in the multiple isotype groups (types II and III), 
together with the equal number of A light chain isotypes in type II, 
make it unlikely that the heavy chain findings are attributable to 
extrinsic autologous serum Ig binding. 
Table 4.II which shows the results of similar studies in CLL, 
using the rosette method, demonstrates a clear difference in Sig 
expression in the two diseases. The distribution of types in CLL 
shows a preponderance of type III, which was rare in HCL. Type I which 
was the most common in HCL, has only one representative in 25 cases of 
CLL. Again, within group II, which is common to both diseases, 
IgM expression in CLL is much more marked and IgA was not detected in 
the 21 cases tested; IgA was observed in 2, or possibly 3, of the 
group II HCL cases. Non-T cells which did not express Sig were not 
I 
:1 , 
,. 
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seen in HCL although this group (type IV) represented some 16% 
of the CLL cases. However, 2 of the type I group from the HCL cases 
(RH and FW) appeared to be progressively losing their SigG, and may 
eventually become type IV cells. 
Table 4.I shows that, at different times of study of a single case, 
whereas wide variations were observed in the percentage of Sig 
expression and in relative proportions of the different heavy chain 
isotypes (type II), the cells maintained the same isotypes. Moreover, 
the major heavy chain type was consistently expressed on approximately 
the same percentage of cells as bore the exclusive light chain type. 
In 2 patients (HR and AB), Sig expression was studied sequentially 
over short time intervals after splenectomy; these results are shown 
graphically in Figure 4.6. The marked variations observed cannot be 
attributed to technical artifact since the specimens were sometimes 
collected on the same day and tested with identical reagents. Also, the 
anti-lg-coated indicator cells have been shown to give reproducible 
results, with no loss of activity, for up to two weeks. (Ling et al, 1977)~ 
In the present study, the same batch of indicator cells was used over 
any 8-day period, 1 with frequent checks of reproducibility. 
As is seen in Figure 4.6, immediately post-splenectomy there is a 
marked rise in the total white cell (wbc) count which is attributable 
mainly to a rise in the absolute count of HCs. The estimate of total 
- + HC numbers (% E yFc cells x wbc count corrected for polymorphonuclear 
leucocytes: this method of calculation is justified because of the 
virtual absence of both monocytes and non-neoplastic B lymphocytes in 
HCL) very closely parallels the absolute number of cells bearing the 
+ predominant heavy chain isotype {% Sig cells x wbc count corrected for 
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Table 4.II Sig phenot;YJ?e of isolated PB l~i 
mononuclear cells in CLL lli 1 ' : I 
'1~•1 I 
··,,, ii:,.i 
1'·1 
'11 
Jj• 
% Sig positive cells 
;;!, 
iJl i' 
Patient by rosette method 
,:I 
: lJ· % % 111 
;\ c5 
iE 
K ]J y a E rosettes yFc rosettes Type 11:1 ',
I ' 1 71 5 0 0 80 0 0 100 ,J: 
(repeat 
I r 
57 0 0 0 67 0 4 97 ( 6 mo) ;j i j 
, , 
2 91 0 95 81 89 o* 10 95 q 
3 <l 97 80 91 82 ND 3 98 
(repeat 0 85 75 90 30 0 5 91 8 mo) 
4 46 5 58 62 26 ND 29 85 II 
(repeat 78 0 ND 68 85 0 25 80 16 mo) 
5 89 0 31 86 22 0 8 94 
6 80 0 80 63 65 <l 10 70 
7 0 82 0 63 31 0 4 65 
8 0 50 62 57 6 ND <l 97 
(repeat 0 45 15 76 0 0 3 98 4 mo) 
(repeat 0 64 50 76 0 0 <l 95 8 mo) 
9 93 5 92 87 2 0 1 93 
10 0 45 14 32 4 0 2 92 
11 50 0 30 63 0 ND 31 85 
12 <l 90 71 74 6 ND 5 94 
(repeat 0 94 70 27 0 0 4 96 III 4 mo) 
13 71 0 47 51 0 0 1 95 
14 91 1 32 41 8 ND 0 94 
15 0 47 43 23 0 0 20 91 !I, 
16 40 0 20 26 0 ND 10 87 I' 17 97 0 12 91 0 0 4 97 :;!·I 
18 0 52 20 50 5 0 <l 95 
:111 ;h,: 
19 0 38 36 56 0 0 1 91 ii ,111 
20 0 0 0 0 0 0 12 80 
i•1 d 
21 0 0 0 0 0 0 5 93 
1:11 
22 2 0 0 0 0 0 <l 98 IV 
23 0 3 4 4 3 0 0 95 
IV/V ,1.r 24 0 15 2 13 0 0 4 93 ::ir I J, 
96 V 
,,r I 
25 0 90 0 90 1 0 <l :,,,, d: l! i 
,, I ii i 1··,, 
:E 
Vi 
for Table 4.I: 
, I. , , 
Types I-III as Type IV No Sig detected: Type V SigD ' d1: 
only. l!i:1 
* Not done PI; 
111
11 
I' ', 1 
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polymorphs). The predominant heavy chain type was IgG in one case 
(Figure 4.6, lower), but the similar pattern of heavy chain expression 
in the other (mixed) case, in which IgD was the dominant isotype, is 
further evidence against yFc-binding of autologous, but extrinsic, Ig. 
The second peak observed in both patients around days 5-8 post-
splenectomy (Figure 4.6) was attributable mainly to a rise in absolute 
polymorph numbers. 
3.3 Removal and ne-expne~~ion 06 SI9 
Attempts to remove surface immunoglobulin using trypsinization or 
papainization under standard conditions (Preud 'homme and Seligmann, 
1972) were uniformly unsuccessful and complete removal could not be 
achieved without killing the cells. 
Sig was then removed by a capping process using the anti-lg-coated 
erythrocytes as a stripping agent. Mononuclear cells were mixed with 
the indicator erythrocytes as for the Sig rosette test, and the mixture 
incubated at 37°c. Aliquots were removed at time O and at various 
time intervals thereafter, and read for percentage Sig rosette formation. 
Figure 4.7a illustrates the rate of removal of SigD in one case of 
multiple heavy chain isotype HCL (LP, Table 1), and Figure 4.7b 
demonstrates the removal of SigG in a case of IgG only (Type 1), HCL 
(FB, Table 1). As will be discussed later, the failure to re-express 
Sig in this case after 10 h of culture may be attributable to the 
continued presence of the indicator red cells constantly stripping off 
re-synthesised Sig. However, when anti-IgG, rather than anti-IgD, 
indicator cells were used to strip the same multiple heavy chain case 
of HCL, an increase in SigG rosette formation was seen to occur, and 
this is shown in Figure 4.7c. Since this unexpected result suggested 
IgG secretion, an experiment was set up to establish whether Ig was 
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Legend to Figure 4.6 Peripheral blood leucocyte changes following 
splenectomy. Patient HR (upper) and AB (lower). (0-0) indicates 
the total peripheral white cell count, including polymorphonuclear 
leucocytes; (A -- -A) charts the estimated total HC count assessed by 
the non-T, yFc-rosetting mononuclears; (~) records the total 
mononuclear cell count forming E-rosettes (X---~ charts the absolute 
nwnber of cells bearing the major heavy chain isot¥pe (IgD upper, 
IgG lower). All these counts are expressed as 10- /1. Also charted 
( ) are the maximal percentage of Sig rosette-forming cells (scale 
indicated on the right ordinate). For most of the period of study, 
patient HR (upper) was on continuous prednisone as indicated on the 
graph. In patient AB (lower), up to 10% of plasmacytoid cells were 
observed in the PB between days 7 and 9; these cells were Sig-, E-. 
Patient AB (lower) received only a single dose of steroid (200 mg 
hydrocortisone intravenously) at the time of splenectomy (ton graph). 
1.' /!
!il I 
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secreted into the culture supernatant. The mononuclear cells from 
the peripheral blood of four HCL patients, none of whom had 
recognisable plasma cells in their differential count, were thoroughly 
washed and cultured for between 3 hand 12 h (1 x 107 cells/ml) in serum-
free medium at 37°c. Control cultures were incubated for the same 
time at o0 c, or at 37°c in the presence of puromycin (2.5 µg/ml). The 
supernatants from these cultures were then titrated for agglutination 
of indicator erythrocytes coupled to sheep IgG against the various 
Ig classes and the results are set out in Table 4.III. Control 
supernatants were completely negative. The results suggest that all 
four HC cultures were secreting IgG (3A, lK) and that the cells from the 
SigG-only group (type I) were secreting an excess of light chain. The 
same experiment, modified and quantitated, was also carried out on 
patient FB (Table 4.I) who has a paraprotein (IgG K), and cells from 
this patient also secreted IgG. These results will be documented fully 
in the next section. 
Additional stripping experiments were performed with free, 
fluoresceinated, rabbit anti-Ig and mononuclear cells from a multiple 
isotype (type II) case (HR, Table 1). Washed mononuclear cells were 
incubated with antiserum for 40 min at room temperature, washed 
thoroughly, and then incubated at 37°c for 30 min to allow capping to 
take place. An aliquot of cells was then tested by immunofluorescence 
to confirm that the Sig had been removed. In all the experiments described 
below, the Sig was seen to be either absent or completely capped when 
assessed by f+uorescence. Culture was continued and aliquots were 
removed for Sig rosette testing at various time intervals up to 36 h. 
The results of these experiments are graphed in :Figure 4.8. ln the 
initial experiment, polyvalent anti-Ig was used and the re-expression 
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Figure 4.7 (_a) The rate of removal of SigD over a short period in 
the continued presence of anti-IgD coupled to indicator erythrocytes 
is shown (patient LP) • (.b) The complete removal of SigG (_patient FB) 
by anti-IgG-coupled erythrocytes is shown. (_c) The increasing 
percentage of SigG rosette formation observed in the continued presence 
of anti-IgG-coupled erythrocytes is shown (same patient as (a) LP}. 
These results are the mean of two separate experiments. 
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Table 4.III Agglutination titre of indicator erythrocytes 
by PB HC cultures 
Immunoglobulin class 
Patient Type 
K \ µ cS y a 
KD II 0 neat 0 0 1/2 
DC I 1/32 0 0 0 neat 0 
AD I 0 1/8 neat 
LP II 0 1/16 0 1/16 
r 
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of SigD examined by the rosette method; having shown an initial 
marked reduction in SigD (the cells were completely capped or negative 
by fluorescence) by 5-6 h the SigD had returned to levels approaching 
those observed before stripping. Repeat stripping experiments were 
performed with monospecific anti-Ig antisera (including three different 
anti-o reagents) and rosette tested for re-expression of the heavy 
chain type stripped off. Incidentally, testing for other heavy chain 
types showed that the anti-a and anti-o antisera stripped only a or 
o respectively, no reduction being observed in the other heavy chain 
classes. This independent capping provides further evidence for the 
specificity of the antisera and for the non-association of the heavy 
chain isotypes; it also eliminates the possibility of SigM having anti-
serum Ig activity (Preud 'homme and Seligmann, 1972). As is also seen 
in Figure 4.8, stripping of IgD was almost complete even when tested 
by the sensitive rosette method, and re-expression was taking place, 
although incomplete, by 18 h in one test and by 36 h in another test. 
Complete stripping of SigA could not be achieved even with monospecific 
anti-IgA (but again stripping appeared complete by fluorescence) and 
the percentage SigA positive cells remained similar at 18 h: this 
probably reflects a low level of IgA synthesis and secretion, especially 
since SigA was expressed after more prolonged periods of culture (Table 
4. V) • 
Stripping and re-expression of SigG was performed, in the same 
way on the cells of patient FB. SigG was demonstrated to re-express 
on stripped cells in a time of between 24 hand 72 h (Section III). 
3,4 Cytopla.6mie Ig 
The results of cytoplasmic staining are set out in Table 4.IV. 
the cases studied exhibited cytoplasmic staining of restricted light 
All 
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Figure 4.8 The stripping and subsequent re-expression of Sig, as 
monitored by Sig rosette formation, is shown. The experiments all 
involved leucocytes from patient HR. Stripping was performed with 
polyvalent { O-<>), with anti-a {0-0) and with three different anti-o 
(o-e ,JI-iii ,A· · ·•) antisera. At the time indicated by the arrow, all 
cell preparations (including o and C) were completely capped or 
negative for Sig when tested by fluorescence. 
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Table 4.IV Cytop lasmic immuno9lobulin staining of HCL cells 
Percent mononuclear cells 
Patient Tissue Type 
K ;\ ).1 c5 
KD PB II 0 767 f.:, 0 
DC Spleen I 903 0 
FB PB 67
3 0 0 0 I 493 BM 0 0 0 
AD PB I 0 43 5 0 0 
LP Spleen II 0 793 0 0 
LH Spleen II 963 2 24 2/1006 0 
FW PB II 0 53 7 0 0 
I 
123 GH PB I 26 0 0 
TN PB III 706 0 0 743 
LK PB II 603 0 0 0 
Superscript numbers indicate the pattern of fluorescence: 
1, strong diffuse; 2, strong granular; 3, moderate diffuse; 
stairiing 
'Y 
703 
693 
493 
0 
202/906 
0 
I 
26 
124 
0 
4, moderate granular; S, weak/moderate diffuse; 6, weak, diffuse; 
7, very weak, diffuse. 
= not done 
* = some cells showing strong IgA fluorescence resembled plasma cells 
1 
a 
0 
0 
0 
0 
0 
'* 17 
0 
0 
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chain type. Although the staining was much weaker than that of 
control plasma cell preparations, it seemed unlikely that the 
fluorescence was attributable solely to Slg since in the multiple 
isotype cases, all of which had lgD at the surface., no intracytoplasmic 
lgD was detected, except in one case (TN, Table 4.lV). The possibility 
that yFc-bound extrinsic lg was causing apparent cytoplasmic staining 
was minimized by the routine use of preincubation and washing. The 
possibility of interalization by either the phagocytosis or pinocytosis 
of extrinsic lg during this preincubation cannot be excluded, but the 
light chain restriction and the diffuse nature of staining (except in 
one case - LH) make this an unlikely explanation for the intracytoplasmic 
staining pattern. The cytoplasmic lg findings are therefore further 
evidence of immunoglobulin synthesis by HCs. 
3. 5 CultWLe.. 
During the period of culture, the great majority of cells resembled 
HCs morphologically although, after 60 days, increasing numbers (up to 
10%) of larger cells with a transformed appearance began to appear. 
Virtually all the leucocytes, including the larger cells, were positive 
for tartrate-resistant acid phosphatase and all the HCs, but not the 
larger cells, were positive for the µFe receptor. Other surface marker 
data are presented in Table 4.V. The cells consistently expressed Slg 
of a single light chain type (K). After short-term culture (18 days), 
only 36% of cells expressed Slg (mainly o), while after more prolonged 
culture a greatly increased percentage of cells expressed Sig of multiple 
heavy chain isotypes, including lgA. After 66 days culture, the cells 
were tested for cytoplasmic lg and only faint diffuse K reactivity was 
detected, A and all the heavy chain isotypes being absent in both 
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the morphological HCs and in the larger transformed cells. It should 
be stressed that no human serum was present in the culture medium, 
that the culture fluid was changed repeatedly, and that almost all 
the cells contained tartrate-resistant acid phosphatase; also it is 
noteworthy that, of the heavy chain isotypes, only o was detected on 
an appreciable number of the cells in the first three weeks of culture. 
All these points make it highly likely that the results reflect the 
increasing expression on the same cell of genuine monoclonal Sig of 
multiple heavy chain isotypes. 
4. DISCUSSION 
All 24 cases of HCL in this study expressed Sig of restricted 
light chain type (16K, BA). In 13 cases, the only heavy chain isotype 
expressed at the surface was IgG, while in the other 11 cases multiple 
surface heavy chain isotypes (including IgG in 10 and IgA in 3), were 
detected. 
The existence and incidence of genuine intrinsic SigG on B cells 
has been the subject of much controversy, although very recently it 
has become widely agreed that SigG is present on a small population of 
normal human lymphocytes (Cooper and Seligmann, 1977; Gathings et al·, 
1977) and on the cells of some cases of chronic lymphocytic leukaemia 
(Cooper and Seligmann, 1977; Brouet and Seligmann, 1977; Dhaliwal et al, 
1978). In mice, most memory B cells carry IgG (Coffmann and Cohn, 1977; 
Black et al, 1978) and the less mature memory cells also carry IgD 
(Black et al, 1978). It is also of interest that a very successful 
method of removing Sig-positive B cells in man is the use of glass beads 
coated with F(ab) 2 fragments of human IgG and F(ab) 2 fragments of 
232 
anti-human IgG (Perlmann et al, 1976) indicating that IgG-bearing 
cells are probably more common than has been suspected. 
The controversy over SigG arose because of a number of important 
technical points. These include: the necessity of eliminating monocytes 
(Winchester and Fu, 1976; Cooper and Seligmann, 1977); the need to 
remove labile extrinsic autologou~ IgG (whether autoantibody or 
immunoglobulin bound by the yFc receptor) (Winchester and Fu, 1976; 
Horwitz and Lobo, 1975); and the avoidance of problems arising from the 
attachment of heterologous reagent antibody (Cooper and Seligmann, 1977; 
Siegal and Good, 1977). Therefore, in the present study particular 
care was taken with these technical aspects. First, HCL is characterised 
by an almost complete absence of monocytes (Seshadri et al, 1976), and 
this was shown to be the case in the present series (Section I, Chapter 
4). Secondly, a routine preincubation step at 37°c removes the problem 
of autoantibody attachment since such antibody, although potentially 
monoclonal, is rapidly removed by short periods of incubation in v.Lt!to 
(Horwitz and Lobo, 1975; Winchester and Fu, 1976). Detection of extrinsic 
autologous IgG attached by the yFc receptor is unlikely to show the 
restricted light chain pattern consistently observed in the present 
study, more especially since only one of the patients (Section III, 
Chapter 4) had a paraprotein and half of the type II group expressed 
only A light chains. Furthermore, Sig persisted unaltered in the cases 
tested after short-term culture for from 12 h to 4 days. In the case 
cultured for a prolonged period, although the percentage of cells 
expressing Sig varied, they continued to express multiple heavy chain 
isotypes, all of a single light chain type. 
The problem of binding of heterologous reagent Ig via the Fe 
receptor, either because of soluble complex formation between reagent 
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Ig and residual serum Igor as a result of aggregates formed in the 
reagent, is usually overcome by employing F(ab) 2 reagents (Winchester 
and Fu, 1976). The former problem does not arise with the rosette 
method used in the present study since the anti-Ig reagent is 
irreversibly bound to a solid matrix and therefore not free to form 
soluble complexes. Sheep IgG does not readily bind to the human yFc 
receptor {Alexander and Sanders, 1977), and Haegert has also 
demonstrated that the rosette method yields exactly comparable results 
for Sig, whether whole serum IgG or F(ab) 2 preparations are coupled to 
the indicator erythrocytes (Haegert et al, 1978; Haegert, 1978). Moreover, 
in the present study, the control employing non-immune sheep IgG was 
always negative, thus refuting Fe binding and also controlling for 
the possibility of attachment of reagent via the receptor for the 
F(ab) 2 fraction of IgG recently described on some human lymphocytes 
(Hofman et al, 1977). 
Another important technical consideration is the specificity of 
reagents. In addition to the details given in the Methods, it should 
be noted that in the IgG-only cases as demonstrated with the rosette 
method, the affinity purified fluorescent reagents also detected only 
IgG. Also, the existence of these G-only cases, together with the 
case of SigM and D, without G, substantiates the lack of cross-reactivity 
of the reagents used in the rosette method. This was further 
substantiated by the data obtained in CLL, where Mand D alone was 
common. Similarly, the demonstration of SigA in only three cases of HCL, 
and none in CLL, provides evidence of the lack of cross-reactivity of 
the anti-a reagent. 
Because of the close relationship between HCL and CLL, the 
distribution of Sig phenotypes in these two chronic leukaemias was compared. 
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In this work, like others using the rosette method (Dhaliwal et al, 
1978), it is shown that there is a group of CLL patients with multiple 
heavy chain isotype expression (.type II) but that G-only cases (type I) 
are rare. The present study found a lower incidence of type II CLL 
patients than Dhaliwal et al, (1978), and indeed M- and D-only cases 
(type III) constituted the major group. Similar results in CLL have 
been obtained by the fluorescent me~hod of Sig detection (Preud 'homme 
and Seligmann, 1972). The Sig results obtained in CLL with the more 
sensitive rosette method (Haegert et al, 1978) confirm the presence of 
a Sig negative group (Cooper and Seligmann, 1977; Jayaswal et al, 1977; 
Dhaliwal et al, 1978) (type IV) and the virtual absence of SigA 
previously observed in both fluorescent and rosette studies (Cooper and 
Seligmann, 1977; Jayaswal et al, 1977; Dhaliwal et al, 1978). This is 
one difference between CLL and HCL, but more striking is the very low 
level of SigM expression in HCL. In a very recent study of 15 cases 
of HCL by Jansen et al, {1978), who employed fluorescent staining of 
formaldehyde-fixed cells, 7 cases expressed SigA (all type II) and only 
6 cases expressed a low level of SigM. 
Attempts to remove Sig enzymically using trypsin or papain under 
standard conditions were unsuccessful since this treatment killed the 
HCs before removing Sig. This has also been the experience of others 
in HCL (Rieber et al, 1977; Braylan et al, 1977), although claims of 
complete removal and re-expression of Sig following trypsinization of 
HCs have been made (Leech et al, 1975; Kitani, 1976; Utsinger et al, 1977). 
Anti-Ig reagent, however, produced rapid and virtually complete removal 
of Sig as assessed by fluorescence and by the rosette method, and 
re-expression was seen to be taking place after 18 h of culture. In 
the one case where stripping, although complete by the fluorescent method, 
f.· ( fl 
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was only partial as monitored by the rosette method (thus demonstrating 
the greater sensitivity of the latter method), re-expression was seen 
to have occurred in less than 12 h. This is interpreted as 
redistribution of persisting Sig, rather than genuine resynthesis. Since 
others have shown re-expression times of greater than 48 h in HCL following 
stripping with anti-Ig reagent (Rieber et al, 1977, 1978), reports of 
Sig re-expression after overnight culture following trypsinization 
{Leech et al, 1975; Kitani, 1976; Utsinger et al, 1977) must be 
interpreted with caution. However, HCs stripped by exposure to 
erythrocytes coupled to anti-Ig failed to re-express Sig in their 
continued presence, probably as a result of continuous stripping (Loor 
et al, 1972). It is conceivable, therefore, that the anti-Ig method of 
stripping, which is known to result in the persistence of some anti-Ig 
on the cell membrane for up to 3 days (Nash and Ling, 1976), results 
in a falsely long re-expression time (Ault and Unanne, 1977). 
One of the stripping and resynthesis experiments suggested that 
the cells from this case were secreting IgG. This evidence of IgG 
secretion was substantiated both by the demonstration of IgG (of a 
single light chain type) in the medium from short-term cultures of HCs, 
and by the detection of cytoplasmic Ig in a number of cases of HCL. 
It is therefore concluded that the majority of cases of HCL express 
at the surface IgG which is a product of the cell. Whether this Sig is 
inserted into the membrane as 'true Sig', or whether it is attached via 
the Fe receptor immediately after secretion, requires further 
investigation. As an extension of this point, IgG secreting cells may, 
at least partially, account for the higher percentage Sig positive cells 
detected by fluorescence when whole Ig rather than F(ab) 2 reagents are 
used, especially since a population of normal human PB cells actively 
"1 
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synthesising and secreting Ig has recently been identified (Strelkauskas 
et al, 1977). Thus it is likely that intrinsic secreted IgG in the 
immediate micro-environment of the secreting cell is bound to anti-Ig 
and the soluble complex formed with whole anti-Ig is able to attach 
via its Fe region, whereas the F(ab) 2 complex is not. This seems at 
least as plausible an explanation of the difference in SigG positive 
cells detected by whole and F(ab) 2 anti-Ig reagents as that of Winchester 
and Fu (1976) who proposed Fe-binding of complexes formed with extrinsic 
serum IgG. This is substantiated by the fact that, when the precautions 
of preincubation and thorough washing are carried out, leukaemic monocytes, 
which have a strong yFc receptor (Koziner et al, 1977), are completely 
negative for Sig even by the rosette method (Cawley et al, 1978b). 
The results in this section clarify the previously confused 
situation in the literature concerning Sig expression and Ig synthesis 
in HCL. Work showing polyclonal Sig patterns (Preud 'homme and Seligmann, 
1972; Stein and Kaiserling, 1974; King et al, 1975; Reyes et al, 1976; 
Zidar et al, 1977; Banerjee et al, 1978) is probably explicable in terms 
of Fe binding. The literature showing a monoclonal pattern of Sig 
expression is fully compatible with the present findings since examples 
of SigG alone (Aisenberg et al, 1973; Leech et al, 1975; Kitani, 1976; 
Rieber et al, 1977, 1978; Catovsky, 1977; Jansen et al, 1978) and mixed 
heavy chain expression (including IgG and IgA) have been described 
(Haak et al, 1974; Haegert et al, 1974; Stein and Kaiserling, 1974; 
Deegan et al, 1976; Kitani, 1976; Boldt et al, 1977; Rieber et al, 1977, 
1978; Jansen et al, 1978). These mixed heavy chain types are in accord 
with recent evidence that the onset of expression of different Ig 
classes is completely random and that any class can appear singly or in 
combination with others and that this need not be a sequential step-wise 
phenomenon (Gearhart, 1977). 
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Similarly, the demonstration of IgG (and IgM) secretion in HCL 
has precedents in the literature (Rubin et al, 1969; Stein and 
Kaiserling, 1974; Debusscher et al, 1975; Gordon and Smith, 1978), and 
the presence in a paraprotein in one case (Section III, Chapter 4) 
suggests in viva synthesis. 
In several of the mixed phenotype cases, and in several mixed 
cases reported by others (Haak et al, 1974; Haegert et al, 1974; Deegan 
et al, 1976), the percent cells bearing SigG is lower than that bearing 
SigM or (more especially) SigD. It is likely, therefore, that these 
mixed cases bear relatively low levels of SigG which require sensitive 
methods of detection such as the rosette method employed in the present 
study, or autoradiography (Rieber et al, 1977, 1977). Prefixation of 
the cells with formaldehyde before immunotluorescent staining appears to 
enhance the sensitivity of this methodandSigG is readily detected on 
most cases of HCL (Jansen et al, 1978). The two mixed cases tested on 
the same occasion by both the rosette method and fluorescence in the 
present section showed a much lower percentage of SigG-pos itive cells by 
fluorescence. 
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III Typical HCL with IgG K paraproteinaemia 
1. INTRODUCTION 
In the last section it was shown that IgG secretion by HCs 
in vi.tJr..o was probably a general phenomenon. In this section a patient 
with typical HCL who also had an IgG (K) paraprotein is described, and 
it is suggested that the HCs are secreting the immunoglobulin. 
2 • MATERIALS AND METHODS 
2. 1 The. pa;U,e.n:t, J.iigni6ic..an:t c..CU> e. hif.i:tofltj 
The patient (FB) was included in the previous chapters as a 
typical case of HCL. However, although he exactly fulfilled the 
immunological criteria of HCL, further details of the diagnosis are 
given here. 
Briefly, the relevant clinical findings were: gross splenomegaly 
without lymphadenopathy or hepatomegaly; pancytopenia (with a 
differential showing 37% HCs, and no monocytes, in a wbc count of 2.3 
x 109;1 at presentation); marrow aspiration and trephine biopsy revealed 
diffuse infiltration with HCs and increased reticulum fibrosis. Shortly 
after presentation the patient's thrombocytopenia gave rise to increased 
bruising and this responded to prednisone therapy. 
Routine serum electrophoresis showed a paraprotein band in the 
a2/S region of 6 g/1 (8% of total protein) and immunoelectrophoresis 
showed this was IgG K. There was no immuneparesis (IgG 15 g/1 (NR 5-16), 
IgA 2.4 g/1 (NR l.0-4.5), IgM o.6 g/1 (NR o.4-1.7)). No Bence-Jones 
protein was detected in concentrated urine. Skeletal survey was normal, 
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showing no evidence of lytic bone lesions. 
Morphologically, the HCs were typical both at light and electron 
microscopy. By TEM, some cells contained typical ribosome lamellar 
complexes (Katayama et al, 1972a), and by SEM the cells showed the 
characteristic combination of ruffles and villi (Golomb et al, 1975). 
Cytochemically, the cells possessed the tartrate-resistant isoenzyme of 
acid phosphatase (Yam et al, 1971) and gave the characteristic HC 
esterase pattern (Higgy et al, 1978) in a high number of cells and, 
incidentally, esterase staining confirmed the absence of monocytes 
typifying HCL (Burns et al, 1976). The leucocyte alkaline phosphatase 
score was repeatedly high (>150), a finding again characteristic of 
HCL (Hayhoe et al, 1977). Most HCs were capable of ingesting latex. 
The immunological marker profile of the patient's cells will be given 
below, but in addition, on the 2 occasions studied, the membrane turnover 
of the µFe receptor showed the 6 h peak-to-peak re-expression time typical 
of HCL (Burns et al, 1977b). 
2. 2 Immun.olog,lc.al mcvik.e.Jt 1.>tucUe1.i 
The reagents and the methods used for all of the marker studies in 
Results have been described in previous sections. The microtitre 
agglutination method described in Section II, Chapter 4, was however, 
modified slightly as follows. 
Isolated mononuclear cells from PB were suspended in HBSSA and 
0 incubated for 24 hat 37 c. Control cultures were incubated for the 
same time at o0 c, or at 37°c in the presence of puromycin (2.5 µg/ml). 
The Ig content of the supernatants was determined by microtitre (Cooke 
Engineering Co.) agglutination of sheep erythrocytes coupled by 
chromic chloride to monospecific, affinity purified, sheep IgG against 
human IgD, IgM, IgG, IgA, Kand A. These antisera were purchased from 
;; 
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Dr. J.L. Smith, Southampton. The concentration of secreted IgG and 
K was calculated by comparing the agglutination titre with that produced 
by normal human IgG of known concentration; for Ka 2:1 ratio of K:A 
in normal IgG was assumed. Supernatants from the control cultures 
were invariably negative for coupled erythrocyte agglutination. 
3. RESULTS 
3. 1 Immunologic.al ma!LkeJU 
The immunological marker studies carried out on patient FB are 
shown in Table 4.VI. A high proportion of the cells possessed the 
µFe receptor, and he consistently belongs to Sig type I. Cytoplasmic 
staining was performed on three occasions, and both PB and BM HCs 
stained with a moderate diffuse pattern for IgG and K, but for no 
other Ig class. 
3. 2 Sig Jte.-e.x.p11.e61.,ion 
On 20.8.78, PB mononuclear cells were tested for Sig by the 
rosette method. Only IgG and K were detected (Table 4.VII). Both the 
IgG and K were independently stripped off, with monospecific sheep 
0 antisera for 30 min at 37 c, and the cells were thoroughly washed with 
sterile HBSS. Upon retesting for Sig, it was observed that the anti-IgG 
had also stripped off K, and the anti-K had removed IgG-indicating 
that no other Ig classes were present on the cells. 
The stripped cells were then cultured in TC 199 + 10% foetal calf 
serum (tubes gassed with co2) and,as a control, untreated cells were 
cultured in parallel. At various time intervals (Table 4.VII), the 
cells were tested for SigG and K re-expression. The small number of 
cells which were available for study (the patient was still severely 
!! 
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Table 4.VI Immunological marker studies on patient FB 
Date Tissue 
E yFc ]JFc 
21.1. 77° PB 50 62 55 
19.2.77 PB 38 68 37 
17.6.77 PB 50 82 55 
12.5.78 PB 37 73 58 
11.8.78 PB 43 63 49 
11.8.78 BM 23 72 23 
:E Moderate diffuse fluorescence 
0 
6 
Sig determined by immunofluorescence 
Not done 
% rosette formation 
Sig 
EAC K :\ ]J 0 'Y a 
33 47 0 2 3 53 0 
- 57 2 3 3 46 
- 40 2 2 2 38 -
15 24 2 0 0 13 0 
4 27 0 0 0 30 0 
8 44 0 0 0 43 0 
% cells staining 
;I; 
K :\ ]J 0 'Y a 
11 
42 0 0 0 17 0 
67 0 0 0 69 0 
49 0 0 0 48 0 
·-- ...aa.-"- · -
-·=--=- _:_= .:. .... ·_;-:-=~;:~_:>-:-~·,;:~:;-:-:;~-:- ~:-~----~c.:.·~=~_':~,-:~ - =-~  ~7-··_~;==-·~:.;. _,.. _::_--:::,:"- "- ,_=;~"~-=~~~~_:~;,~_F~~±~~~-~--~~~;."· -~ -~r-=-~-- ~:;-c's_:_~c~"C~ - ~ 
I\.) 
,i,:. 
I-' 
Table 4.VII Re-expression of Sig following s
tripping 
with anti-lg reagents 
Control Capped with anti-IgG Capped with a
nti-K 
Time 
* Pre""'.cap 
0 
12 h 
18 h 
72 h 
* 
IgG 
40 
46 
30 
31 
K IgG 
40 
46 0 
30 3 
28 
33 
Other Sig classes were negative 
Not done or not applicable 
K IgG K 
0 3 0 
7 2 5 
14 13 
26 22 
..... 
leucopenic), and the apprecia
ble decrease in viabilit
y, particularly 
of some cultures, limite
d the number of tests w
hich could be carried 
out. However, with the 
fluorescein diacetate me
thod routinely 
employed for scoring, on
ly viable cells are coun
ted and the dead cells 
did not present a major problem
, especially since no pa
rticular sub-
population appeared to b
e dying off. The result
s in Table 4.VII 
indicate that SigG and K
 were progressively rest
ored, and that by 72 h 
of culture this process 
was virtually complete. 
At no time were any 
plasma cells seen in cy
tocentrifuge preparation
s of the cultured cells.
 
3.3 Ig ~eCJr..et.ion 
The culture supernatant
s from PB HCs cultured f
or 24 h in serum-
free medium were tested 
for agglutination of she
ep erythrocytes 
coupled to sheep IgG aga
inst human Ig of differe
nt classes on two 
occasions (12.5.78 and 11.8.7
8). On both occasions only Ig
G and K 
synthesis was detected. 
On the earlier date, the
re appeared to be an 
-1 7 
excess of light-chain se
cretion: IgG, 1.95 x 10 
µg/10 cells; 
-1 7 
K, 5.1 x 10 µg/10 cel
ls. On repeated testing
, there was an equal 
-1 7 
1 7 
secretion of both IgG an
d K: IgG o.77 x 10 /10 
cells; K 0.8 x 10- /10 
cells, and the level of 
secretion appeared to ha
ve decreased. However, 
it should be stated that
 at such dilutions of th
e standard IgG solution,
 
the margin of experimen
tal error may be high, an
d also, the well 
selected as the end poin
t is somewhat subjective since 
clear-cut 
positive to negative wa
s not obtained, (although at 
the lower dilutions 
the agglutination by sup
ernatants was very defin
ite and this was 
confirmed microscopicall
y). 
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4. DISCUSSION 
In this section, a patient with clinically, morphologically and 
immunologically typical HCL is described with an IgG paraprotein, 
and the evidence suggests that the HCs are producing the paraprotein. 
The HCs are synthesizing IgG as evidenced by the cytoplasmic 
staining, Sig re-expression and the supernatant agglutination 
experiments. 
It was shown in the previous section, that cytoplasmic staining 
(Cig) in HCL is a regular feature when powerful antisera are used. Also 
since SigD positive cells were negative for cytoplasmic IgD, the 
technique is probably not detecting Sig, and the diffuse nature of 
staining, together with light chain restriction, makes pinocytosis an 
unlikely explanation. Cytoplasmic Ig is readily detected in plasma 
cells, but in CLL intracytoplasmic staining by immunofluorescence is 
generally only detectable in cases with a paraprotein (Preud 'homme 
and Seligmann, 1974): this type of staining, therefore, probably reveals 
only quite high levels of active Ig synthesis. 
In the present case, the demonstration of SigG re-expression after 
stripping was particularly important, to eliminate yFc binding of the 
paraprotein as a possible explanation for HC Sig. The time taken for 
the Sig to re-express during culture is of some interest. Dhaliwal 
et al, (1978) have suggested that SigG may take longer to reappear on 
the membrane than other Ig classes, and certainly in this case the 
time taken (72 h) far exceeds the routine culture time used by 
Seligmann's group (Preud 'homme and Seligmann, 1974; Brouet and Seligmann, 
1977). As discussed in the last section, a long time for re-expression 
may also be a feature of HCs, but the routine culture time of 6-7 h for 
i 
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Sig re-expression in CLL employed by Seligmann and colleagues might 
account for their repeated failure to detect SigG re-expression in 
this disease. 
The detection of IgG and Kin the supernatant of cultured 
HCs suggested IgG K synthesis by these cells. No plasma cells were 
detectable in cytocentrifuge slides of the mononuclear cell preparations, 
and Ig was not detected in control cultures which contained puromycin. 
It is possible that the test was detecting SigG released from the 
membrane (Vitetta and Uhr, 1972) but the quantity of Ig suggested active 
secretion. Also, type II Sig HCs, with both SigD and SigM, appear to 
secrete only IgG by this method {Section II, Chapter IV). 
The demonstration of paraproteinaemia in HCL strongly supports the 
evidence favouring a B lymphoid origin for HCs. No previous cases of 
IgG paraprotein in this disease have been reported although the evidence 
of secretion by HCs reported here, and in the previous section, suggests 
that more might be expected. The present patient only had a small 
paraprotein peak and more sensitive methods of detection may well reveal 
more cases as has occurred in CLL. In this disease, the incidence of 
paraproteins (IgM and IgG) is about 20% (Preud 'homme et al, 1975), but 
with more sensitive methods, monoclonal serum Ig has been found in 75% 
of cases (Eipe et al, 1976). 
The only previous report of HCL with paraproteinaemia was that of 
Golde et al, (1977a) in which an IgM paraprotein was present. However, 
their patient was atypical in a number of respects and the diagnosis 
has been questioned (Katayama, 1977; Banerjee et al, 1978). Thus, 
Golde's case had marked leucocytosis, no marked thrombocytopenia, only 
9 
20% "hairy cells" in a count of 66 x 10 /1, and there was immuneparesis. 
The ultrastructure of the cells was described as being lymphoid, rather 
,-:~ 
j, 
( 
I• 
,1 
L4b 
than that characteristic of HCs, and no rib
osome lamellar complexes 
were seen. No histopathological informati
on was given and some of 
the immunological marker characteristics, 
in particular the presence 
of a receptor for C3, were atypical for HC
s. Their main diagnostic 
criterion, the tartrate-resistant isoenzym
e of acid phosphatase (Yam 
et al, 1971) typical of HCL, can frequently be found
 in the cells of 
CLL (Katayama et al, 1977). Moreover, the patient's
 paraprotein had 
been present for some twenty years, and lig
ht chain studies were not 
performed to establish that the pathologic
al cells bore the same 
isotype. 
The evidence of Sig expression and Ig secr
etion by HCs provided 
in this chapter, suggest that further case
s of paraproteinaemia in HCL 
can be predicted, but that these are more l
ikely to be IgG than IgM 
in type. 
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CHAPTER 5 
PROBLEMS IN IMMUNOLOGICAL MARKER STUDIES 
I CLL with Sig antibody having activity against ox erythrocytes 
i, 
1. INTRODUCTION 
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PROBLEMS IN IMMUNOLOGICAL MARKER STUDIES 
I CLL with Sig having antibody activity against ox erythrocy tes 
1. INTRODUCTION 
The immunoglobulin nature of Sig on lymphocytes has been known 
for some years (Warner et al, 1970), and antibody activity has been 
described for the monoclonal Sig on the cells of some lymphoproliferative 
disorders (Preud'homme and Seligmann, 1974). The range of antibody 
activities of such monoclonal Sig is remarkably limited and most appears 
to be directed against self antigens (Brouet and Seligmann, 1977). Only 
one case of heteroantibody activity by the monoclonal Sig of CLL has 
been reported (Brouet and Prieur, 1974) and this was against the 
Forssman antigen of sheep erythrocytes. 
In the present section, a case of CLL is described with monoclonal 
Sig on the cells directed against an antigen on ox erythrocytes. Since 
many of the surface marker studies employ ox erythrocytes as indicator 
cells, the initial findings from this patient were something of a 
problem and this case provides a warning on the importance of controls 
in rosette testing. 
2. MATERIAD-S AND METHODS 
2 • 7 P a.t.len,t 
The patient was an old man of 97 who died shortly after presentation. 
He had a high leucocyte count and an IgM (K) paraprotein. 
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2. 2 Immuno.loglc.al.. mMk.Vt -6.tud.1..v.i 
Mononuclear cells were isolated as previou
sly described. Also, 
all the reagents for marker studies and the
 conditions employed were as 
described in previous chapters. 
3. RESULTS 
3. 1 Swr.6ac.e. mMk.Vt-6 
The initial studies on this patient showed
: yFc 93%; µFe 88%; EAC 
84%; mouse erythrocytes 49%; sheep erythroc
ytes 1%. However, the 
unsensitized ox erythrocyte (ox) test used as a 
control for yFc and 
µFe revealed 79% rosette formation. Tryps
inization of the ox 
erythrocytes did not reduce rosette formati
on, indeed ox rosette 
formation increased to 84%. 
'Antigen' capping The first premise was 
that Sig on the CLL cells 
had antibody activity against an antigen on
 the ox. To determine whether 
Sig, and thus antibody activity, could be c
apped off with the ox antigen, 
the formed ox rosettes were incubated at 37
°c and aliquots examined 
periodically. After 30 min at 37°c, no ma
rked polarity of the rosetting 
ox was seen and rosette formation was only 
reduced by 10%. 
Antibody capping of Sig Lymphocytes 
from the patient were stained for 
Sig by direct immunofluorescence, and a mo
noclonal M, D, K pattern of 
staining was obtained for approximately 90%
 of the cells (Table 5.I). 
The stained cells were allowed to cap at 37
°c for 40 min and aliquots 
removed at this time showed that the fluore
scent pattern of staining 
(for M, D and K) was capped, or extensively patched, 
on all the positive 
cells. The capped cells were then tested f
or ox rosette formation 
,, 
' ;.i 
Table S.I The effect of removing Sig on ox rosette formation 
Test 
;i; 
Fluorescent Sig 
staining (%) 
Capping and ox * 
rosette testing 
K 
93 2 
5 70 
µ () y 
92 87 2 0 
14 58 68 72 
;i; Lymphocytes were treated with FITC-labelled monospecific rabbit 
antiserum to the class indicated for 20 min at 4°c. The stained 0 
cells were then thoroughly washed at 4 C and read for% Sig staining. 
* The stained and washed cells were incubated for 40 min at 37°c 
and tested for ox rosette formation. 
and the results are shown in Table 5.I. 
Since virtually no cells possessed SigG, A or A, these results 
provide the necessary control for rosette formation after the capping 
treatment. From Table 5.I it can be seen that most of the antibody 
activity was removed with K, and that removing SigM also reduced ox 
rosette formation to a major extent. Capping off of SigD reduced ox 
rosette formation by only 14%; the reduction in rosetted formation 
caused by removing SigM + SigD was 100%. 
4. DISCUSSION 
The leukaemic lymphocytes from this patient possessed monoclonal 
Sig directed against an antigen on ox erythrocytes. The capping 
experiments described demonstrated that the Sig was restricted to IgM 
and IgD, and confirms the idiotypic identity of these two classes on 
the cells of CLL (Fu et al, 1975). The results also suggested that 
IgM predominated over IgD in this case. 
Naturally occurring antibody activity of the Sig on lymphocytes 
against erythrocyte antigens is not uncommon in the lymphoproliferative 
diseases (LPD) since the cells from patients with chronic cold 
agglutinin disease will form rosettes with human O erythrocytes which 
have I or i antigen (Feizi et al, 1973). Antibody activity against 
a heteroantigen is, however, very rare in the LPD, and only one case 
of CLL, which bound the Forssman antigen of sheep and cat erythrocytes, 
has been described (Brouet and Prieur, 1974). Another case which probably 
displayed the same phenomenon, since the CLL cells spontaneously bound 
both ox and sheep erythrocytes, was mentioned by Pichler and Knapp 
(1977). The specific antigen detected by Sig in the present case was 
not determined because of the early demise of the patient, however, it 
I 
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was not the Forssman antigen since sheep erythrocytes did not bind; 
another type of heteroantigen activity can therefore be added to Sig 
antibody activity in the LPD - against an ox erythrocyte antigen 
which is not destroyed by trypsin. 
Not surprisingly, the serum from the present patient agglutinated 
untreated ox erythrocytes, thus confirming previous work in animal 
models that Sig and secreted Ig have the same idiotype (McConnell, 1971). 
Ox erythrocytes themselves, however, did not strip the Sig. After 5 min 
of culture at 37°c, preformed ox rosettes showed marked polarity, but 
by 30 min complete morulla-like rosettes were again seen and rosette 
formation was reduced by only 10%. Murine splenic lymphocytes with Sig 
activity for sheep erythrocytes (induced by immunisation) provided a 
similar phenomenon (Ashman, 1973). Thus although sheep erythrocytes 
induced some cap formation when rosettes with the lymphocytes were 
0 incubated at 37 c, cap formation was much slower than that caused by 
anti-Ig antibodies and only caused some 14% cells to cap. It was 
suggested that the bulky erythrocytes physically resist the efforts 
of the lymphocyte to pack Sig together into caps (Ashman, 1973). 
Ox erythrocytes are widely used as indicator cells in rosette 
tests, since, in contrast to sheep, mouse or human erythrocytes they 
do not adhere to any lymphocyte subpopulation (Hallberg et al, 1973). 
The case described in the present section illustrates that non-adherence 
of ox cannot be assumed, particularly in the LPD with a clonal 
expansion of cells bearing monoclonal Sig, and that care in checking 
the unsensitized erythrocyte control must always be observed. 
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II HCL with hybrid membrane phenotype 
1. INTRODUCTION 
Individual surface markers differentiate Band T cells with 
varying degrees of certainty, and it is generally agreed that a panel 
of immunological markers is required to assign a particular cell to 
either category. In general, the ability of human lymphocytes to 
form E rosettes and to react with anti-T-cell antisera are characteristics 
of T cells, whereas B lymphocytes are characterized by the presence of 
Sig, C3 receptors and the presence of readily detectable la-like antigen. 
However, in some instances lymphocytes are detected which exhibit 
combined B- and T-cell features (Cooper and Seligmann, 1977) and this 
has been particularly true in human leukaemias where a variety of 
unusual phenotypic markers has been described (Sandilands et al, 1974; 
Hsu et al, 1975; Toben and Smith, 1977). 
In this section a case of HCL with unusual combined B- and T-cell 
membrane characteristics is described. In addition, the changes in 
membrane phenotype observed in the cells from the patient over a 13 mo 
period amply confirm the observation of Hsu et al, (1975) that 
sequential studies in such cases are essential. 
2 • 1 Patient 
The patient was clinically and haematologically absolutely 
typical of HCL. He has been included in the series of patients 
described in Chapter 2. The unusual marker phenotype of his cells 
(below) did not give rise to any unusual features. 
2. 2 Immunologic.a£ mank.e.Jt 1.itucli..e.1.i 
The reagents and tests used for the study of this patient have 
[· 
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all been described in previous chapters, except for the anti-T-cell 
serum. This serum {Greaves and Janossy, 1976) was an extensively 
absorbed rabbit antiserum to monkey thymic cells and was kindly given 
by Dr. G. Janossy, ICRF Membrane Immunology Laboratory, Lincoln's Inn 
Fields, London. Before use, the antiserum was ultracentrifuged, and 
in staining tests an indirect immunofluorescent technique was employed 
using FITC-labelled goat anti-rabbit serum. 
3. RESULTS 
In all experiments, mononuclear cell preparations were cyto-
centrifuged and stained to exclude granulocyte contamination (always 
less than 5%) and the characteristic absence of monocytes was confirmed. 
The percentage PB mononuclear cells (11.1.77) showing the HC 
esterase pattern was 65%, while some 28% possessed the single dot 
pattern characteristic of normal T lymphocytes. 
In the splenic cell suspension (12.1.77), 92% of the cells showed 
acid phosphatase activity, and 90% gave the HC esterase pattern. Some 
3% of splenic cells showed the T-cell dot pattern with esterase 
staining. 
Transmission electron microscopy of the PB showed many 
morphologically typical HCs, and a proportion of these were demonstrated 
to contain the ribosome-lamellar complex. The almost total replacement 
of splenic tissue by HCs was confirmed at the ultrastructural level 
and some of the HCs were again seen to contain the ribosome-lamellar 
complex. 
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3. 2 Immu.n.ologic.a.l maJI.k.eJt 1.i.:tu.dieo 
The marker studies performed on the unusual cells from patient 
LH over a 13 mo period are shown in Table 5.2. The expression of 
the individual Band T markers fluctuated over this time and two 
main patterns are discernable 
In the first week of December, 1977, the patient suffered a 
severe trauma (unrelated to HCL) and, during his stay in hospital, he 
contracted a bacterial infection. After this time the patient underwent 
apparent 'spontaneous remission' and very few HCs could be detected in 
his PB either morphologically or immunologically. There were, however, 
many HCs still present in his bone marrow (24.2.78) although the E 
rosette forming capacity seen in the patient's HCs in earlier studies 
was no longer evident. 
Before this traumatic event, the HCs from this patient, in addition 
to bearing the conventional B-cell markers normally present on HCs 
(Sig, Ia), appeared to possess T-cell features (E rosettes and anti-T 
cell staining). The summation of B-cell and T-cell features, on most 
occasions, greatly exceeded 100%. Also, morphologically typical HCs 
were seen to form E rosettes. The HCs did not form rosettes with 
erythrocytes from a variety of other species including ox, rabbit, guinea 
pig, rat and donkey. They were also negative for the Epstein-Barr 
nuclear antigen and for the C3b receptor. 
The combination of Band T cell markers on the cells of the 
patient are particularly well documented for his splenic cells (Table 
5.2) which were morphologically and cytochemically almost all HCs. 
In addition to the data presented in Table 5.2, over 90% of splenic 
mononuclear cells possessed cytoplasmic IgM, IgG and K as detected by 
diffuse staining by direct immunofluorescence. 
Table 5.2 Immunological marker studies on isolated mononuclear cells from PB and sp leen 
Sig Ia-like 
Anti-T p29,34 Mouse 
Material Date E cell staining K ;\ cS y a antigen yFc µFe erythrocytes µ 
11.1. 77 84 + 30 34 PB - - - - - - - -
PB 12.1.77 95 75 - - - - - - - 62 - 9 
Spleen 12.1.77 73 - 78 0 5 82 - 0 90 96 23 47 
PB 26.1.77 76 - 19 3 5 18 5 - - - 22 - N u, 
441'.\ 
O'I 
PB 12.2. 77 79 - 52 4 11 10 - - 65 - 1 
* PB 26.2.77 52 70 70 16 77 37 72 0 79 78 66 
PB 13.3.77 84 - 34 - - 33 - - - 47 38 
PB 18. 5. 77 49 - 50 3 9 46 9 - 50 79 24 
PB 30. 6. 77 40 - 44 2 0 44 27 - - 80 
PB 2.12.77 22 - 64 <l 25 53 18 2 - 77 21 <l 
PB 6.2.78 70 - 11 2 3 3 8 1 - so 10 
PB 20.2.78 85 - 6 0 2 2 2 0 - 38 7 
BM 24.2.78 33 - so 1 15 55 10 0 - 65 1 
+ L\ * Not done: Sig persisted for 3 days in culture: E rosette formation increased to 76% after 6 h of culture 0 
at 37 C (Table 5.3). 
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Conditions affecting E rosette formation Table 5.3 shows some of the 
physical and chemical conditions which affected E rosette forma
tion 
by this patient's HCs. It was considered that some serum facto
r 
attached to the cell membrane (perhaps anti-heterophile antibody 
attached via the Fe receptor) was causing spurious E rosette formation. 
Culture of the cells for 6-12 h, followed by thorough washing in
 warm 
medium, however, increased rosette formation (Table 5.3). On the 
other hand, a reduction in E rosette formation by HCs, similar 
to that 
seen with normal T-cell controls, was observed when rosette for
mation 
0 
was carried out at 4 c, without centrifugation, or in the prese
nce of 
sodium azide or cytochalasin B. Thus, like E rosette formation
 by 
normal T lymphocytes, this E rosette formation was energy depen
dent 
and required an intact micro-filament system. 
Blocking of E rosette formation E rosette formation by HCs wa
s 
specifically blocked by an anti-T serum (which also stained a percentage 
of the HCs (Table 5.2)), but antisera to the Ia-like antigen, p29,34, 
Sig, or anti-hairy-cell serum (all of which also stained most HCs) did 
not block rosette formation (Table 5.4). The anti-T-cell serum did 
not block HC Sig rosette formation, although it did reduce yFc 
rosette 
formation from 65% to 47% (12.2.77). 
The effect of Sig removal The possibility existed that E 
rosette 
formation might be caused by Sig antibody activity which was no
t blocked 
by antisera directed against the Fe region of Sig. Sig was the
refore 
removed by stripping with antiserum and E rosette testing perfor
med on 
the Sig-negative cells. E rosette formation was not reduced by
 this 
treatment, and in some cases it was actually enhanced (Table 5.4). 
I 
I 
I 
I 
I 
I 
I 
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Table 5.3 Factors affecting E rosette formation+ 
E 
Control 
52 
84 
76 
52 
76 
84 
Treatment 
Cells cultured for 6 hand washed 
Cells cultured for 12 hand washed 
Formed rosettes . incubated 30 min 37°c 
Rosette formation at 4°c 
-1 Azide (10 M) 
Cytochalasin B (20 µg/ml) 
E 
after treatment 
76 
93 
2 
26 
18 
58 
+ Results from testing on different occasions. Some tests were 
repeated on different dates with similar results. 
-, 
il 
" 
ii 
:J I 
+ 
+ 
6 
* 
+ 
Type of 
Table 5.4 The effect of blocking with antisera 
and of removal of Sig on E rosette formation 
% E rosette formation 
* Experiment Control Anti-T + . 6 Anti-Ia AHS + Anti-µT . 8+ Anti-K Anti- Anti-y 
Blocking 52 0 59 51 59 53 36 
79 4 - 67 72 - 77 
Capping 
§ 52 65 69 66 
- - -77 66 77 65 
The anti-T cell serum blocked at 1/10 and 1/20 and had no effect on Sig rosette formation 
Antiserum to the p29,34 Ia-like antigen used at 1/20 
Anti-HC serum at 1/25 
Anti-Ig reagents blocked Sig rosette formation 
52 
82 
-
+ 
§ Sig shown to have capped with each of the antisera by direct immunofluorescence and by the failure 
of cells to form Sig rosettes 
" (j C 
4. DISCUSSION 
In this section, a case of HCL is described in
 which the 
morphologically typical HCs possess both Ban
d T cell surface markers. 
Analysis of the marker studies showed that se
veral B-cell and T-cell 
features were present on the same cell since 
the sum of cells possessing 
features of both usually greatly exceeded 100%
. 
Thus, the patient!s HCs possessed the B-cell 
features shown to 
be typical of HCL. They bore Sig and the Ia-
like antigen, and, splenic 
cells at least, synthesized cytoplasmic immu
noglobulin. A proportion 
of splenic HCs also formed rosettes with mous
e erythrocytes which is 
considered to be a B-cell marker (Siegal and Good, 1977
). 
However, a high percentage of the patient's P
B and splenic 
mononuclear cells both formed E rosettes and 
stained with an anti-T-
cell serum. In addition, formation of these 
E rosettes required 
conditions known to be necessary for E rosett
e formation by normal T 
lymphocytes (Jondal, 1976) and it was specifically block
ed with the 
anti-T cell serum but not by an antisera to t
he Ia-like p29,34 antigen 
or by an anti-hairy cell serum. Removal of S
ig did not reduce rosette 
formation, indeed in some tests this treatmen
t enhanced E rosette 
formation perhaps by clearing the membrane ar
ea surrounding the E 
receptor. Clearly E rosette formation was no
t caused by Sig antibody 
activity for an antigen on sheep erythrocytes
 as was described for a 
case of CLL in the last section. 
This patient's HCs therefore appeared to be t
rue hybrid cells with 
+ . + + + + + 
+ 
the surface marker profile: E, anti-T, µFe
, Sig, Cig, Ia, yFc, 
+ -Mo, C3b, EBNA. 
The existence of a human leukaemia with true
 hybrid cells bearing 
both an E receptor and Sig is not without precedent. Hsu et al, 
(1975) have reported a case of lymphosarcoma cell leukaemia in which 
sequential studies of leukaemic T cells revealed an increasingly 
large proportion of cells generating Sig. In addition, Brouet and 
Prieur (1974) have reported a case of CLL that may have been similar 
since it expressed Sig of restricted light chain type and rosetted 
with sheep erythrocytes, but no blocking studies were reported. There 
is also a recent report of an Ig secreting, human B-lymphoblastoid 
cell line which both binds an anti-T-cell serum and forms E rosettes 
(Pellegrino and Ferrone, 1978). 
Hsu et al, (1975, 1976) have emphasized the importance of 
sequential studies in unusual cases of this kind, since the marker 
profile may change and their case showed increasing Sig expression on 
E-positive cells. The present case appears to have been studied during 
. + + . 
a different transition with Sig, E cells gradually losing the E 
receptor. Thus shortly before the patient's infection and 'spontaneous 
remission', and subsequently, very few, if any, HCs are forming E 
rosettes. The high percentage of E-rosette forming cells observed in 
the most recent studies appear to be normal T lymphocytes by cytochemical 
and morphological criteria. 
no longer formed E rosettes. 
+ Also, the Sig HCs seen in bone marrow 
Certainly this work bears out Hsu's point 
about the necessity of sequential studies but the reasons for the 
changing phenotype remain unclear. 
Scattered cases of T-cell derived CLL have been reported 
(Brouet and Seligmann, 1977), and very occasionally such cases, while 
lacking Sig, have been shown to possess less definitive B-cell markers 
such as receptors for yFc and fixed C3 (Toben and Smith, 1977). These 
T-cell cases of CLL were frequently associated with unusual clinical 
features such as skin lesions (Brouet and Seligmann, 1977). Only 
one other case of HCL with T-cell features has been described (Saxon 
et al, 1978a), and the cells from this case did not possess any of 
the common B-cell markers. Like the present case, however, the cells 
were morphologically typical HCs and the patient was clinically and 
haematologically typical of HCL. 
Finally, the existence of cases of HCL with T-cell features provides 
additional evidence for the lymphoid, rather than monocytoid, nature 
of HCs. 
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CONCLUSIONS 
The classification of HCL and its position 
in a scheme of B-cell differentiation 
Hairy-cell leukaemia is a distinct clinicopathological entity 
in which characteristic mononuclear cells, whose most distinctive 
feature is the possession of numerous surface projections or hairs, 
circulate in varying numbers and infiltrate a variety of organs, 
especially the bone marrow and spleen. 
The first unequivocal recognition of HCL was by Bouroncle et al, 
(1958) who identified 'reticulum cells' with a serrated border in a 
group of 26 patients presenting a well-defined clinicopathological 
picture. The authors concluded that this constituted a distinct 
entity that they chose to term leukaemic reticuloendotheliosis. 
Subsequent work has amply confirmed this conclusion (Catovsky et al, 
1974b; Burke et al, 1974; Katayama and Finkel, 1974) and there is now 
wide recognition of this distinct disease entity. 
In the years following Bouroncle and colleague's classic paper, 
the terms leukaemic reticuloendotheliosis and the more descriptive 
hairy-cell leukaemia (Schnitzer and Kass, 1974) came to be regarded 
by many authors as syn~nymous, whereas in fact leukaemic 
reticuloendotheliosis originally had a broader usage covering what are 
now regarded as several distinct entities including monocytic leukaemia 
and a variety of non-Hodgkin's lymphomas, as well as HCL. The 
selection of this unfortunate name by Bouroncle et al may account, at 
least in part, for the large. munber of confusing terms which have 
been regarded as synonyms for the entity, but which have probably not 
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referred to HCL; these include histiocytic leukaemia, histioleukaemia, 
reticulosis, malignant leukaemic reticulo-histiocytosis and aleukaemic 
reticulosis (early literature reviewed by Bouroncle et al, 19581. 
Hence, confusion about the clinicopathological entity under consideration 
has been one of the reasons for controversy over the nature of the 
hairy cell and the term hairy-cell leukaemia is preferred. 
The early literature considered the HC to be derived from primitive 
undifferentiated reticulum cells whose normal progeny would have 
included cells of the lymphoid, myeloid and monocyte-macrophage series 
(Bouroncle et al, 1958; Mitus et al, 1961). The hybrid features of HCs 
are readily understood in terms of this scheme, but since more recent 
work has shown that the lymphoid and monocytoid series develop independ-
ently from a very early stage, the existence of such a hybrid cell type 
has proved both intriguing and perplexing to immunologists and 
haematologists alike. 
Many of the monocytic features of HCs can possibly be explained 
by the nature of the cell membrane. In almost all manipulations HCs 
are 'sticky': they tend to clump together during handling and before 
any immunological tests they must be very thoroughly washed and 
dispersed, much more than normal lymphocytes. In lymphocytes, the hairs 
are microvilli (MV) which can be quite well visualised with immuno-
peroxidase staining; indeed with this technique a proportion of normal 
circulating lymphocytes (many of which are SigG positive) appear quite 
hairy (Mason et al, 1977). It is likely that the expression of MV on 
circulating lymphocytes corresponds to an 'activated state' making 
the cells capable of recognising the endothelial cell wall and to adhere 
to it (reviewed by Loor, 1977). Thus the quiescent state of 
lymphocytes is characterized by a smooth surface. To enter the specific 
~OJ 
homing area in the lymphoid organs they have to pass between the 
high endothelial cells forming the wall of the post-capillary venules, 
which are the main site of entry of lymphocytes in lymph nodes. In 
these venules, the lymphocytes become quite villous and it has been 
proposed that they use MV to adhere to the endothelial wall and that 
they progressively lose the MV as they traverse the wall to arrive 
smooth in the specific homing area (Loar, 1977). 
It is proposed here that HCs are lymphocytes 'frozen' at the 
villous 'activated state'. This theory accounts for some of the 
monocytic features of HCs. In Chapter 4 it was demonstrated that while 
HCs adhered to glass and plastic, they were only weakly phagocytic 
for latex (with occasional exceptions) and were not professional 
phagocytes. Cell adherence to glass and plastic is a function of 
microvilli (Loor, 1977), and it can be argued that weak phagocytosis 
of latex is a function of most cells but made much more conspicuous in 
HCs because of the strong attachment phase caused by the 'sticky' 
microvilli. Such a hypothesis might also explain the frequent 
appearance of nucleoli in cells which are otherwise morphologically 
mature, and possibly accounts for the failure of HCs to populate lymph 
nodes since they cannot complete the smooth phase required for homing; 
however this last point may reflect the marker phenotype and ontogenic 
maturity of the cell (see below). 
The only convincing evidence left favouring a monocytic origin 
for HCs is the presence of a strong yFc receptor which deforms 
attached indicator erythrocytes and is not blocked by anti-Ia-like 
antigen. However this type of receptor is also a feature of the 
unidentified cell group (UCG: K cells, L cells, null cells Chapter 3). 
The UCG is heterogeneous both in markers and function (Chess and 
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Schlossman, 1977) but it generally agreed that this group contains 
cells with a strong yFc receptor and with the ability to mediate 
antibody dependent cell-mediated cytotoxicity (ADCC). HCs have not 
been properly tested for the ability to induce ADCC but it is of 
some interest that this can, on occasion, be brought about with IgM 
antibody (Wahlin et al, 1976; Fuson and Lamon, 1977) which suggests 
a µFe receptor. A population within the UCG can synthesise and 
secrete immunoglobulin (Chess and Schlossman, 1977), and when sensitive 
methods of Sig detection are employed only a very small population of 
non-T Sig-negative cells can be identified (Strelkauskas et al, 1975; 
Haegert, 1978; Haegert et al, 1978). These results suggest that at 
least some of the UCG might be B lymphocytes, and while there is 
controversy about the incidence of yFc receptors on B lymphocytes 
(Gergely et al, 1977), some B cells, at least, possess this receptor . 
The other evidence throughout this thesis favoured a B-lymphocyte 
origin for the HC. Moreover, several pieces of evidence suggest that 
HCs derive from a cell which occurs late in B-cell differentiation. 
A number of partly theoretical schemes of B-cell development in man 
have been proposed (Cooper et al, 1973; Cooper and Seligmann, 1977; 
Sweet et al, 1977), and while much of the information has come from the 
study of B-cell malignancies (and it is therefore rather artificial 
to reintroduce malignant cells), it is of some interest to establish 
the relative position of HCL. One scheme of B-cell development is 
shown in Figure 6.1. The scheme was constructed from the information 
obtained in a detailed marker study of the plasma cells from 25 
patients with a range of immunoproliferative diseases including IgG, 
IgA, IgD, IgM and IgE myeloma (Burns et al, 1978d). For the purpose 
of this discussion, the IgG memory cell loop has been added, and it is 
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Figure 6.1 Schematic representation of the terminal stages of 
B-cell development. 
Key )/ Predominant Sig of a given class 
y Sig of a given class weakly expressed 
I la-like antigen 
• C3 receptor(s) 
Q (!3 receptor (_s) weakly or partially expressed 
A. yFc receptor strongly expressed 
~ yFc receptor weakly expressed 
µFe receptor 
-· - - -+ Intermediate steps unknown, if they exist. 
L cytoplasmic light chain (Kor A) 
The scheme is based partly on results in the dissertation and in a 
separate .study (Burns et al, 1978d), but some stages are obtained, or 
confirmed, from previous studies and from the reports of others -
these references are numbered and given below. 
1. Dhaliwal et al, 1978. 
2. Burns et al, 1978a. 
3. Parkhouse and Cooper, 1977. 
4. Preud 'homme et al, 1977a. 
5. Cooper and Seligmann, 1977. 
6. Burns et al, 1978c. 
7. Coffman and Cohn, 1977. 
8. Burns et al, 1977c. 
9. Black et al, 1978. 
10. Gathings et al, 1977. 
11. Cawley et al, 1978. 
12. Preud 'homme and Seligmann, 1974. 
13. Ferrarini et al, 1976b. 
14. McConnell, 1971. 
15. Preud 'homme et al, 1976. 
271 
conceded that there are possibly similar loops for the other isotypes 
and that the scheme is oversimplified. 
Leukaemic cells may express neoantigens or receptors which are 
not the result of development along the B-cell pathway. Nevertheless 
several features suggest that HCs are memory cells. In relation to 
Figure 6.1, it is suggested that most HCs occupy the final stage of 
the IgG memory cell circuit whereas CLL cells would mostly derive 
from the first stage. Thus the features of multiple heavy chain Sig 
isotype (Gathings et al, 1977) and, in particular, SigG expression 
and secretion (Coffman and Cohn, 1977; Parkhouse and Abney, 1977; 
Zan-Bar et al, 1978; Black et al, 1978) _are features of B memory cells 
in the mouse. Also, it has been suggested that a slow Sig replacement 
time is a feature of memory cells (Melchers et al, 1975; Lewis et al, 
1976). 
The loss of the C3 receptor illustrated in the figure is a 
constant feature of all types of plasma cells and appears to have taken 
place in the memory circuit as well; this may start with the loss of 
C3b as for CLL cells (Ross and Polley, 1975) which do not carry 
a C3b receptor but still bear a C3d receptor, but HCs bear neither 
receptor. The yFc receptor is weakly expressed by plasma cells which, 
however, lack the Ia-like antigen. As was discussed above HCs bear 
a strong yFc receptor which perhaps suggests a more complex memory 
circuit than illustrated. 
One weakness of the scheme, as illustrated, is the emergence of 
the µFe receptor on the memory circuit (proposed CLL and HCL counterparts). 
Most of the other receptors are progressively shed with maturation and 
it is therefore unusual for a new membrane marker to arise. This may 
represent a neoantigen feature. However, a subpopulation of normal B 
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cells express a µFe receptor (Ferrarini et al, 1977) and it can be 
argued that the receptor becomes revealed with the loss of the C3b 
receptor and only continues on memory cells. The function of the 
µFe receptor, incidentally, remains obscure, but in their discussion 
of a similar receptor on mouse peritoneal macrophages Ehlenberger 
and Nussenzweig (1976) suggest that the IgM-antigen complex is bound 
but not interiorised by the receptor, and thus remains exposed and 
available for the stimulation of immunocompetent cells. 
The distinctive clinical picture of HCL - bone marrow replacement 
and splenomegaly without prominant lymphodenopathy - presumably reflects 
the migratory pattern of HCs. Little is known about the various factors 
influencing cell migration (reviewed by Sprent, 1977) but it is thought 
that surface markers play a role, and certainly the Sig isotype has 
some effect on the migratory properties of cells. One example relevant 
to HCL is the absence of receptors for complement on HCs. Splenic 
histiocytes do not bind EAC reagents whereas lymph node histiocytes 
do (Shevach et al, 1973; Jaffe et al, 1974). Also, low concentration 
trypsin treatment of lymphocytes before injection completely prevents 
localization of the cells in lymph nodes and leads to above normal 
numbers homing to the spleen. After several hours the cells begin to 
enter lymph nodes, and this capacity can also be restored by 
in v,l;tJr.o culture for 6-12 h before transfer. This reversal of the 
homing defect is temperature dependent and requires protein synthesis 
(Sprent, 1977). These data suggest a role for a trypsin-sensitive 
surface receptor in the control of lymph node, but not splenic, homing 
capacity: the complement receptor on lymphocytes is trypsin sensitive 
(Lay and Nussenzweig, 1968) and might therefore be the receptor in 
question. 
I 
I 
I 
I 
I 
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To conclude, the work described in this thesis suggests that 
HCL is a clonal proliferation of a population of memory B lymphocytes 
'frozen' at an activated state. 
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Additional publications submitted during the period of research 
for the dissertation but unrelated to the main thesis. 
Burns, G.F., Cawley, J.C., Barker, C.R., Worman, C.P., Raper, C.G.L. 
and Hayhoe, F.G.J. (1978) Differing surface marker characteristics 
in plasma cell dyserasias with particular reference to IgM myeloma. 
Clinical and Experimental Immunology, l!_, 414. 
Burns, G.F., Cawley, J.C., Flemans, R.J., Higgy, K.E., Worman, C.P., 
Barker, C.R., Roberts, B.E. and Hayhoe, F.G.J. (1977) Surface 
marker and other characteristics of Gaucher's cells. Journal of 
Clinical Pathology, 2£, 981. 
Hayhoe, F.G.J .• , Burns, G.F., Cawley, J.C. and Stewart, J.W. (1978) 
Cytochemical, ultrastructural and immunological studies of 
circulating Reed~Sternberg cells. British Journal of Haematology, 
~, 485. 
Higgy, K.E., Burns, G.F. and Hayhoe, F.G.J. (1977) Discrimination of 
B, T and null lymphocytes by esterase cytochemistry. Scandinavian 
Journal of Haematology, 18, 437. 
Karpas, A., Gulzar, G., Burns, G.F. and Hayhoe, F.G.J. (1978) 
Continuous culture of malignant haemic cells from human acute 
myelomonocytic leukaemia: cytological, cytochemical, cytogenetic 
and immunological studies. British Journal of Cancer, I]_, 308. 
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